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Abstract 
Background 
The Clinical Research Nurse (CRN) workforce has developed alongside a 
growing National Health Service (NHS) research infrastructure. However, 
evidence suggests this workforce is isolated with minimal awareness in acute 
trusts of the work of CRNs. There is a lack of evidence concerning how best to 
structure CRN teams within acute trusts. 
Aim  
The overall aim of the study was to explore how the CRN workforce is currently 
organised within NHS Acute trusts, to explore the experience of CRNs working 
within acute NHS Trusts and determine the most effective way to structure this 
workforce.  
Methods 
A sequential mixed methods design was used. Phase 1 comprised a national 
online survey sent to Lead CRNs in acute NHS trusts and a statistical analysis 
of National Institute of Health Research study recruitment data over the period 
2010-2016. The survey response rate was 77% (111/144).  Survey analysis 
used descriptive statistics and thematic analysis. Phase 2 comprised four 
purposively sampled organisational case studies which included 14 semi-
structured interviews and 4 focus groups. Qualitative data were thematically 
analysed using NVIVO 10.  
Findings 
Over the last fifteen years the CRN workforce has evolved in a reactive and 
inconsistent manner, shaped by local and external influences. The effect of 
reviewing CRN workforce structures was found to have a statistically significant 
effect on recruitment into interventional studies. Lead CRNs have an important 
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role in providing leadership and direction for the workforce and a link to clinical 
nursing colleagues. The current NHS climate means research delivery can be 
difficult and often overlooked as it is not perceived as a priority. The level of 
support and understanding from clinical nursing colleagues impacts CRN 
experience.  
Recommendations 
- Organisations should ensure the CRN workforce is well led with the 
establishment of a Lead CRN post. 
- A CRN workforce model is proposed to provide a suggested framework. 
- Work should be undertaken to address the lack of understanding of 
research and the CRN role. 
- R&D Departments should consider the timing of a full review of their 
CRN workforce. 
- Work is needed to understand the role of the emerging non nursing 
workforce within research. 
Conclusion 
Development of well-structured CRN teams supported by a local leader with 
formal links into internal stakeholders is key. Improving integration of the CRN 
workforce into existing organisational structures and processes will raise the 
profile of research and may facilitate a longer term shift in attitudes.  
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Chapter 1: Background 
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1.1. Introduction 
The Clinical Research Nurse (CRN) workforce is now present within most NHS 
acute trusts although over looked in comparison to the more conventional 
clinical nursing role. Over time this relatively unstudied - but growing - nursing 
workforce has taken root within the NHS but it is one which lacks visibility and 
wider awareness of its functions. This study seeks to enable a better 
understanding of this national workforce and understand the contemporary 
experiences of CRNs working within it.  
The focus of this thesis is to explore the experience of Clinical Research Nurses 
(CRNs) working within acute National Health Service (NHS) Trusts and 
determine the most effective way to structure the CRN workforce. In this context 
this background chapter will examine the growth of the CRN role and workforce 
since the 1980’s and the influences that have shaped this. The origins of clinical 
research and its importance to healthcare, as well as the external influence of 
the pharmaceutical industry, are discussed in relation to the CRN role and its 
development within the NHS. Key policies and legislation are highlighted 
including the more recent role played by the Department of Health. 
1.2. The History of the Role of the Clinical Research Nurse 
The role of the Clinical Research Nurse (CRN) has developed over the last 30 
years. CRNs are now an established part of the nursing workforce across NHS 
organisations. This has taken place due to the many developments within NHS 
research infrastructure over this period including a change in the management 
and organisation of funding streams available to support research, as well as 
increasing attention to research governance requirements in order to ensure 
patient safety  
The ongoing development of effective pharmaceutical treatments to improve 
patient care - supported by the pharmaceutical industry - has in part been the 
catalyst for the development of the CRN role. Statins are an example of a novel 
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treatment; launched in the UK in the 1990s this new class of drugs are now 
used worldwide and have led to a 50% decrease in deaths from heart attacks 
and strokes (Fox et al 2007). Today an estimated 30 million people are 
prescribed statins and millions of lives have been extended (Endo 2010).  What 
started with the identification, by a Japanese scientist in 1976, of an enzyme 
involved in the metabolism of cholesterol, led to a successful drug development 
programme comprising 14 clinical trials and 91,000 patients (Stossel 2008).  
Conduct of pharmaceutical studies such as these was supported by CRNs. This 
led to an eventual market leader in the management of one of the most 
prevalent diseases of the 20th century, so demonstrating the importance of 
clinical research and the impact that it can have on disease and health.  
1.3. Origins of clinical research and the mistakes of the 
past 
The early evolution of a robust structure and governance support for clinical 
research began in the 1970s and 1980s following examples of previous 
unethical practices. The Nuremberg Code was created in 1947 following the 
Nuremberg Trials which unveiled details of the atrocities and unethical 
experiments carried out on Jewish prisoners during the Second World War. 
Later, the Tuskegee Syphilis study enrolled 400 Afro-American men diagnosed 
with asymptomatic syphilis and aimed to see the effect of syphilis on this group. 
Even when penicillin became the standard cure in 1947 these men remained 
untreated. This lack of treatment and unethical research practice led to many 
early deaths as well as transmission of the disease to partners and children 
(Gorbie-Smith, 1999)  
History has demonstrated the negative impact of insufficient research and 
knowledge around a newly licensed drug and how - when used without 
sufficient ethical oversight - individuals could be at risk of abuse and 
exploitation. The Thalidomide disaster of the late 1950s and early 1960s led to 
the birth of approximately 10,000 babies worldwide with phocomelia (shortened, 
absent, or flipper-like limbs). Despite limited and poorly conducted research, 
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women around the world had been recommended Thalidomide as a treatment 
for morning sickness.  This is a catastrophic example of the human impact of a 
lack of sufficient research and oversight.  
As a result the pharmaceutical regulation industry emerged in the late 1960s. 
Within the United States the Food and Drug Administration (FDA) introduced 
amendments that required manufacturing companies to prove that a drug was 
not only effective but also safe. Approvals had to be based on sound science 
and companies had to introduce additional post marketing surveillance to 
monitor safety reports. Across Europe countries had already started to work 
together to enhance economic development. The European Economic 
Community (EEC) had begun in 1957 with the Treaty of Rome and the 1960s 
and 1970s saw the publication of a series of EU directives which focused on 
defining standards and practices for the development of new pharmaceutical 
drugs. The World Medical Association published the Declaration of Helsinki in 
1964. Still seen today as a key document it defined the ethical principles for 
medical research involving human subjects. These guidelines form the 
foundation of the research governance structure that was to develop towards 
the end of the century (Shah and Griffin 2003). 
1.4. Development of the Clinical Research Nurse role 
A CRN is described as being “employed principally to undertake research within 
the clinical environment” (UK Clinical Research Collaboration – UKCRC 2007). 
The main remit of their role within the NHS is to manage the set up and running 
of research studies and to oversee the care of patients treated within a research 
study.  This includes ensuring all approvals are in place prior to commencement 
of a study, informing patients of the study prior to obtaining written consent and 
managing trial related appointments and investigations during the study. The 
CRN becomes the patient’s advocates and often a source of support for them 
throughout their treatment pathway. The CRN will also support the patient 
during any treatment side effects or incidences that occur during the study. 
Known as adverse event reporting, this is part of the large amount of data 
collection for which CRNs are responsible (Coulson and Phelan 2000). 
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The CRN role has not always been part of the nursing workforce. Its early 
development was initiated by the pharmaceutical industry and their need for 
some dedicated support within drug development programmes. By the early 
1980s nurses could be found working in Phase 1 units and caring for healthy 
volunteers participating in the studies. Phase 1 studies are the first in a series of 
stages within the development of a new drug. Within phase 1 the drug is tested 
on a small number of volunteers in order to determine the maximum tolerated 
dose. A further explanation of the phases of drug development is provided in 
table 1.  
Table 1.4-1 Phases of Clinical Trials 
Phase of Study Description  
I Initial safety trials on a new medicine. Involves small numbers of healthy 
volunteers and aims to assess safety and not efficacy.  
II Small scale studies on relevant patient population.  Objectives may 
focus on dose-response, type of patient, frequency of dosing, or other 
safety and efficacy characteristics. 
III Involve larger numbers of patients with the relevant disease. Compares 
the new drug against an existing treatment within the same class or a 
placebo to see if it's better in practice and identify any relevant side 
effects. Following this phase all information is submitted to the regulatory 
Authorities for license approval. 
IV Post marketing studies or trials conducted to provide additional details 
about the medicine's efficacy or safety profile. 
1.5. Set up of the CRN role within the NHS 
The literature available on the development of a specialist nursing role within 
the hospital setting specific to research and clinical trials is - at best - anecdotal; 
explanations of how the role evolved are most commonly found in discussions 
with those directly involved at the time. Initially, early studies involving hospital 
patients were supported and run by clinician’s with direction from 
pharmaceutical companies; the companies provided some suggested practices 
in the form of guidelines as to how research using human volunteers should be 
conducted. Nurses were not directly involved in research developing new drugs; 
rather the pharmaceutical companies would approach clinicians’ directly to carry 
out studies on new drugs under development prior to submission to the 
licensing authority. However, during the 1970s and 1980s nurses began to be 
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employed as research nurses. This was an informal process as the role was not 
developed within the profession and progression to it was generally related to 
an opportunistic discussion by a ward based nurse with a research minded 
clinician who wanted support for their study within a hospital setting.  
Within the UK nurses were beginning to specialise in clinical areas, informed by 
developments within the United States where the phrase “Nurse Clinician” had 
been coined in the 1940s to describe a nurse with advanced education and 
clinical competence who remained actively engaged in clinical practice (Reiter 
1966). This new role –  termed a clinical nurse specialist (CNS) - was described 
as “a graduate professional nurse who is an expert practitioner because she 
has a broader  knowledge, deeper insight and appreciations, and greater skills 
than those that can be acquired in a basic nursing course of generally accepted 
standards” (Mayo 1944: 580). This CNS role began to be adopted in the UK in 
the 1980s, typically within specialist areas such as oncology. Although not 
identified as such, a small amount of nurses began to shift the focus of their 
nursing career towards the specialism of research and by the mid to late 1980s 
the nursing press began to identify substantive roles within a hospital setting. 
So the CRN role was evolving at the same time as the more general CNS role.  
Within the same decade Clinical Research Units were beginning to develop to 
support the pharmaceutical industry in the early drug development process. 
The Drug Development Unit at Guys Hospital in London was opened in 1983 
and two research nurses were appointed. This role initially involved treating 
volunteers in Phase 1 studies covering activities such as taking blood pressure 
measurements and entering data. At this point it did not include taking blood 
samples as this was still very much seen as a clinician’s responsibility. 
However, within a few years the role had begun to expand in order to 
adequately support the needs of the studies. The nurses began to take on tasks 
such as the taking and processing of blood samples. This involved being trained 
on new pieces of equipment and so the responsibilities of the role began to 
develop. Within the research field the role was developing faster than the 
profession. There were few nurse specialists posts developed within other 
 Page 19 
areas and it remained a rare requirement for a nurse to be trained in 
venepuncture. 
1.6. Influence of the pharmaceutical sector on CRN role 
development 
Worldwide drug development was also seeing progress and changes that would 
have some impact on the developing role of nurses in clinical trials research.  
Simbec Research, now one of Europe’s leading contract research organisations 
specialising in early clinical research services for the international 
pharmaceutical industry, was founded in 1976 in the back garden of one of its 
founders. Within three years it was awarded the title Small Company of the 
Year by the BBC for its pioneering work post the thalidomide tragedy. Quintiles, 
now the world’s largest provider of biopharmaceutical development, was 
founded in America in 1982 and opened its first UK site in 1987 (Quintiles 
2013). It sought to support pharmaceutical phase 1 drug development and 
quickly became recognised for its role in this process. These new research 
companies began to recruit nurses to support participants within the studies, 
further acknowledging their important role in the research arena. UK based 
pharmaceutical companies such as Roche and Glaxo also had on site phase 1 
units staffed by nurses to care for participants enrolled in their research studies. 
This helped to further recognise the emerging role of the research nurse as this 
group began to develop skills in phase 1 research. 
The development of guidelines to ensure international consistency within drug 
development began to create an ongoing requirement to ensure and confirm 
adherence. Within the drug licence application system pharmaceutical 
companies were keen to demonstrate that they had adhered to this now 
internationally recognised gold standard. The ongoing development of a CRN 
role provided a dedicated individual to ensure this and also a link between the 
clinician and pharmaceutical company. 
 Page 20 
1.7. Added impetus to the development of the CRN role 
The late 1990s saw significant time points in the development of the research 
arena, impacting on the emerging role of the CRN and the need for a dedicated 
workforce to support this process. Two significant reports were commissioned in 
the 1990s following events surrounding patient deaths at two UK hospitals. The 
Bristol Royal Infirmary inquiry was set up in 1998 to investigate the deaths of 29 
babies undergoing heart surgery in the late 1980s and early 1990s. This led to 
the revelation of events at the Alder Hey Children’s Hospital in Liverpool where 
details began to emerge of children’s organs being retained after their death 
without parental consent or knowledge. As the details of organ retention at 
Alder Hey began to come to light the public learned that such practices went 
back decades. An investigation was opened in 1999 and when the report was 
published two years later it revealed that that during his time at the hospital the 
Dutch pathologist Dick van Velzen had systematically ordered the unethical and 
illegal stripping of every organ from every child who had had a post-mortem 
(House of Commons 2001).   
1.8. Growth of Research Governance 
As a result of the Alder Hey and Bristol enquiries the laws governing the taking 
and storage of blood and tissue for research were reviewed. In 2006 the Human 
Tissue Act was published and became incorporated into British law. The law 
specifically focuses on consent of the individual and established an updated 
legislative framework for regulating the removal, storage, and use of human 
organs and tissues (Price 2005). It also established the Human Tissue Authority 
to oversee implementation and adherence of the legislation. A growing research 
governance structure was developing that provided further rationale for a 
dedicated workforce to ensure implementation and adherence. However, no 
national structure or model was in place; roles were generally developed 
reactively across organisations with no oversight of the workforce.  
An important addition to the growth in research governance was the 
development of the principles of Good Clinical Practice (GCP). Now recognised 
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and adhered to worldwide it forms the beginning of an emerging governance 
structure that necessitated a dedicated workforce to support adherence, sound 
science, production of robust clinical research data and ongoing patient safety.  
Throughout the 1980s many countries began to independently develop their 
own guidelines related to the ethical conduct of research based on the 
Declaration of Helsinki. The World Health organisation brought these together in 
1993 and in 1995 published the first GCP document (Otte et al 2005). In order 
to ensure greater international consistency within drug development the 
International Conference on Harmonisation (ICH) brought together the EU, 
Japan and the United States; the first ICH GCP guidance document was 
published in 1996. This set the standards in clinical research to ensure the 
protection of the rights and safety of trial participants and ensure the quality of 
the data.  
However, within the UK, the GCP document was not linked to those hospital-
based academic studies which did not involve drugs. Throughout the 1990s the 
Department of Health (DOH) had been undertaking a thorough examination of 
research and development within the National Health Service (NHS). This led to 
the publication of the Research Governance Framework (RGF) in 2001 which 
laid out the principles of how hospital based research should be undertaken and 
the responsibilities of the individuals and organisations that were carrying it out. 
Since 2004 it has been mandatory for NHS trusts who host research to have 
systems in place to ensure that the standards and principles set out in the RGF 
are met.  
1.9. Department of Health influence on the growth of the 
CRN workforce and the establishing of a structure 
DOH policy and strategy has supported a growth in research infrastructure. In 
2000 it published the NHS Cancer Plan which identified a need for a greater 
focus on research to enhance patient care and treatment options. This led to 
the creation of the National Cancer Research Network (NCRN) and a system of 
32 cancer research networks which would help support the greater involvement 
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of patients within research. Funding was provided to support the appointing of 
CRNs to work on these cancer research studies. 
Within a few years the success of the NCRN was evident and by 2006, 14% of 
all oncology patients were being treated as part of a clinical trial, over three 
times that of baseline activity. In addition, nearly three hundred NCRN research 
nurses had been appointed and were working across the networks on a 
portfolio of 431 studies (NCRN 2006). The development of the NCRN had seen 
the first dedicated funding from the DOH being directly allocated towards 
establishing nursing roles to support research studies. It also provided a 
mechanism for researchers to widen the number of organisations who would be 
able to support their study.  
This in part led to the DOH publishing a further document in 2006; “Best 
Research for Best Health”- a new five year Research and Development (R&D) 
strategy. Its aim was to improve the health and wealth of the nation through 
research and one of its goals was to “Attract, develop and retain the best 
research professionals to conduct people based research” (DOH 2006:2). This 
document recommended the establishment of the National Institute of Health 
Research (NIHR) which aimed to: “create a health research system in which the 
NHS supports outstanding individuals, working in world-class facilities, 
conducting leading-edge research, focused on the needs of patients and the 
public”. (DOH 2006:5). This publication proved to be another significant time 
point in the development and growth of the CRN workforce.    
The development of the NIHR infrastructure over the next 2-3 years saw the 
implementation of a system that was to directly impact the CRN workforce. A 
system of topic specific research networks, each focusing on a clinical area, 
was developed as well as a generic research network, known as the 
Comprehensive Local Research Network (CLRN) (appendix 1). This became 
the route by which acute hospitals received the majority of their annual 
allocation of research funding from the NIHR. Funding was also allocated 
towards establishing dedicated research units within hospitals known as Clinical 
Research Facilities (CRFs) as well as centres of excellence known as 
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Biomedical Research Centres (BRCs) or Biomedical Research Units (BRUs). 
With all of these units came additional funding which supported the further 
development of a range of research focused posts including research nurses. 
Once fully established the NIHR comprised 102 research networks within a 
system of 8 network topic specific structures (appendix 1). Although successful 
in its work to continue the development of research within the NHS, by 2011 this 
system was thought to require improvement as there was recognition that 
variation in practice was putting the system at risk (Corbett-Nolan 2011). In 
2011 the Good Governance Institute was asked to review the existing 
governance arrangements for clinical research networks. Their main 
recommendation was that the current system should be changed to create a 
rationalised, geographical pattern of networks (Corbett-Nolan 2011). From April 
2014 the NIHR changed to a system of 15 geographical research networks as 
illustrated in Figure 1.9-1. The Clinical Research Network is made up of 15 
Local Clinical Research Networks that cover England (see Figure 1.9-1). Each 
individual network comprises 30 clinical specialties within 6 divisions (appendix 
2). 
 
Figure 1.9-1 NIHR structure (April 2014 onwards) 
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1.10. The National Institute of Health Research (NIHR) 
The establishment of the NIHR has had an enormous impact on research within 
the NHS. In 2014/2015 just under 620,000 people took part in studies hosted by 
the NIHR Clinical Research Network (NIHR 2016) and now all NHS Trusts are 
now involved in research (NIHR 2014a). It is recognised as the research 
delivery arm of the NHS and functions to achieve its high level objectives which 
include to “increase the number of participants recruited into NIHR Portfolio 
studies” and to “increase the proportion of studies in the NIHR portfolio” (NIHR 
2015).  
Understanding the mechanisms within the NIHR is key to further understanding 
the important role it now holds within NHS research. “Research delivery” is of 
relevance to all those funded by the NIHR and an understanding of its 
mechanisms highlights the important role held by the CRN workforce within this. 
Research delivery has been defined as “all the elements, systems and 
processes and governance that need to be in place to ensure research is 
effectively delivered within the NHS” (personal communication with C Morgan, 
Research Delivery Director, October 2016). Research delivery incorporates the 
running of patient centred research studies for which the CRN role is key. 
An NIHR study is known as a “portfolio study” which means it has met the 
specific eligibility criteria defined by the NIHR and is now listed (known as 
adopted) on their database of studies (NIHR 2017). Portfolio studies are divided 
into two categories -interventional or observational. An observational study has 
been defined as “observing natural relationships between factors and 
outcomes”  whereas interventional studies,  also called experimental study 
designs, are those “where the researcher intervenes at some point throughout 
the study” (Thiese 2014: 199). Examples include studies developing new drug 
treatments or new surgical techniques.  Adoption onto the portfolio is a favoured 
status as once achieved; researchers are able to access local research support 
to help run the study including the support of CRNs and other healthcare 
professionals and research staff. 
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The NIHR operates a system of “activity based funding”. Within this a large 
amount of the funding is allocated to organisations based on the numbers of 
patients who are recruited onto portfolio studies. Therefore, the greater amount 
of patients recruited leads to higher levels of NIHR funding to support further 
recruitment the following year. Hence there is a significant focus by 
organisations on recruitment to ensure the continuation of the funding. 
1.11. Background to Research Project 
A developing research infrastructure and the growth of the CRN role across the 
NHS supported the overall growth and establishing of a national CRN 
workforce. Within the first few years of the NIHR being established it was 
recognised that there was an ongoing increase in the number of CRN posts 
being developed. However, there was a lack of evidence to describe the 
national picture and a lack of understanding as to how the structure of the 
national CRN workforce had developed. Only estimates could be given as to the 
size of the overall workforce. Pidd et al (2013) forecast a workforce of 10,000 by 
2013 but this figure lacked empirical evidence.  
The development of the UK research infrastructure led to the recognition of the 
need for a centralised research system to co-ordinate the employment, 
management and development of CRNs (Ledger et al 2008). This developed 
infrastructure has demonstrated that the UK government has acknowledged the 
benefits to be derived from a well organised high quality system of research 
networks (Chester 2007). Ledger et al (2008) reported on the first organisation 
to review their CRN workforce and introduce a model for recruitment, 
employment, line management, training and development. Since this initial 
report other organisations had followed but the number and location of these 
was unknown. It was known, however, that there were sporadic unpublished 
organisational reviews of the CRN workforce but no accurate data on their 
numbers or review outcomes. There was also minimal data on the experience 
of CRNs within acute NHS trusts although many had published anecdotal 
reports of their own experiences.  
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Therefore this was planned as the first national study which aimed to provide a 
clearer understanding of the number of CRNS working across the UK and 
identify all UK acute NHS Hospital Trusts which have reviewed their CRN 
structure. Use of the word “review” was intended to mean a formal assessment 
of the roles and structure of the CRN workforce.  The study aimed to explore 
how the CRN workforce is currently organised within NHS Acute trusts, to 
explore the experience of CRNs working within acute hospital trusts and to 
determine the most effective way to structure the CRN workforce.  
The overall objectives of the study were: 
- To identify acute hospital trusts which have reviewed the structure of their 
CRN workforce. 
- To identify which acute hospital trusts have subsequently introduced a 
new structure. 
- To explore how the CRN workforce is currently organised within NHS 
Acute trusts using a quality framework.  
- To explore and compare the experience of Clinical Research Nurses 
within different organisations using a quality framework. 
- To explore the experience and perception of senior research staff (R&D 
Directors, Lead CRN and Principal Investigators) concerning the 
research nurse workforce within their organisation. 
 
1.12. The Researcher 
This work was planned and carried out by an experienced research nurse with 
over 20 years’ experience of the role and clinical research. Having spent most 
of my career working as a research nurse I have seen the development of the 
research nurse role and the impact of the NIHR and the establishment of a 
national infrastructure. When I commenced my first research nurse post in 1994 
there was minimal awareness of the role and research nurses were often 
isolated from their nursing colleagues with post holders generally being 
appointed by Clinicians and based within medical teams. With a growth in 
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research governance including Good Clinical Practice and the Research 
Governance Framework and the set-up of the National Cancer Research 
Network (NCRN) and the NIHR, I experienced not only an increase in the 
awareness and understanding of the role but a development of a new workforce 
within nursing. My early research nurse roles were based within small research 
teams with one or two research nurse colleagues. However, by 2007 I was 
working as a Lead Research Nurse within a large oncology research team. 
Therefore I had experienced first-hand the development of the workforce and 
the establishing of dedicated research nurse teams.  
My current role as a Lead Research Nurse within a large acute teaching trust 
has enabled me to link in with similar post holders across the country. Through 
this national network we have been able to share best practice. Therefore at the 
commencement of this study I had access to a group of peer colleagues, many 
of whom were equally aware of the development in research and the CRN role. 
This provided an accessible starting place for my initial data collection to 
support the overall study objectives. 
1.13. Summary 
This background chapter has provided an overview of key influences in the 
development of the CRN role over the last 30 years. Within this it has sought to 
describe the parallel development of the research structure within the NHS, the 
role of the Department of Health in supporting this and the increasing 
governance around research to ensure that patient safety remains of paramount 
importance. It has set the scene for the rationale for this study and 
demonstrated why the researcher is best placed to carry out this work. The 
NIHR is now thought to fund a large amount of the CRN workforce which in turn 
provides support for portfolio studies. The following chapter will review the 
current evidence in relation to the structure of the CRN workforce and 
experience of CRNs within it. This will provide further evidence and justification 
for this study. 
 Page 28 
Chapter 2: Literature Review
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2.1. Background 
Clinical Research Nurses (CRN) are crucial members of the research team who 
acquire highly developed skills in multiple areas relating to the research process 
(Hill and MacArthur 2006). They have been described as a vital link between 
patients, principal investigators, the study sponsors and administrative staff 
(McKinney and Vermeulen 2000) and their positive impact on patient 
recruitment has long been demonstrated (Isaacman et al 1996). They are seen 
as having a key role in the conduct and support of research projects (Coulson 
and Grange 2012); their patient focused role gives them unique insights into the 
practical issues around research that are necessary to make it applicable to the 
development of ongoing evidence based care and treatment (United Kingdom 
Clinical Research Collaboration – 2007, Finch Report). 
However, the role is often confused with that of a nurse researcher and the 
terms are often used inter changeably with a lack of awareness of the 
differences. Authors have tried to overcome this by describing the differences 
between these two roles (Deave 2005, Jones 2015), not least to help nurses to 
decide their chosen research career pathway. The CRN role involves working 
on projects related to treatments and patient care where as nurse researchers 
work on projects which are based on the acquisition of new knowledge related 
to the progression of nursing. There is however, recognition that CRNs are 
ideally placed to become nurse researchers and move between the two roles.  
CRNs are now part of the nursing workforce in most if not all NHS acute 
hospital trusts and present in many clinical specialities.  Their role has been 
described in clinical areas such as oncology (Bird and Kirshbaum 2006), 
diabetes, (Chester et al 2007), primary care (Walsh 2010) and paediatrics 
(Coulson and Phelan 2000). The increasing size of the national CRN workforce 
has supported a rise in the recognition and importance assigned to it from 
numerous high profile organisations. These include the Royal College of 
Nursing (RCN) and the National Institute of Health Research (NIHR). The RCN 
views CRNs as one of the “fastest growing specialism’s in healthcare delivery” 
and now has dedicated pages within their website to provide information and 
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direction for those interested in pursuing the role as a career (RCN, 2017). The 
NIHR, who have been instrumental in the development of the national CRN 
workforce through the setup of the National Clinical Research Network 
structure, view CRNs as vital to delivering their research and recognise their 
important role in providing high quality patient care and supporting the 
development of multi-disciplinary teams that deliver research (NIHR 2017). 
The development of the CRN role and growth of the workforce size has enabled 
post holders to become established within research teams of CRNs. More 
recently other members of the multi-disciplinary team (MDT) have also 
developed roles dedicated to support research, such as Research Pharmacists. 
However, there remains little empirical evidence as to how organisations, 
especially those with a large number of CRNs, have structured their workforce 
in order to ensure effective leadership and relevant and ongoing professional 
development. 
2.1.1. Review of the evidence 
Despite the steady growth in the CRN role since the beginning of this century, 
there remains little empirical published work focusing on the CRN role within the 
UK. However, there is a growing amount of anecdotal literature that describes 
the wide range of responsibilities within the role with many focusing on the array 
of clinical areas within which post holders are based. These articles often also 
highlight the difficulties and challenges faced by CRNs working within a busy 
clinical healthcare environment.   
In order to identify relevant empirical work and inform the study a literature 
review was undertaken to explore the following specific questions: 
1) What is known about the experience of CRNs within their role? 
2) What current workforce structures are in place? 
3) What is known about the experience of other research staff in relation to 
the CRN workforce? 
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2.2. Methods for the Literature Review  
Within the UK, the CRN role has gradually developed since the 1980’s. There 
are sporadic articles from this time period on some aspects of the role. Due to 
uncertainty of when the first reviews were completed and to ensure that no 
potential articles were omitted, no specific time period was used when carrying 
out the individual database searches. The relevant inclusion and exclusion 
criteria are presented in Table 2.2-1. Articles from outside of the UK were 
excluded due to differences in healthcare systems and research infrastructure. 
Table 2.2-1 Inclusion and Exclusion Criteria for literature search 
Inclusion criteria 
 Primary research articles. 
 Studies published from the year the database started.  
 Articles relating to UK CRN role and UK CRN workforce. 
 Published in English language peer reviewed journals. 
Exclusion criteria 
 Articles published on roles based in countries outside of the UK as lessons not 
relevant to NHS based roles due to different healthcare structures. 
2.2.1. Search methods 
Electronic search 
Four major healthcare related bibliographic databases were searched from their 
year of being established to week 52 of 2016. These databases included: 
Medline (1946), EMBASE in Ovid SP (1974), Cumulative Index to Nursing and 
Allied Health (CINAHL) (1961) and the British Nursing Index (BNI) (1985). Key 
terms were used to explore around the research questions. Key search terms 
as listed in the search strategy were entered into the database to identify 
relevant papers (Appendix 3). This identified a large amount of papers as 
illustrated in the PRISMA flow diagram (Moher et al 2009) (Figure 2.2-1). 
Search terms were combined in order to exclude those not completely relevant 
to CRNs. 
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Search of other sources 
There were two additional sources of papers – unpublished workforce studies 
and reference lists. 
Three unpublished CRN workforce reviews (see table 2.3.2) were obtained from 
a leading academic who was aware of some local CRN workforce reviews. 
Although unpublished, they were deemed to be suitable as they matched the 
remaining search criteria and offered empirical data in an area which is largely 
unstudied. 
In addition, the reference lists of all retrieved articles were also checked for any 
possible relevant studies. 
Selection of relevant studies and extraction of data 
The searches identified a total of sixty six studies which matched the search 
criteria. The article title and abstract were then reviewed in depth and relevant 
papers were selected using a data eligibility form (appendix 4) Selected studies 
were reviewed with my academic supervisors (GR & JP) to confirm eligibility 
and provide an important validity check. This resulted in five papers. These 
were then reviewed using a data extraction form (appendix 5). Review of papers 
included identification of study aims, methodology used and key findings.  
2.2.2. Methodological quality 
The majority of studies identified within this review were stated as being mixed 
methods. However, as they all had a strong qualitative element the critical 
appraisal tool for qualitative studies from CASP (Critical Appraisal Skills 
Programme)  (CASP, 2014) was used to further assess the quality of the 
studies (appendix 6).  
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Excluded studies: anecdotal accounts of CRN role 
In addition to the empirical papers, the search identified a total of 35 anecdotal 
accounts of the CRN role across the UK (see appendix 7). These include 
personal accounts of a CRN role (Oyebode 2012, Hemingway and Storey 
2013), articles describing responsibilities within the role (Gibbs and Lowton 
2012, Pick and Drew 2011) and other which highlight particular issues such as 
isolation, lack of understanding and poor line management (Gordon 2008). 
None of these had applied a systematic methodology and so present a 
subjective account of experience.  
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Figure 2.2-1 Summary of data search and retrieval process for the literature review using Prisma 




Papers excluded on 
the basis of titles 
and abstracts 
n = 6182 
Additional papers 
identified in reference 
lists and unpublished 
workforce reviews 
n = 15 
Medline: n = 5583 
BNI: n = 56 
CINAHL: n = 369 
EMBASE: n = 948 
 
Total hits = 6956 
 
n = 6236 
 
Potentially relevant 
papers for review 
n = 54 
Full papers read and 
screened using eligibility 
criteria: 
 
n = 69 
Papers and unpublished 
reviews to include 
in final review 
n = 8 
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2.3. Overview of included studies 
A summary of the five studies and three workforce reviews included in this 
review is presented in the tables below. All of the reviewed articles and 
workforce reviews were published between 2006 and 2014. The overview of 
these five studies will be followed by the three workforce reviews and consider 
how each helps to address the study questions.  
Table 2.3-1 Summary of peer reviewed studies. 
 Study Type of study Data collection 
method 
Aim 
1 Hill, G & Mac 
Arthur, J (2006) 
Mixed Methods Postal questionnaire 
Focus Group 
interviews 
To develop a profile of 
CRNs working across the 
trust 
2 Spilsbury, K et al 
(2007) 
Qualitative  Focus  Group  To explore experiences 
of being a CRN.  
3 Ledger, T et al 
(2008) 
Mixed Methods Questionnaire survey 
Overview covering 
pilot of new structure 
To explore a method to 
develop the CRN 
workforce in a consistent 
manner and introduce a 
working framework to 
guide this.  
4 Coulson, C & 
Grange, A (2012) 
Mixed Methods Questionnaire survey 
Interviews 
Focus groups 
To identify CRNs within 
organisation, examine 
their role & describe their 
experiences. 
5 MacArthur, J et al 
(2014) 
Mixed Methods Online survey 
comprising open and 
closed questions and 
free comments 
Examine development of 
the CRN role 
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Table 2.3-2 Summary table of unpublished workforce reviews 
 Author Aim of review Method used within review 
1 Simpson, K (2006) Identify and describe nursing 
roles involved in research 
across trust & university. 
Provide recommendations for 
the future. 
Email questionnaire 
2 Carrick – Sen (2007) To identify all those working 
in a CRN role. 
To identify local concerns & 
current ways of working. 
To recommend new ways of 
working. 
Mixed Methods approach to 
include: 
Postal questionnaires. 
One to one interviews. 
Group consultation. 
3 Edwards, C (2008) Identify nurses working in 
research across trust and 
university. 
To identify range of roles, 
current working practices & 
local issues. 
Develop a support strategy to 
incorporate education and 
training. 
Email questionnaire 
Four of the empirical articles looked at the experience of the CRN with three of 
them exploring as part of a local workforce review (Hill and MacArthur 2006, 
Spilsbury et al 2008, MacArthur et al 2012 and Coulson and Grange 2012). 
Hill and MacArthur (2006) reported on two workforce reviews carried out in 
neighbouring organisations a year apart. Their key finding was that the CRN 
workforce exhibited a plethora of diverse experiences including line 
management structure, educational support and employment and working 
arrangements. Their subsequent study ten years later showed demonstrable 
progress in the development and recognition of the CRN role across Scotland 
(MacArthur et al 2014). Following their review, Coulson and Grange (2012) 
reported that CRNs carried out a myriad of responsibilities. Spilsbury et al 
(2008) carried out a focus group of nine CRNs working across the same 
randomised controlled trial (RCT) to explore their individual experiences and 
highlighted the challenges of the CRN role.  
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The unpublished workforce reviews (Carrick-Sen, 2007, Simpson 2006 and 
Edwards 2008) primarily focus on aiming to identify the local CRN workforce, 
recommend new ways of working and identify how best to support their 
professional development and training needs. Key themes identified were 
similar to the empirical studies. However, additional themes were also identified 
including leadership and research activity.  
2.4. Review applied to research questions 
2.4.1. Review Question 1: What is the experience of CRNs 
within their role? 
There were common themes related to the experience within the CRN role: 
1) Role isolation 
2) Lack of support and understanding 
3) Line management and role set up 
4) Training and development 
Role isolation 
This was reported across four empirical papers and echoed previous anecdotal 
reports. In their initial study Hill and MacArthur (2006) reported that 58% (29/50) 
of CRNs felt isolated in their role and this was confirmed in their follow up study 
(MacArthur et al 2014). Adopted strategies to overcome this included discussion 
with clinical colleagues, interacting with other research nurses and seeking line 
management support. For some isolation was linked to lack of interaction with 
clinical colleagues and poor understanding around the CRN role. CRNs felt they 
were perceived as a minority group (Spilsbury et al 2012) who held a “cushy 
Monday to Friday nine to five job” (MacArthur and Hill 2006: 44). Feelings of 
isolation impacted their motivation which was felt to further impact patient 
recruitment rates (Spilsbury et al 2012). This was confirmed by MacArthur et al 
(2014: 42) with one CRN commenting it was “hard to maintain motivation and 
enthusiasm”. Feelings of isolation also impacted line management structure 
especially when not a nurse (MacArthur et al 2006) and resulted in a lack of 
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supervision to support the development of research specific skills which was 
seen to reduce opportunities for role development (Coulson and Grange 2012).  
This theme was less prevalent within the three workforce reviews. Carrick-Sen 
(2007) reported only 7% of CRNs felt isolated and Simpson (2006) identified it 
as a recurring theme throughout the review but gives no further information. 
Edwards (2008) does not refer to it being raised. However, her review does 
identify that a three monthly CRN forum meeting was held which everyone 
within the workforce was able to attend. This may therefore help to explain why 
role isolation was not identified as a concern of these CRNs.  
Lack of support and understanding 
Lack of support from clinical colleagues and failure to understand the CRNs 
contribution to clinical care was reported (Coulson and Grange 2012). Spilsbury 
et al (2007) also reported numerous examples of the CRNs feeling 
unsupported. The study involved ward based patients and CRNs reported 
hostility from clinical nurses and a general lack of support towards the study. 
They reported that overall the trust would agree to run the trial but the ward staff 
would not co-operate. This was termed “consent but not co-operation” (pg 553) 
and sometimes led to animosity towards the CRNs and dealings with difficult 
characters. Co-operation from ward staff was unpredictable and could often 
change over time. The CRNs reported examples of clinical staff making 
decisions about clinical care which prevented patients being included in the 
study. Avoidance of patient involvement and poor compliance from ward nurses 
around trial procedures was felt to be related to ward staff perceptions that the 
study created extra work. 
CRNs felt that support and understanding could be improved with better 
integration into clinical teams and highlighted possible strategies (Coulson and 
Grange 2012). These included helping out in ward areas and involving 
themselves in clinical care (Spilsbury et al 2007) as well as raising the profile of 
CRNs so that trust staff better understood the role and relevance to patient care 
(Coulson and Grange 2012).  
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General recommendations are also made at the end of some reports to facilitate 
an improvement in the support and understanding behind the role. These 
include identifying nurse managers for all CRNs, streamlining recruitment 
processes (Edwards 2008) and exploring new ways of working to maximise the 
interface between clinical nursing and research and appointment of a senior 
research nurse manager to oversee the CRN workforce (Carrick-Sen, 2007).  
Line management and role set up 
Three of the empirical studies reported on the difficulties that CRN faced with 
line management arrangements (MacArthur and Hill 2006, Coulson and Grange 
2012 and MacArthur et al 2014). In their initial study MacArthur and Hill reported 
that only 17% (12/72) of CRNs were line managed by a clinical nurse with 43% 
(31/72) being line managed by a doctor and 40% (29/72) by the Directorate 
Manager; this had increased in their later study with 71% (65/92) being line 
managed by a nurse and the remainder by a doctor. Coulson and Grange 
(2012) reported disparities concerning line management and listed various post 
holders who could be responsible for this including clinical matrons, Lead CRN, 
Research & Development (R&D) Manager and consultants. Some CRNs 
struggled to identify their line manager and made comments including they 
didn’t “feel managed in any practical sense” and “the support is there but at a 
distance” (MacArthur et al 2014: 42). 
There was inconsistency in how the CRNs were employed. MacArthur and Hill 
(2006) reported that only 26% (19/72) were wholly employed by the trust with 
the remainder being employed through a variety of routes including the 
university (17%, 12/72)), a research charity (18% 13/72) or other non-specified 
employer (39%, 28/72). In addition 65% (47/72) were on fixed terms contracts in 
the range between three months to four a half years. They identified a lack of 
honorary contracts being in place for 56% (20/36) of CRNs so implying a 
possible omission for this governance requirement. In their subsequent study 
65% (70/108) of CRNs were wholly employed by the trust and 34% (37/108) by 
the university. An honorary contract was only missing for 10% (4/40) of the 
CRNs, demonstrating some improvement.  
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Disparity around line management and professional responsibility of CRNs was 
also reported with just over 50% (numbers not stated) reporting to both 
Consultant and nurse manager (Simpson 2006). This was felt to be 
unsatisfactory with comments of “I feel my nurse manager is not aware of my 
job” and “my nursing line manager has no research background”. This 
arrangement was seen as partly responsible for the feelings of isolation within 
their role.  In the review by Edwards (2008) 25% (13/52) CRNs responded that 
they had no line manager. Of those who did, 43% (17/39) of these were nurses 
and 52% (20/39) were a consultant or service manager. Carrick-Sen (2007) 
reported similar findings with 46% being line managed by a nurse or midwife 
and 23% by a medical colleague. However, line management arrangements of 
30% of the workforce were not stated. 
Looking at role set up, a further lack of consistency was identified. Simpson 
(2006) found that CRN posts were funded from a variety of sources with 12% 
reporting they had no contract and 12% reporting they had no job description; it 
was suggested this may be linked to those who had no nursing line manager. 
The majority of CRNs were an F grade (29%) or G grade (43%) which generally 
equates to band 6 and 7 as also identified by Carrick-Sen (2007). Agenda for 
Change was ongoing at the time of the review by Edwards (2008) and this 
appears to have led to some discrepancies in the banding of some CRN posts. 
For 79% of CRNs the outcome had been a band 5 level for their post despite 
the fact that they had been a mixture of grade E, F and G posts.  Although 
Edwards (2008) found that 95% of CRNs had a job description there was no 
consistency in the competency between different bands, a factor which was felt 
to have been exacerbated by the Agenda for Change review process.   
Contracts were also explored by Edwards (2008) who reported a combination of 
permanent (52%) and fixed term (38%) with the majority employed by the NHS 
(83%). Simpson (2006) identified that 54% were employed on an NHS contract 
and that - although 19% were employed by the university - only 2% stated they 
had an honorary contract. 
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Training and Development 
Training around induction and continuing professional development (CPD) was 
inconsistent across the three empirical studies (MacArthur and Hill 2006, 
Coulson and Grange 2012, MacArthur et al 2014). In their initial study, 
MacArthur and Hill (2006) identified that only 50% of CRNs had attended an 
induction programme when starting their role and this had dropped to 36% in 
the subsequent study ten years later (MacArthur et al 2014). It was felt that the 
latter figure may be skewed by those who had been in post longer but closer 
inspection still found that only 46% of newly employed CRNs had attended an 
induction programme. The 54% that had not were all appointed by the 
university. It was felt that this lack of induction may explain the reason why 
CRNs are to some extent “hidden” (pg 44) in the organisation as they are not 
identified at the start of their employment. Ongoing professional development 
was also highlighted as an issue with MacArthur and Hill (2006) reporting that 
only 64% had attended mandatory training in the previous 12 months. Coulson 
and Grange (2012) identified a need for better support of training and 
professional development. They reported that CRNs were uncertain around 
opportunities for career progression, a concern also identified by MacArthur et 
al (2014) who identified that CRNs lacked a career framework with many feeling 
that their roles had expanded without appropriate recognition and reward.  
In the workforce reviews the authors reported that attendance at induction 
programmes was high with rates of 93% (Edwards 2008) and 71% (Simpson 
2006). Both reviews identified a wide variety of possible research specific 
training programmes with a range of attendance rates across the CRN 
workforce. Simpson (2006) listed training options such as research governance 
and good clinical practice training with attendance rates ranging from 
approximately 15% to just fewer than 80%. Carrick-Sen (2007) found that 25% 
of CRNs had never undertaken GCP training despite regularly taking consent 
for participation in research studies. Edwards (2008) also identified a range of 
research training programmes but attendance appears lower at rates of 
between 10% and 40%. In addition, Simpson (2006) also identified a variety of 
clinical skills training available with a wide range of attendance rates between 
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approximately 5 - 60%. Further information regarding specific role requirements 
to explain this range does not seem to have been obtained. 
Lack of career development and a career pathway was a consistent theme 
across all 3 reviews, each of which included within their recommendations that 
this should be addressed and a clear career structure be developed for all 
CRNs. 
Summary 
Within this section I have aimed to review the current literature on the 
experience of CRNs within their role and identify the themes. A theme has been 
defined as “an idea that can be seen running through several responses” 
(Harding, 2013: 6). Although there was consistency within the reviewed papers 
of the 4 identified themes, caution should be used when making generalisations 
concerning the CRN workforce due to the small numbers of papers available to 
review. However, themes such as role isolation and a lack of support and 
understanding are additionally highlighted in some anecdotal reports or 
personal accounts so giving further credibility to these (Kenkre and Foxcroft 
2001, Gordon 2008). 
2.4.2. Review question 2: What current workforce structures 
are in place? 
Within the empirical studies, Hill and MacArthur (2006) describe two 
consecutive studies across the same organisation which were carried out a year 
apart. The article appears to be the first published article of a UK CRN 
workforce review. The initial study identified 108 CRNs working across their 
organisation who were then all sent a postal questionnaire. The second study 
used the same population of which 104 were sent the questionnaire. Response 
rates were 72% and 48% respectively. The authors of this study carried out a 
further questionnaire study in 2012 to compare the findings across all 3 studies 
(MacArthur et al, 2014). The response rate was 58% (108/186). Both reviews 
revealed that the majority of the workforce was appointed at a grade F or G (pre 
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Agenda for Change) and the majority of CRNs had a job description. The 
reviews did not examine how the CRN roles had been structured within the 
research or clinical teams. The impetus for the initial two consecutive studies 
reported by MacArthur and Hill (2006) was the creation of a senior CRN post 
and the establishment of a Clinical Research Facility (CRF). However, no 
information was provided on the support this gave to the CRN workforce. 
Coulson and Grange (2012) identified 36 CRNs working across a variety of 
clinical directorates. They were supported by a part time lead CRN at band 8b 
level and a part time lead CRN at band 7 level. However, no further information 
was provided on the structure of the CRN workforce.  
Ledger et al (2008) describe a project aimed to implement a framework to co-
ordinate the employment, management and development of CRNs within a 
large acute NHS teaching trust. Led by a working group they identified 100 
CRNs working within 9 clinical care groups across 5 hospital sites and the CRF. 
The working group nominated one of these to be the Lead CRN who would be 
available for advice at least one day a week. The framework was piloted in a 
research active directorate and aimed to introduce consistent procedures for job 
descriptions, recruitment, induction, professional development and a 
competency document for research skills. The pilot highlighted the complexity of 
the CRN role and the need for a dedicated Lead CRN. Following the pilot the 
framework was implemented and the Lead CRN role was made a substantive 
post with the remit that it included responsibility for the CRN workforce across 
the trust. This has ensured that the recruitment, employment and professional 
development of CRNs occurs in a more cohesive manner. This appears to be 
the only published paper describing a CRN workforce review and restructure.  
Carrick-Sen (2007) carried out a review of all nurses working in a research 
capacity within an NHS acute trust. Within this 94 CRNs were identified and a 
questionnaire response rate of 77% (72/94) was achieved. No further 
information regarding whether the CRN roles were structured within clinical or 
research teams was given. However, the review did identify difficulties with the 
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work environment with 68% sharing an office and 39% sharing a desk. The 
CRNs identified ‘work environment’ as the most difficult aspect of their role.  
Simpson (2006) led a review of the CRN workforce using a questionnaire 
structure based on the reviews reported by MacArthur and Hill (2006). Here 
numbers were smaller with a total of 51 full time post holders and 25 post 
holders who had research as a secondary remit within their role. The workforce 
had a diverse range of experience and job titles and worked across a variety of 
clinical areas.  Edwards (2008) identified a workforce of 60 CRNs but only 55% 
(33/60) had research as the main remit of their role. 
Summary 
Within this section I have aimed to review what CRN workforce structures are in 
place. Only 3 organisations have published on the structure of their workforce 
and I was able to identify a further 3 unpublished reports. The majority of these 
were carried out 10 years ago. With ongoing growth in the CRN workforce and 
development of the national research infrastructure within that time, caution 
should be used when making generalisations from these reports. However, they 
do provide a background to this with some early examples of how some 
organisations initially structured their workforce and the issues encountered.  
2.4.3. Review question 3: What is the experience of other 
research staff concerning the CRN workforce? 
No empirical papers or unpublished articles were identified that explored this 
issue. 
Within the workforce reviews there were two additional themes. 
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The aim of this search had been to identify whether other health professionals 
had published on their interaction with the CRN workforce. However, an in-
depth literature search did not reveal any publications and the author was not 
aware of any additional themes identified 
 
Leadership 
The importance of effective leadership was suggested within the workforce 
reviews. The catalyst for initiation of the review reported by Edwards (2008) was 
the appointment of a research co-ordination and training manager to identify 
and oversee the workforce; similarly, the review by Carrick-Sen (2007) 
recommended the appointment of a senior research nurse manager to take on 
this role. Simpson (2006) reported that the review had shown that nurses and 
midwives in research do not always have clear links with the nursing / midwifery 
structure so do not have the opportunity to influence policy or develop 
leadership skills. She therefore recommended that they should be encouraged 
to develop a leadership role to input at a strategic and operational level. 
Research activity 
The reviews by Simpson (2006) and Edwards (2008) explored the nature of the 
studies on which the CRNs were working. Both reviews demonstrated that they 
were working on a variety of research projects both commercial and non-
commercial (but with a greater amount of commercial activity running clinical 
trials of a medicinal product). Both reviews highlighted the very small amount of 
nursing research that was being done. Edwards (2008) explored this further and 
found that only 27% (14/52) had the opportunity to conduct their own research 
with the main barriers being time and funding. 
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2.5. Discussion 
This review has found a lack of studies looking at the structure of the CRN 
workforce and the experience of CRNs within their role. Therefore, further high 
quality research is needed in order to provide greater understanding concerning 
both of these areas. However, a number of key issues have emerged from the 
findings of this review which do provide some insight and understanding relating 
to the aims of this thesis. 
There appears to be a general lack of understanding concerning the CRN role. 
This can impact how research is perceived within the clinical environment and 
how much support the CRNs receive from their clinical colleagues. Spilsbury et 
al (2007) gives a comprehensive insight into the reality for CRNs of running 
their study within a ward environment. However, the study was completed over 
10 years ago and only includes the views of 9 CRNs.  The remaining papers 
offer a small amount of information as to the experience of CRNs but this is 
limited as the aim of most of the papers was a general review of the workforce 
and not to examine specific issues within it. Line management arrangements for 
CRNs have also been identified as a consistent theme across the published and 
unpublished papers. Lack of a robust process to oversee and line manage post 
holders may contribute further to other themes identified such as role isolation, 
lack of support and lack of personal and career development. Training and 
development also appears to take place in an inconsistent manner leading to 
CRNs potentially lacking key skills for their role in areas such as research 
governance.  
Ledger et al (2008) have demonstrated the benefits to be gained when a 
structured consistent process is implemented to oversee and support the CRN 
workforce. By initially taking steps to understand the issues faced and 
implementing a co-ordinated framework, they were able to demonstrate the 
benefits this brings in terms of better co-ordination of the running of research 
studies and support of the CRN workforce. However, as mentioned above this 
work was carried out over 10 years ago and so the picture may have changed 
within this one organisation.  
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CRNs appear to be self-motivated in their role especially in their attempts to 
overcome challenges such as role isolation. Spilsbury et al (2008) demonstrate 
the steps that some CRNs go to in order to facilitate the integration of their role 
alongside their clinical colleagues. However, in terms of gaining a greater depth 
of understanding, the focus group would need to be repeated within other CRN 
research teams to truly understand the challenges they face.  
Despite the rapid growth in the size of the national CRN workforce, there is only 
speculative literature on the size of this workforce. The three unpublished 
reviews give an indication of the set up within the relevant organisations. 
However, these are isolated reviews and not available within the public arena. 
They all include comprehensive recommendations on suggested actions to 
facilitate better support of the CRN workforce. However, they are all 
approximately ten years old and it is highly likely that the CRN workforce within 
each of the organisations will have changed in size and structure.  
The review has identified some common themes of role isolation and a lack of 
support and understanding which are also confirmed by some of the anecdotal 
reports and personal accounts of the role. However, the additional themes of 
leadership and research activity are more sparsely represented within the 
literature and so may be viewed as weaker. This limits their significance and 
restricts researchers in their ability to make generalisations. However, it does 
identify these as potential additional themes which could then be explored in 
future research.  
2.6. Summary 
This review has demonstrated the sparse amount of current literature and 
understanding concerning the questions under review. However, it has 
generated some initial knowledge regarding the size of the CRN workforce 
within some NHS trusts and the challenges faced by CRNs in the conduct of 
their role. Within this it has identified areas which should be examined in greater 
detail in order to gauge a better understanding. It has given an overview of the 
difficulties faced by a nursing workforce which has seen a large amount of 
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growth since the beginning of this century and how some organisations have 
attempted to support this.  
Building on the findings of this review, the following chapter will now define the 
aim of the study and research questions within this. It will also describe the 
framework used to structure the data collection.  
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Chapter 3: Study aims and 
theoretical framework  
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3.1. Introduction 
This chapter will discuss the overall aim of the study and the research questions 
relating to this. It will also describe the framework which has been used to 
structure the data collection and the rationale for its use. 
3.2. Overall research question 
How is the CRN workforce is currently organised within NHS Acute trusts,  what 
is the experience of CRNs working within acute NHS hospital trusts and what is 
the most effective way to structure the CRN workforce? 
3.3. Research objectives 
In attempting to meet this overall research question the following research 
objectives were considered. 
- To identify acute hospital trusts which have reviewed the structure of their 
CRN workforce. 
- To identify which acute hospital trusts have subsequently introduced a 
new structure. 
- To explore how the CRN workforce is currently organised within NHS 
Acute trusts using a quality framework.  
- To explore and compare the experience of Clinical Research Nurses 
within different organisations using a quality framework. 
- To explore the experience and perception of senior research staff (R&D 
Directors, Lead CRN and Principal Investigators) concerning the 
research nurse workforce within their organisation. 
- To examine the effect of re-organising the CRN workforce on NIHR 
targets. 
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3.4. Data collection framework  
There was no available tool that could be used to collect data on the structure of 
a CRN workforce and examine attributes within it. The “Organising for Quality” 
framework (Bate, Mendel and Robert 2008) was identified as a helpful 
framework for organising data collection as the components within it matched 
several of the areas that had been identified within the literature review, such as 
education and structure, as being important to be examined within this study. 
This framework was originally designed to describe the factors (defined as 
challenges, see Figure 3.4-1) that enable healthcare organisations to achieve 
and sustain quality improvement. The challenges within the framework are as 
follows:  
- Structural  
- Educational  
- Emotional  
- Cultural  
- Political  
- Technology and Infrastructure 
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3.4.1. Origins of “Organising for Quality Framework” 
 
Figure 3.4-1 Organising for Quality Framework (Bate et al 2008) 
This framework was the result of an international study, conducted jointly by 
researchers from the UK and the USA, that was designed to help practitioners 
and researchers understand the factors and processes that enable health care 
organisations to achieve and sustain high quality services for their users. The 
existing literature had focused on a “menu mentality” (Bate et al 2008: 6) of the 
key success factors that equate with quality healthcare but with no 
understanding of how or why some organisations perform better than others. 
The researchers carried out in depth case studies in eight leading hospitals to 
give an international, evidence based outlook that focuses on the organisational 
and cultural processes of Quality Improvement (QI). They examined hospitals 
and medical centres (four in America and four in Europe) that had earned a 
reputation for sustained achievements in QI and performance with the aim of 
understanding the process of QI. The authors conclude that there are many 
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different paths to successful, sustained QI but the unifying features are an 
ability to address multiple challenges simultaneously and to adapt the strategies 
to the organisations own needs. They present a model (see Figure 3.4-1) of 
what they see as the six core challenges for organisations to achieve and 
sustain QI. They propose that these are problems which any organisation will 
need to find solutions to and if ignored will lead to disappointment and failure in 
their QI. 
Since its development this framework has been used by other researchers to 
support data analysis although the data collection was not structured around the 
framework as it has been in this study. Krein et al (2010) carried out a study to 
examine QI efforts related to the prevention of central line infections. Data was 
collected using semi – structured interviews (telephone and in person). During 
the course of data analysis they found that the 6 challenges of QI as described 
in the Organising for Quality framework corresponded with their results and 
provided a useful interpretative framework for their findings. Hamilton et al 
(2014) used this framework to explore the QI capacity of 8 hospitals that were 
implementing the Releasing Time to Care (RTC) programme. Interviews were 
conducted with staff who worked in nursing units where RTC had been 
implemented. In the data analysis phase identified themes were mapped to one 
of the domains (called challenges within the framework) which were seen as 
important to the success or failure of the RTC initiative. Use of the Organising 
for Quality framework enabled them to articulate the QI impact of the RTC 
programme.  
3.4.2. Rationale for use of the “Organising for Quality 
Framework” 
This framework was chosen for this study as it offered a structure to define 
categories of data collection in order to answer the research questions.  The 
challenge of structure is self-explanatory in its choice when the study was 
looking to identify those acute trusts that have reviewed and restructured their 
CRN workforce.   The challenges of education, culture, emotion and politics are 
 Page 54 
all likely to have an impact when exploring the experience of CRNs and 
research staff. The challenge of technology and infrastructure also offers 
important insight into the structure of a workforce. Therefore all components of 
the framework - and the interactions between them - were felt likely to be 
relevant to the research questions being examined.  
A definition of each of the six challenges is given by the framework’s original 
authors. Within this they define “solutions” and provide an explanation for each 
which gives further clarity and direction for the reader around each challenge. 
These definitions within the framework were examined and applied to research 
and the CRN workforce; a modified definition for each challenge (see Table 
3.4-1) was then devised and this was used as the foundation for data collection. 
Questions were devised for each of the challenges to examine the CRN 
workforce, factors related to the experience of the CRNs within the clinical 
environment and the organisation of research within the organisation.  
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Table 3.4-1 Practical application of the ‘Organising for Quality’ framework to a 
clinical research setting. Adapted from Bate et al 2008. 
Challenge Original definition in framework Definition applied to CRN workforce 
Structure Structuring, planning and co-
ordinating the quality and service 
improvement effort, and embedding it 
within the organisational fabric. 
Structuring, planning and co-ordinating the 
Clinical Research Nurse workforce, and 
embedding it within the organisational 
fabric to ensure high quality research 
governance and patient safety. 
Cultural Building a shared understanding, 
commitment and community around 
the improvement process 
Building a shared understanding, 
commitment and community around 
research and the CRN workforce 
Education Embedding and nurturing a 
continuous learning process in 
relation to quality and service 
improvement issues, including both 
formal and informal mentoring, 
instruction, education and training, 
and the acquisition of relevant 
knowledge, skills and expertise. 
Embedding and nurturing a continuous 
learning process for the CRN workforce in 
relation to high quality research 
governance and patient safety including 
both formal and informal mentoring, 
instruction, education and training and the 
acquisition of relevant knowledge, skills 
and expertise. 
Emotional Energising, mobilising and inspiring 
staff and other stakeholders who 
want to join in the improvement effort 
by their own volition and sustain its 
momentum through individual and 
collective motivation, enthusiasm and 
movement. 
Energising, mobilising and inspiring staff 
and other stakeholders to be involved in 
processes to ensure high quality research 
governance and patient safety. 
Political Negotiating the politics of change 
associated with implanting and 
sustaining the improvement process, 
including securing stakeholder buy in 
and engagement, dealing with conflict 
and opposition, building change 
relationships and agreeing and 
committing to a common agenda for 
improvement. 
Negotiating the politics of change 
associated with implanting and sustaining 
the CRN workforce, including securing 
stakeholder buy in and engagement, 
dealing with conflict and opposition, 
building change relationships and agreeing 
on a common agenda to ensure high 
quality research governance, support the 
achievement of NIHR objectives and 
ensure ongoing patient safety. 
Technology 
The design and use of a physical, 
informational and technological 
infrastructure that improves service 
quality and the experience of care. 
The design and use of a physical, 
informational and technological 
infrastructure that improves research 
governance and the experience of patients 
who take part in research studies. 
3.5. Summary 
This chapter has laid out the study aim and questions to be explore within this 
study. It has described the framework that has been selected to structure the 
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data collection and given rationale for its use.  The study methodology within 
the phases of the study will be described in the next chapter. 
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Chapter 4: Research design 
and methods 
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4.1. Introduction 
This chapter presents the overall study design to meet the aims and research 
questions presented in the previous chapter, details the two phases of the 
project and also explains the approach taken to sampling decisions, data 
collection methods and data analysis.  
4.2. Study Design 
The study itself was designed and conducted in two phases which are the focus 
of the following chapter. Appendix 8 provides a timeline for the phases of the 
study. 
Phase 1a: a national online survey of NHS acute hospital trusts who were 
involved in recruiting into research studies was carried out. It aimed to identify 
the Lead CRN at each NHS acute trust or someone within the R&D Department 
who was responsible for the CRN workforce. A survey tool was developed using 
the “Organising for Quality Framework”. This survey included the following: 
- 161 Acute NHS Hospital Trusts in England 
- 14 Scottish Health Boards 
- 1 Acute Trust in Wales 
- 1 Acute Trust in Northern Ireland 
The survey was distributed via Survey Monkey, an online survey development 
tool. 
Phase 1b: statistical analysis of NIHR recruitment figures over a six year period 
(2010 – 2016) for all organisations that completed the survey. 
Phase 2: Case studies of four organisations selected from those that took part 
in phase 1a. Data collection comprised of three or four semi-structured 
interviews and a focus group at each organisation. 
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4.3. Methodology 
The methodology describes the research design, data collection tools used and 
the approach to data analysis. Underpinning the methodology is the 
philosophical stance which focuses on the differences between the quantitative 
research paradigm, which is generally associated with the philosophical 
traditions of positivism and the qualitative research paradigm, most commonly 
allied with post positivist philosophy (Polit et al 2001) or Interpretivism. Morgan 
(2007) describes these paradigms as epistemological stances with “distinct 
belief systems that influence how research questions are asked” (pg 52) and 
“worldviews or all-encompassing ways of experiencing and thinking about the 
world” (pg 50).  
Positivism is a philosophy that uses reason and rational thought to explain 
phenomenon. It assumes a stable, observable reality that can be measured and 
observed, and is derived in a systematic, rigorous way (Bruce et al 2009). The 
ontological position is that there is only one truth that is an objective reality that 
exists independent of human perception (Sale et al 2002). Within this 
epistemological stance the investigator and subject are independent variables 
which do not influence each other.  One of the primary characteristics is that the 
researcher takes an objective distance from the phenomena so that the 
description of the investigation can be detached and undistorted from emotion 
or bias (Davey 1994). Others refer to this as researchers withholding their 
beliefs in order not to contaminate the data (Larkin et al 2014). 
A contrary or alternative view is interpretivism. This grew from the writings of 
Kant who proposed that perception relates to human interpretation and Dilthey 
who emphasised the importance of understanding and studying lived 
experience (Ormston et al 2014). The ontology position is that there are multiple 
realities or truths. Epistemologically, there is no access to reality independent of 
our minds so that the investigator and subject are interactively linked. The data 
has no existence prior to the activity of the investigation and ceases to exist 
once the activity is complete. This data aims to interpret actions and understand 
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behaviour. It uses language and looks at the what, how and why of a 
phenomenon (Green and Thorogood 2009). 
4.3.1. Mixed methods 
A combination of both of these approaches, known as a mixed methods design, 
provides more evidence for studying a research question and can access 
knowledge or insights unavailable when data collection methods are undertaken 
independently (O’Cathain et al 2007). Cresswell and Piano Clark (2011) refer to 
it as “multiple ways of seeing and hearing and multiple ways of making sense” 
(pg 4) whereas Johnson et al (2007) refers to it as “the third major research 
approach” (pg 112).  In seeking to answer the research question and aims 
above it was decided that the mixed methods design was most appropriate 
Within this discussion it is pertinent to briefly consider the difference between 
multiple method research and mixed methods research in order to offer some 
clarity and confirmation in the choice of mixed methods. The terms are easily 
confused and mistaken as synonymous. However, there is a general agreement 
that there are differences between the two (Johnson et al 2007). As previously 
explained a mixed methods approach uses both qualitative and quantitative 
data collection methods. However, multiple or multi method research involves 
data collection using two methods from the same paradigm, such as interviews 
and focus groups (Andrew and Halcomb 2009). Important aspects of mixed 
methods research include its consideration from initial philosophical 
underpinnings, through data collection, analysis and interpretation as well as 
the mixing of data (Halcomb and Hickman 2015). In addition an important 
component is also the mixing or triangulation of data (Bryman 2006).   
Mixed methods research has become a common component of research within 
the health service (O’Cathain et al 2007). The main purposes for combining 
methods in studies have been highlighted by O’Cathain (2007). These include: 
- Complementarity – methods are used to address different aspects of the 
same question. 
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- Expansion – methods are used to address different questions. 
- Development – one method is used to inform the development of 
another. 
- Confirmation – the results of the two methods converge. 
This study utilised mixed methods to address the need for complementarity and 
confirmation. Use of the ‘Organising for Quality’ framework to structure the 
collection of data allowed subject areas to be examined for each phase of the 
study within the six challenges; the findings could then be applied to the study 
aims during the analysis. For example, for the challenge of “Culture” the survey 
asked “Do your nursing colleagues understand the CRN role?” whereas within 
the interview participants were asked “What is the understanding of the 
research nurse role?” Within the survey, statements were provided concerning 
the importance and value of research within the organisation and respondents 
were asked to rate their agreement on a 5 point Likert scale. Within the 
interview participants were asked “What is the importance associated with 
research across the organisation and how much value is put on it from a 
nursing perspective?” Data from these would then be used to help interpret 
factors around the experience of CRNs. This allowed the researcher to address 
different aspects of the same question in order to determine whether the results 
converged.  
Within mixed methods a research problem is examined using different methods 
of data collection to gain a more complete picture (O’Cathain et al 2010).  Both 
sets of data can then be analysed using a process known as “Triangulation”. It 
was Denzin (1978) who first outlined how to triangulate research methods and 
described 4 types including: 
1) Data Triangulation – using a variety of sources within a study. 
2) Investigator Triangulation – use of different researchers. 
3) Theory Triangulation – use of multiple perspectives and theories to 
interpret results. 
4) Methodological Triangulation – use of multiple methods to study a 
research question. 
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This study uses methodological triangulation through the use of a survey, 
interviews and focus groups within a case study presentation. When the 
methods are integrated a process of interpretation takes place when the data 
from each method is initially analysed separately and the findings are integrated 
(O’Cathain 2007). Each set of data on its own provides part of the story for the 
research question, but together they contribute to a broader understanding of 
the research question (Farmer et al 2006).  
According to O’Cathain et al (2010), triangulation enables the findings to be 
explored for the following: 
- Convergence – do the findings agree? 
- Complementarity – do the findings offer complementary information on 
the same issue? 
- Discrepancy – do the findings contradict each other? 
Farmer et al (2006) add an additional category of “silence” to capture whether 
one set of data covers a theme whereas the other remains silent. This would be 
important as it may demonstrate different perspectives on the same point under 
discussion.  
When considering the philosophical stance within mixed methods, authors refer 
to pragmatism as it is not committed to any one system of philosophy and 
reality but “draws liberally from both the quantative and qualitative assumptions” 
(Cresswell, 2009, pg 10). It can be viewed as a set of philosophical tools that 
can be used to address problems (Biesta 2010). Pragmatism allows the 
researcher to use a combination of whichever methods are needed to find 
answers to the research questions. Authors emphasise that instead of focusing 
on methods, researchers initially emphasise the research question and then use 
all approaches available to understand the issues within it (Morgan 2007). 
Therefore for the mixed methods researchers, pragmatism opens the door to 
use of multiple methods, different worldviews and different assumptions gained 
from different forms of data collection and analysis (Cresswell, 2009).  
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Therefore, within this study a pragmatic approach enabled the researcher to 
initially consider the research questions to be explored both nationally within the 
survey and locally within the individual case studies. This then led to the use of 
a variety of data collection methods such as open and closed questions within 
the survey, interviews and focus groups in order to gain a broad understanding 
of the issues being explored.  
4.3.2. Case study design 
Case study design was chosen as the method for phase 2 of data collection as 
it allows the researcher to “retain holistic and meaningful characteristics of real 
life events” (Yin, 2009, pg 4). It also enables researchers to empirically 
investigate and gain in depth, in context understanding of a phenomenon from 
key informants who were directly involved in the activities being studied (Yin 
2009). One of the study aims was to “explore and compare the experience of 
research staff within different organisations”.  By choosing this design the 
researcher was able to directly speak with CRNs and those involved with 
research (the key informants) across different organisations (the context) in 
order to explore their experience (the phenomenon). By collecting data in real 
life settings, case studies provide thick descriptions which enable others to 
make a judgement about the relevance of the findings to their own setting 
(Taylor 2013). This would then allow analysis of themes across the different 
participants within each of the case studies. As confirmed by Baxter and Jack 
(2008) the goal of data analysis within a case study is not to analyse individual 
data sources independently but to combine the data from all sources in each 
setting and then across settings. By interviewing the same groups of staff 
across different organisations the researcher was able to examine themes for 
consistency or differences. Yin (2009: 106) refers to “guided conversations” 
rather than “structured queries” when carrying out interviews within a case 
study. This allows the interview to be fluid as opposed to rigid. Additional 
flexibility allowed the researcher to discuss single issues (such as CRN 
experience) across all study groups.  
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4.4. Research methods  
The following section presents the different methods used to collect the study 
data. 
Quantitative data collection 
The collection of quantitative data was planned in order to obtain data regarding 
the workforce size and structure in as many acute trusts as possible. In recent 
years organisations have developed a senior CRN post to take overall 
responsibility for the workforce. This post of a Lead CRN will lead on the 
support and development of the total CRN workforce. It was therefore 
anticipated that within organisations where this post had been developed, the 
individual would have the greatest awareness and knowledge of their CRN 
workforce.  
A structured questionnaire was developed that asked participants to provide 
information on workforce size and an overview of experiences and challenges 
faced by individual CRNs. Questions were structured and 5 point Likert scales 
were also used to uncover strength of opinion. Some questions included an 
open comments box to allow participants to expand answers.  
In order to approach all Lead CRNs within the target populations the 
questionnaire was sent as an online survey using “Survey Monkey”. This 
allowed the researcher ease of access to the planned UK wide study 
population. Known advantages of electronic surveys include the low cost (Scott 
et al 2011) and ease of data analysis as simple descriptive statistics are usually 
embedded providing concurrent analysis for researchers (Evans and Mathur 
2005). Disadvantages include access to up to date email addresses and a 
possible lower response rate compared to postal surveys (McPeake et al 2014). 
Problems with incorrect email addresses were overcome as the researcher was 
part of an active national group of Lead CRNs which provided the initial batch of 
contact details after relevant approvals. For those organisations where the Lead 
CRN was not known, the R&D department was directly approached by the 
 Page 65 
researcher so preventing the possibility of incorrect contact details. Results from 
the survey were analysed using descriptive and inferential statistics and these 
processes are described in a later section of this chapter.   
Qualitative data collection 
Including qualitative data was necessary in order to uncover a depth of 
understanding concerning individuals within the organisation to add richer data 
to describe the experience of the research process. A growth in the size of the 
workforce has led to some organisations reviewing and re-structuring their 
teams. A secondary aim of the study was to identify which organisations have 
performed a review and carried out changes within the CRN structure based on 
the results. Therefore a case study approach was adopted in order to examine 
two organisations that had reviewed and restructured their CRN workforce and 
two that had not. Data collection was in the form of focus groups and interviews 
with different members of the research team as it was important to directly hear 
the voice of those involved.   
4.5. Phase 1: Online questionnaire 
4.5.1. Development of phase 1 survey tool 
The objectives of the questionnaire are: 
1) To identify the acute hospital trusts that have reviewed the structure of 
their CRN workforce. 
2) To identify which acute hospital trusts have subsequently introduced a 
new structure. 
3) To explore how the CRN workforce is currently organised. 
4.5.2. Expert Review Panel 
An “Expert Review Panel” was set up by the Researcher to gain feedback on 
the questionnaire structure and content. Eight panel members who were nurses 
experienced in clinical research were selected (see appendix 9 for summary).  
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They were sent a PDF copy of the questionnaire and a review template which 
they were asked to complete (appendix 10). This included questions on their 
overall opinion of the questionnaire as well as content, layout and the length of 
time to complete. Responses were analysed and adjustments made.  
It is acknowledged that expert groups may have their limitations due to the 
subjective nature of their set up by the researcher. However, it remained 
important in the design of the questionnaire to gain the views and feedback 
from experienced peer colleagues as to the approach being taken. Completion 
of the template did ensure a consistent approach to their review and it was felt 
by the researcher that valuable feedback on the questionnaire design and 
content was received.  
4.5.3.  Alterations to the questionnaire 
1) Some felt it was too long which may affect completion rates. This was 
considered but the majority of questions remained as they were 
considered important to the study aims.  
2) Average time to complete was 20 and 30 minutes. Therefore information 
added to inform participant’s completion may take up to 30 minutes.  
3) Suggestion that further instructions for completion of the survey should 
be given.  
4) Suggestion that additional research support roles including Quality 
Assurance Manager should be added.  
5) Concern that not all requested information would be available. This was 
acknowledged as a possibility but not felt to be a reason for removal of 
some questions.  
6) Some felt that easy questions were towards the end and that these may 
be missed because of the length of the survey. These were therefore 
moved to near the beginning. 
7) Suggestion made for addition of other research relevant training 
requirements so added. 
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4.5.4. Questionnaire Pilot 
Once finalised it was necessary to pilot with a small group of senior CRNs who 
would be similar to the main study population.  The pilot was carried out 
towards the end of 2013. At this time the National Cancer Research Network 
(NCRN) had been set up for 12 years and comprised 32 Research Networks 
each led by a Network Manager who over saw a large team of staff, mainly 
CRNs. This had marked the beginning of an identifiable structure within which 
CRNs could be based and offered the opportunity to pilot the survey within a 
small number of the main study population.  
The NIHR Co-ordinating Centre in Leeds was approached for permission to 
contact the NCRN Network Managers. The request to take part in the pilot was 
then included in their regular newsletter and a link to the survey was provided 
(appendix 11). The network managers were also due to attend a regular 
national update meeting. Therefore a presentation about the study and intended 
pilot was prepared and sent to the NIHR Co-ordinating Centre and was 
delivered during the meeting. The survey ran throughout December 2013 and 
early January 2014. 
4.5.5. Pilot Results 
The pilot study was analysed and a report produced. A summary report was 
sent to the NIHR co-ordinating centre to distribute to the network managers. A 
response rate of was 65.5% (21/32) was achieved.  All questions were 
completed by 44% of respondents (14/32) but all surveys contained answers to 
at least 50% of questions unless they were optional and linked to a previous 
question. 
The pilot study gave a comprehensive overview of the CRNs working within the 
NCRN structure and identified twelve issues that were of particular relevance to 
the main study. These are summarised in appendix 12. 
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4.5.6. Alterations following the pilot 
Changes were made to the questionnaire based on feedback from the NCRN 
Managers and from observations related to how it had been completed. These 
included: 
1) The original survey used the term CRN for Clinical Research Nurse. The 
networks were in a state of transition and the term for the new structure 
was the Clinical Research Network - abbreviated to CRN. Therefore due 
to some confusion within the main questionnaire the abbreviation RN 
was used for Research Nurse. 
2) In the pilot, questions were clustered within each challenge of the 
framework. The majority of respondents completed at least 50% leaving 
some challenges missed. Within the main questionnaire, questions were 
mixed around with the demographics and structure questions placed 
towards the beginning. 
3) The pilot asked “Does your organisation have any new IT developments 
that have been introduced over the last 2 years?” in order to determine 
whether any organisation wide IT developments, such as electronic 
patient records, had been introduced. Many interpreted this as being 
related to research and so referred to research related technology. In the 
main survey the question was changed to “Has there been any 
organisation wide IT developments that have been introduced over the 
last two year? (for example electronic patient notes). 
The finalised questionnaire comprised of 56 questions which included both 
open ended and closed questions. These were uploaded onto Survey Monkey 
with an introduction to the survey on the first page. See appendix 13 for a copy 
of the full survey. 
4.6. Data analysis – Phase 1a and 1b 
Analysis used both descriptive and inferential statistics.  Descriptive statistics 
allow data or samples to be described in a succinct and meaningful way but do 
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not allow any conclusions to be drawn about the data or sample.  Typically 
descriptive statistics are simple numerical or graphical summaries of data and 
include measures of central tendency (mean, median, and mode) and 
measures of spread such as range, quartiles and standard deviation (Harris and 
Taylor 2010). 
Inferential statistics allow inferences to be drawn from the sample analysed 
about the population of interest. This is achieved by applying statistical tests to 
the data, such as Chi-squared test (Plichta and Garzon 2009).  Combining both 
descriptive and inferential statistics allows large amounts of data to be 
described and relationships within the data or to a larger population shown 
concisely (Creswell 2009). 
4.6.1. Phase 1a study population 
The initial target population for the survey was planned to be University Hospital 
Trusts listed within the Association of United Kingdom University Hospitals 
(AUKUH) as they were known to responsible for a large amount of study 
recruitment. In 2011/12 the average baseline recruitment for an AUKUH Trust 
was 5799 patients compared to a national average of 1463 (Watson 2013). On 
closer inspection and following communication with a Senior Policy Officer 
within the AUKUH it was found that their membership did not include all current 
university hospitals so was not a true reflection of all research active 
organisations.  
Following this a list of acute hospital trusts recruiting into NIHR portfolio studies 
was examined. It identified 161 research active NHS acute hospital trusts in 
England which were then chosen as the main population sample for data 
collection. Despite a lack of consistency in UK healthcare systems the study 
aimed to be as inclusive as possible. Therefore all 14 Scottish Health Boards 
were included as well as one organisation each from Wales and Northern 
Ireland.  This gave a total study cohort of 177 possible organisations. 
 Page 70 
4.6.2. Identification of Lead CRN at each site or individual 
responsible for CRN workforce 
Lead CRNs across all potential organisations were identified through three 
routes in the following sequence: 
1) Membership of a national organisation of Lead CRNs. This was 
established to provide sharing of ideas and peer support for those in the 
role. Membership had grown and at the time of planning the survey 
rollout it stood at approximately sixty nurses of which the researcher was 
one. 
2) NHS R&D Forum website list of R&D Managers across England who 
were individually contacted and asked to provide the name of their Lead 
CRN or someone responsible for the CRN workforce. 
3) If step was not successful or the website information was incorrect or 
missing, individual acute trust websites were viewed in order to identify 
telephone contact details. Organisations were then individually 
telephoned with the aim of speaking to R&D Manager or appropriate 
person. 
From a total of 177 organisations, a Lead CRN or individual responsible for the 
CRN workforce was identified in 144 organisations. This comprised 135 out of a 
possible 161 acute NHS trusts in England and seven out of a possible fourteen 
Scottish Health Boards. It also included one organisation in Wales and one in 
Northern Ireland. Within England there was a good representation across all 
five trust types and therefore the missing thirty three organisations did not 
prevent a representative sample.  Invitations were sent out in five groups as 
contact details were identified. Reminders were sent via the Survey Monkey site 
on two further occasions at fortnightly intervals. The survey ran from April to 
June 2015. 
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4.7. Phase 1b: NIHR recruitment figures 
NIHR portfolio recruitment figures were obtained in order to examine whether re 
– organisation of the CRN workforce had any effect on the amount of 
participants recruited into all studies. The NIHR was contacted in order to obtain 
as full a data set as possible as only recent recruitment figures were available in 
the public domain. The researcher was able to obtain full recruitment data for all 
participating organisations from October 2010 to September 2016 (annual NIHR 
recruitment year measured from 1st October until 30th September).). Annual 
data for each organisation was as follows: 
- Total number of Interventional studies 
- Total number of Observational studies 
- Total recruitment numbers into Interventional studies 
- Total recruitment numbers into Observational studies. 
Additional data about the CRN workforce size was obtained from the 
researchers’ survey of the workforce for 2014/15 but was not available for other 
years. 
NIHR recruitment figures were analysed using the Statistical Package for Social 
Sciences (SPSS), version 23. Choice of statistics for data analysis is 
determined by previous decisions such as the method of analysis, level of 
measurement of the variables and complexity of the research objectives (de 
Vaus, 2002a, b). In order to address the research objectives of the current 
study, data were analysed using descriptive, univariate and bivariate 
procedures.  
A generalised estimating equations (GEE) modelling approach was used to 
ascertain whether the number of studies (intervention or observation) and 
number of people recruited into those studies was explained by trust type, year 
and whether the trust had undertaken a review.  GEE was used specifically to 
account for within-trust clustering (year nested within trust). The models were 
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analysed with SPSS using the command GENLIN and subcommand 
REPEATED (Field 2009). 
The 2014/15 data were also modelled using the following explanatory variables: 
trust type, review and number of CRNs (grouped into quintiles: 0-9, 10-15, 16-
25, 26-50, 51 and over). On this occasion the REPEATED subcommand was 
not required because there was only one year of data. Both models assumed 
that the number of studies and people were generated from a Poisson 
distribution (Field 2009). 
Test of model effects (χ2, degrees of freedom) and estimated marginal means 
(mean for a variable/factor having adjusted for all other variables in the model) 
with 95% confidence intervals are presented. A type I error (p) of less than 0.05 
was the criteria used to determine whether an effect was statistically significant 
(or not). 
Throughout the data analysis process regular meeting with a statistician were 
held to clarify ambiguities and ensure appropriate procedures were followed.  
4.8. Phase 2: Case Study 
Four case studies were purposively sampled and invited to participate in phase 
2 of the study. Purposive sampling means members of the sample are chosen 
with a purpose: to represent a “type” in relation to key criteria (Ritchie et al 
2014). This allows the researcher to use their personal judgement for choosing 
the cases and selection criteria that will allow the research questions to be 
answered and objectives achieved.  
The aim of the case study was as follows: 
- To explore and compare the experience of research staff within different 
organisations using a quality framework. 
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- To explore the experience and perception of senior research staff (R&D 
Directors, Lead CRN and Principal Investigators) concerning the 
research nurse workforce within their organisation. 
4.8.1. Identification of participating organisations 
Within the phase 1 of the survey, respondents were asked whether they would 
consider taking part in phase 2 of the study. Four sites were identified from 
organisations who agreed and were segregated into two groups depending on 
whether the CRN workforce had been reviewed. From each group, two 
organisations were selected with matched criteria linked to (a) workforce size 
and (b) NIHR recruitment numbers as shown in Table 4.8-1. Identification of 
case study 4 was more problematic than for case studies 1-3. The initial and 
second choice organisations were better matched from a recruitment number 
perspective but when approached were unable to take part. Therefore the 
organisation for case study 4 was selected as it matched the workforce size of 
the criteria for its control which was case study 1. However, the NIHR 
recruitment figures were not as well matched as the researcher would have 
ideally liked. 
Table 4.8-1 Characteristics of Trusts in case studies, including clinical research nurse workforce and 









(Range 469 – 
23,187) 
1 Not reviewed 15 Quartile 1 
(Bottom) 
1006 Quartile 1 
(Bottom) 
2 Reviewed 120 Quartile 4 
(Upper) 
7786 Quartile 2 
3 Not reviewed 130 Quartile 4 
(Upper) 
9145 Quartile 2 
4 Reviewed 23 Quartile 1 
(Bottom) 
6685 Quartile 2 
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4.8.2. Planning of data collection visits 
Lead CRNs were contacted to inform them they had been selected for phase 2 
of data collection and to confirm agreement to participate. Information was 
provided regarding structure of data collection and information sheets were sent 
for each group of study participants (see appendix 14 to 17). The Lead CRNs 
was asked to identify the following participants to take part in an interview: 
- Principal Investigators currently recruiting into NIHR portfolio studies 
- R and D Director  
They were also asked to identify approximately five CRNs to take part in a focus 
group and informed that they would be asked to participate in an interview.  
4.8.3. Recruitment of participants 
Participants had all received a copy of the information sheet prior to the day of 
data collection. At the beginning of each interview the researcher introduced 
themselves to the participants and explained their professional background. The 
researcher then explained the following: 
- Brief overview of the study 
- Progress to date 
- Study rationale plus aims and objectives 
- Brief overview of interview structure 
- Confirmed that the interview would be recorded and transcribed. 
As the study was initially defined as Service Evaluation, written consent was not 
sought.  
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4.8.4. Data collection procedures 
Semi-structured interviews 
The interview is the most widely used method of producing data in qualitative 
health research, and is a conversation directed towards the researcher’s 
particular needs for data (Green and Thorogood 2009). Interviews are classified 
as to how far the researcher directs the interview. They range from structured 
where the interviewer follows a specified set of questions in a specified order to 
informal interviews which mimic natural conversations in an opportunistic 
manner with no structure or planning. The most commonly used types of 
interviews are i) Semi-structured – the researcher sets the agenda, ii) In-depth – 
allows the participant enough time to develop their own accounts iii) Narrative 
interview – the researcher facilitates the participant to tell their story.  
Within this study semi-structured interviews utilised a topic guide that was 
structured according to the six challenges within the quality framework 
(appendix 18).   
Questions were designed around some of the general themes within the phase 
1 survey such as: 
-  The understanding around the CRN role and research in general. 
- The interaction with clinical nurses 
- The understanding from clinical staff of research requirements such as 
clinic space. 
- Training and Education issues. 
Each group had the same questions planned with slight variations to account for 
role differences. Data collection was planned to take place on a single day. The 
interviews were planned throughout the day by the Lead CRN who provided the 
researcher with the schedule in advance. 
As described by Dearnley (2005) participants were encouraged to talk about 
their experiences and views through open-ended questions which aimed to 
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encourage depth and vitality and allow new concepts to emerge. Use of semi-
structured interviews within this study ensured that participants across and 
within all the case studies were asked the same questions. It allowed the 
interviewer to focus on issues of particular importance to the research question, 
probe and clarify comments made by the participants and use prior knowledge 
to support the questioning, whilst still allowing the participant the freedom to 
address any issues which they deemed important (Rose 1994). 
Table 4.8-2 Phase 2 Interview lengths 
Case Study Role 
Length  
hh:mm:ss 
1 Lead CRN 
R and D Director 
Principal Investigator 1 





2 Lead CRN 
R and D Manager  
Principal Investigator 1 





3 Lead CRN 
Head of Nursing & Midwifery Research 




4 Lead CRN 
R and D Director 




Fourteen semi-structured interviews were carried out across the four case 
studies. The order was dependant on the schedule prepared by the Lead CRN. 
However, the researcher had requested that the Lead CRN was interviewed 
first in order to gain an overview of the organisation and to give the researcher 
some initial information concerning items to be discussed across all 
participants. This occurred in all organisations except case study 4 where the 
Lead CRN was the second person to be interviewed.  
Interviews were conducted face to face, individually and in a quiet location. 
Each interview was recorded using a Dictaphone and lasted varying lengths as 
shown in Table 4.8.2. Contemporaneous notes were also taken during each 
data collection visit. 
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Focus Groups 
Including the voice of the CRNs was important as it provided greater insight to 
their experience working within different organisational structures. Social 
interaction around a topic, to gain an understanding of a group’s responses to 
similar experiences, is the basis of focus groups (Côté-Arsenault 2013). 
Typically, participants present their own views and experience but also hear 
from other people; they listen and reflect and in the light of this may further 
consider their own standpoint (Finch et al 2014). They ask each other questions 
to seek clarification, comment on what they have heard and may prompt others 
to reveal more. As the discussion progresses, individual responses become 
sharpened and more refined and so move to a deeper and more considered 
perspective (Finch et al 2014). The focus group helps to facilitate people to 
explore and clarify their views through a group process in ways that would be 
less easily accessible in a one to one interview (Spilsbury et al 2007). 
Therefore, one of the strengths of using focus groups is the group interaction 
that promotes spontaneity in responses. This is seen to present more of a 
natural environment than an individual interview as participants are influencing 
and influenced by each other just as they are in real life (Krueger and Casey 
2009). As confirmed by Morgan (1997: 2) “the hallmark of focus groups is their 
explicit use of group interaction to produce data and insights that would be less 
accessible without the interaction found in the group”.  
Each focus group included up to seven CRNs from each case studies. This 
allowed the researcher to gain a direct insight into their experience and provide 
the opportunity to reflect on and describe the reality of their role. The Lead CRN 
had sent the initial invite to their workforce. When the individual CRN confirmed 
their interest a copy of the participant information sheet was sent. The length of 
each focus group, banding and experience level of the CRNs varied as shown 
in Tables 4.8-3 to -6. Each focus group was recorded using a Dictaphone and 
conducted by the researcher in a quiet location. 
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Table 4.8-3 CRN participants in focus groups for Case Study 1 
Duration: 1 hour, 23 minutes and 23 seconds 
CRN 
number 
Role title Band Clinical area Length of time 
in research 
1 Generic CRN 6 Numerous Not stated 
2 CRN 6 Renal, Gastro & respiratory Not stated 
3 Generic CRN 6 Stroke Not stated 
4 Generic CRN 6 Mainly gastroenterology Not stated 
5 Generic CRN 6 Paediatrics, Women’s & neonatal 2 ½ years 
 
Table 4.8-4 CRN participants in focus groups for Case Study 2 
Duration: 1 hour, 15 minutes and 35 seconds 
CRN 
number 
Role title Band Clinical area Length of time 
in research 
1 CRN 6 Neonatal unit 21 years 
2 CRN 6 Oncology 8 years 
3 CRN 6 Generic for Research network 6 years 
4 CRN 6 Clinical Research Facility 7 years 
5 Research Sister 7 Clinical Research Facility 5 ½ years 
 
Table 4.8-5 CRN participants in focus groups for Case Study 3 
Duration: 1 hour, 16 minutes and 40 seconds 
CRN 
number 
Role title Band Clinical area Length of time 
in research 
1 CRN Nurse 
Manager 
7 Gastroenterology & Hepatology 6 years 
2 CRN 6 Emergency Department & 
Critical care 
15 months 
3 CRN 6 Emergency Department & 
Critical care 
5 years 
4 Lead CRN 7 Renal  12 years 
5  CRN 6 Renal Not stated 
6 CRN 6 Paediatrics 6 years 
7 CRN 6 Paediatrics 4 years 
 
 Page 79 
Table 4.8-6 CRN participants in focus groups for Case Study 4 
Case Study 4: 1 hour , 2 minutes and 15 seconds 
CRN 
number 
Role title Band Clinical area Length of time 
in research 
1 CRN  6 Neurosciences 1 year 
2 Oncology Lead 
CRN 
8a Oncology 3 ½ years 
3 CRN 6 Haematology & Oncology 2 years 
4  CRN 6 Haematology  2 years 
5  CRN 6 Gastro-Intestinal 1 year 
6 CRN 7 Cardiovascular Not stated 
All focus groups were conducted in a consistent manner and followed the 
guidance and stages as described by Ritchie et al (2014). These are as follows: 
1) Scene setting and ground rules – Participants were given a study 
overview and ground rules to include confidentiality and allowing others 
to speak. 
2) Individual introductions – Participants were asked to state their name, 
band, area of research and length of time in research. This was 
especially important in the larger organisations where the participants did 
not know each other. 
3) The opening topic – this provided a general neutral topic to facilitate the 
beginning of the discussion. 
4) Discussion – this was the main body and followed the interview schedule. 
5) Ending the discussion – participants were informed when the final 
challenge was being discussed and this helped to signal that the focus 
group was coming to an end. 
Following the focus group each was typed out verbatim to produce a transcript.  
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4.9. Analysis of phase 2 data 
4.9.1. Interviews and focus groups 
Data analysis of qualitative data, whether from interviews of focus groups, 
involves a process of labelling, organising and interpreting in order to generate 
a set of codes, categories or themes (Spencer et al 2014). These can then be 
further analysed in order to gain a deeper understanding and perspective of the 
participants’ views. Categories or themes can be determined in an inductive or 
deductive way (Elo and Kyngas 2008). If there is not enough former knowledge 
about the phenomenon being studied, the inductive approach is recommended 
whereas the deductive approach is based on previous knowledge. Within this 
study a total of 14 interviews and four focus groups were typed verbatim to 
produce 18 transcripts. These were then uploaded onto the data analysis 
package NVIVO version 10.0. All 18 transcripts were analysed together using 
an initial process of cross sectional analysis. Here the researcher devises an 
overall and common system of labels which is applied across the whole data set 
and used as a means of searching for and retrieving similarly labelled chunks of 
data. The initial labels were the six challenges within the Q.I framework. Within 
this initial codes (or main themes) were identified using a deductive approach 
based on the researchers own knowledge and experience. These included the 
value of research, clinical perspective concerning research and the CRN role 
and had been identified from the interview schedule in order to look across the 
data at these areas. As the data was further analysed main themes, such as 
leadership and interaction within staff, were identified using an inductive 
approach. Further sub themes were then identified as they were uncovered 
(see appendix 22 for a list of codes). Spencer et al (2014) refer to this as 
moving from an initial process of indexing and sorting to developing categories 
as analysis and interpretation progresses and it becomes possible to capture 
the essential meaning of the data and address the central research questions. 
Therefore across all interviews and focus groups whole group analysis was 
used. This treats the data produced as a whole without delineating individual 
contributions so that the group becomes the unit of analysis (Spencer et al 
2014). This approach was chosen as the researcher wanted to examine 
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experiences and perceptions across all the participants. It was expected that 
these may not be consistent and that although initial themes may match, the 
further analysis and revealing of sub themes would identify a mixture of 
findings.  
Within this analysis all transcripts and audio recordings were reviewed on 
several occasions. This allowed the researcher to become familiar with the data 
and ensure that for the themes that were identified as the analysis progressed, 
previous transcripts could be re analysed to ensure full inclusion of all data. 
4.9.2. Integration of qualitative and quantitative data 
The goal of integrating the phase 1 quantitative data and the phase 2 qualitative 
data is to provide a broad, rich and in-depth understanding of how the CRN 
workforce is currently organised within acute trusts, the experience of CRNs 
and the experience and perception of other research staff concerning the CRN 
workforce within their organisation 
Integration is seen as the key to mixed methods research and is defined as the 
process of linking qualitative and quantitative findings in the course of data 
analysis (Bryman 2007). Integration can take place at any stage of the research 
process from formulation of the research question to analysis of the data 
(O’Cathain et al 2007). As discussed earlier, analysis of both types of data sets 
involves a process of triangulation. Within this study triangulation was used to 
examine various aspects of the CRN workforce and experience. The study data 
was analysed to explore whether findings from the nationwide survey reflected 
those within the case study where further detail was obtained.  Bringing 
together of the data revealed a greater depth of understanding regarding the 
issues and experiences of the CRNs and other research staff. Aspects of the 
CRN experience and overall workforce which were briefly examined from the 
perspective of the Lead CRN in phase 1 were further explored with the CRNs 
and other members of the research team in phase 2. Within this the quantitative 
data was able to highlight the degree of the problem, e.g. is the CRN role 
misunderstood? The qualitative data was able to further explore this with the 
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Lead CRNs as well as gaining insight directly from the CRNs. As described by 
O’Cathain et al (2010) the data can then be explored for convergence, 
complementarity and discrepancy.  
4.10. Ethical considerations 
Ethical approval was initially granted by Kings College London University in 
August 2013 (appendix 14) and amendments following the pilot were approved 
in August 2014(Appendix 15) (PNM/12/13-123). As no patients were involved in 
the study approval from the NHS research ethics committee was not required.  
The study was classed as “Service Evaluation” according to the definition of the 
National Research Ethics Service (NPSA -2009). Therefore R&D approval was 
not required for either phase of the study.  
All interviews were recorded and then transcribed. Participants of the focus 
group were requested not to discuss the items discussed outside of the group. 
Transcripts were saved on a password protected computer held by the 
researcher. Locations of the case studies could not be identified on any of the 
transcripts. Additionally clinical professionals could not be identified within any 
of the recorded transcripts.  
The focus group discussion may potentially affect group participants emotionally 
due to over disclosure. The researcher therefore, continually monitored how 
participants felt during the session and included a debriefing session at the end 
of the discussion which was not recorded. The researcher discussed the topic 
of sensitive issues and confidentiality at the beginning of each focus group 
session and reminded participants not to discuss anything outside the group 
that was discussed during the focus group interview. 
4.11. Data Security 
All data was handled and managed in compliance with Good Clinical Practice 
and the Data Protection Act 1998. 
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All participants were informed that the recordings from the interviews and focus 
groups would be stored as encrypted files. They were also informed that data 
would be stored for a period of five years and then destroyed as agreed with 
Kings College London Ethics Committee. The location of the case study could 
be identified on the transcripts to ensure anonymity.  
4.12. Summary 
This chapter has provided an in-depth overview of the study design and 
methods used within this mixed methods study. The following chapter will 
present the results of both phases of the study. 
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Chapter 5: Results
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Phase 1 results 
5.1. Introduction 
This section will present the results from phase 1a of the study. The aim of this 
phase was twofold: 
1) To gain an overview of the current CRN workforce and the teams within 
which they were based.  
2) To identify which organisations had reviewed their CRN workforce and 
what form this had taken. 
Responses given in the analysis are based on the responses to each individual 
question as different response rates were received for each question. General 
demographics of the responses will initially be presented. Results will then be 
presented with respect to each of the six challenges within the ‘Organising for 
Quality’ framework. 
5.2. Survey population and sample 
Phase 1 of data collection involved a national survey of all acute NHS Trusts 
who were recruiting into NIHR studies as identified within the NIHR recruitment 
tables 2011/2012 as described in the methodology section. A final total of 173 
organisations were identified to be included within the survey. Table 5.2-1 
shows the breakdown of trust size defined as either small, medium, large, 
teaching or specialist. 
From a total of 173 organisations, a Lead CRN or someone within the R and D 
directorate who was responsible for the CRN workforce was identified in 144 
organisations (83%). For the remaining 29 (17%) organisations an individual 
was not identified for the following reasons: 
- 1 organisation declined to participate 
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-  4 organisations did not have a Lead CRN or someone who would be 
able to complete survey 
- 24 organisations did not respond 
There were small numbers within each type of organisation where it was not 
possible to identify an individual except for teaching acute trusts where 
someone was identified for all 19 of them. The survey was therefore sent to 144 
organisations via the online tool survey monkey. A response rate of 77% (111 
organisations) was achieved. Figure 5.2-1 illustrates the spread of participants 
across the UK and shows a good distribution of respondents. Two clusters 
around London and Manchester are noted where response rates are higher. 
These may be due to a higher prevalence of teaching and specialist trusts in 
these areas.  
Table 5.2-1 Summary of respondent by Trust type 







Small Acute 25 21 16 (14.5%) 
Medium Acute 46 36 26 (23.5%) 
Large Acute 43 38 29 (26%) 
Teaching 24 24 19 (17%) 
Specialist 19 16 12 (11%) 
NHS Scottish 
Health Boards 
14 7 7 (6%) 
Wales 1 1 1 (1%) 
Northern 
Ireland 
1 1 1 (1%) 
TOTALS 173 144 111  
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Figure 5.2-1 The geographical spread of respondents across the UK. Data are clustered based on the 
proximity of locations. Generated using mapsdata.co.uk. 
5.3. Survey respondents 
From the survey responses received, 68% (76/111) were completed by 
someone in a research nursing related role. The remaining 32% (35/111) were 
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completed by those in a non-nursing role. Table 5.3-1 shows the role and band 
of all the respondents.  










Band 6 2 Clinical Research Nurse 




Band 7 41 Clinical Research Nurse 


















Band 8b 12 Lead CRN 
R&D Manager / Research 
Manager 





Band 8c 6 Lead CRN 






Figures 5.3-1 shows the banding level of respondents per type of organisation. 
It demonstrates that the larger the organisation so the more senior the level of 
the individual responsible for the CRN workforce becomes. This is particularly 
pronounced in the acute teaching trusts, where no respondents were below the 
band 8 level. This may lead to limitations in the interpretation of the data. 
However, as this area has not been explored before, it does provide an initial 
overview which was previously not available. 
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Figure 5.3-1 Questionnaire respondents broken down by banding and organisation type.  
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5.4. Respondents’ employment profile 
Respondents were asked to provide information on the length of time they had 
worked in their current post and their pay band. The length of time that 
respondents had been in post ranged from newly commenced to 20 years with 
an overall average of 47 months in post. Sixty-nine percent (74/98) were the 
first person to hold their role and 21.5% (23/107) had been in post 12 months or 
less. 
5.5. Banding of CRN posts 
 
Figure 5.5-1 A graph illustrating the range of pay bands including agenda for change (‘Band’) and 
university scales (Grade) for CRNs within all respondent organisations. 
The majority of the CRN workforce across all organisations are at a band 6 and 
band 7 level with only approximately 50% (55/111) having CRNs at a band 5 
level. Those who had posts at a band 8 level had small numbers of these posts. 
Only a very small amount (11/111, 10%) had CRNs appointed through their 
partner university and those that did were mainly acute teaching trusts (one 
such organisation was a large acute trust). 
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5.6. Research areas 
The survey asked respondents to indicate the clinical research areas where 
CRNs were based. As expected, due to the initial set up of the National Cancer 
Research Networks, the most common clinical area was Oncology. Following 
this Stroke, Haematology and Cardiovascular research were areas in which 
significant research was being supported by the CRN workforce. However, 
within the “other” option respondents also indicated an additional 15 clinical 
areas where research was running within their organisation, including areas 
such as ophthalmology, neurology, anaesthetics and occupational health. 
Figure 5.6-1 shows in more detail the different clinical research areas covered 
by CRN roles 
 
Figure 5.6-1 Clinical areas where CRNs support research studies 
 Page 92 
Further survey results will now be presented within the six challenges that 
constitute the “Organising for Quality” framework which was initially described in 
Chapter 3. 
5.7. Challenge 1: Structure 
5.7.1. Workforce review 
Participants were asked to indicate whether their CRN workforce was reviewed. 
No time frame was stated within this as due to the recent evolution of the CRN 
role and the impact of the NIHR on this, it was not expected that organisations 
would have felt the need to review their workforce over a long period of time. 
Over half (59/107, 55%) stated that their CRN workforce had been reviewed, 
33% (35/107) said it had not and 12% (13/107) were unsure. Actions following 
the review were as follows:  
Table 5.7-1 Actions taken following CRN Workforce reviews 
Percentages of 59 organisations 
reporting having carried out a CRN 
workforce review 
Outcome of review 
42.5 % (25/59) Changes were made within teams but the 
whole workforce was not restructured. 
27% (16/59) Stated that other changes were made 
25.5% (15/59) CRN workforce was restructured 
5% (3/59) No changes made. 
The definition of a workforce review was omitted in the survey as it had not 
been anticipated - or highlighted in the piloting of the survey - that clarification 
would be required. Responses from the open comments indicated that 
interpretations to this ranged from carrying out a full review to a review of just 
individual teams or roles.  The open comments (n = 53), were coded to gain 
further detail on the other actions taken and the most common was that an 
internal restructure of teams and / or posts had been carried out – 34% (18/53). 
Only 13% (7/53) respondents were currently reviewing their workforce and 9.5% 
(5/53) had established a more generic workforce to provide greater cover for 
studies.  
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Table 5.7-2 looks at type of organisation and whether it has been reviewed or 
not. The data was examined in order to determine whether any relationship 
existed between organisation type and review. As shown below a greater 
number of larger organisations (incorporating large, specialist and teaching) had 
reviewed their workforce compared to those of the same type that had not. 
However, there was no statistical significant difference between the two 
proportions (x2 = 0.609, xd.f, p = 0.44). 
Table 5.7-2 Examining the relationship between Trust type and review status. 




which have not 
reviewed 
Small & Medium 34% (20) 40.5% (21) 
Large, Specialist 
& Teaching 
59.5% (35) 50% (26) 
Scotland/other 6.5% (4) 9.5% (5) 
5.7.2. Research structure 
A majority (81%, 71/88) of respondents stated that their CRN workforce was 
embedded within a “defined research structure”.  Further clarification was 
gained and respondents were also asked to indicate from a list what structure 
applied to their workforce. The results were as shown in Table 5.7-3 
Table 5.7-3 Is your CRN workforce embedded in a defined workforce structure? 
Answer Options Response 
Percent (Count) 
RN workforce works as part of the Local Research 
Networks or within one of the divisions. 
86% (73) 
Organisation has one or more Clinical Research 
Facilities (CRFs) 
34% (29) 
Organisation is part of the Network of Experimental 
Cancer Medicine Centres (ECMC) 
16.5% (14) 
Organisation has been assigned as one of the NIHR 
Biomedical Research Units 
10.5% (9) 
Organisation is part of an Allied Health Sciences 
Centre 
10.5% (9) 
Organisation has been assigned as one of the NIHR 
Biomedical Research Centres 
9.5% (8) 
Answered question (Skipped question) 85 (26) 
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The majority of respondents (86%, 73/85) stated that their workforce was part of 
a Local Research Network. As the NIHR supports research within the NHS this 
is only relevant to organisations within England. For the respondents located in 
Scotland, Wales and Northern Ireland, not all aspects of this question were 
relevant (although Clinical Research Facilities are not unique to the NHS so this 
aspect was relevant to all). Some respondents stated that their CRNs were 
employed directly by the trust and did not give further details. Many had a mixed 
model in place and were planning to formalise this in the future. 
There was also a diversity of responses in relation to team structures within the 
CRN workforce (table 5.7.3). 
Table 5.7-4 CRN team structures 
Answer Options Proportion of response (count) 
Working directly with Consultants on their research 
studies 
63.5% (52) 
In a structured research team within one clinical area 55% (45) 
Working within clinical teams with non-research 
colleagues 
51% (42) 
Working within a Clinical Research Facility 40% (33) 
Working in one area in different research teams 38% (31) 
Working independently in one or more clinical teams 
but not within a research or clinical team 
21% (17) 
Other (please specify) 30.5% (25) 
Answered question (skipped) 82 (29) 
 
Open comments in response to this question enabled respondents to indicate 
that their CRNs worked within a “generic” team and covered areas depending 
on where studies were running. Although the survey did not specifically ask 
questions regarding a generic workforce structure, those who indicated this as 
their structure were more likely to be based within a small or medium acute trust 
and have a smaller CRN workforce size (20 CRNs).   
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5.7.3. Research roles within teams 
The survey listed 12 potential research roles (clinical and non-clinical) and 
asked respondents to indicate which ones were employed within their 
organisation as shown in Figure 5.7-1 below. 
 
Figure 5.7-1 Range of roles within research teams. The graph shows the proportion of total respondents 
who identified the named role within their organisation  
Within the “other” category a further 29 roles were provided with some relating 
to other members of the multi-disciplinary team (e.g. Research Radiographer, 
Research Dietician and Research Pharmacy Technician). Many of these roles 
appeared to be non-clinical (e.g. Research Co-ordinator, Research 
Administrator, Research Practitioner and Research Officer). No further 
information was given regarding the remit and responsibilities of these roles 
which may overlap in their day to day activities. The wide range of roles and job 
titles identified in the survey demonstrates the current lack of consistency 
across organisations with regard to research activity. Many non-clinical roles 
have been developed in response to a growing research portfolio, increased 
funding and a recognition of the value and need for such roles within a research 
team. This finding will be revisited further in the discussion chapter. 
Figure 5.7-2 shows the ways in which CRNs are appointed into the 
organisation. A significant percentage (81%, 73/90) was appointed through the 
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Research & Development (R&D) department (perhaps unsurprisingly as 
organisations receive research funding from the NIHR and this is managed 
through such departments). Respondents also indicated other routes through 
which CRNs were appointed such as via the CRF, which would then come 
under the R&D department, directly by the trust or via another trust through a 
local NIHR research network.  
 
Figure 5.7-2 Routes by which CRNs were appointed into the organisation  
Table 5.7-5 shows the funding sources for the CRN workforce. The majority of 
respondents indicated that their main source of CRN funding was from the 
NIHR (as this only covers England those that did not select this option were 
based within one of the other UK countries). Funding from Pharmaceutical 
Companies formed the second main source of funding indicating that many 
CRNs also work on a commercial portfolio of clinical trials. Most organisations 
listed other funding sources. Small and medium acute trusts were more likely to 
employ their CRNs solely via the R&D department alone (especially when they 
had a relatively small workforce). Those organisations with a large workforce 
were more likely to employ their CRNs through several routes including R&D, 
reflecting the various funding streams that support the CRN workforce. 
Please indicate how your CRNs are 
appointed 
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Table 5.7-5 Sources of funding for CRN posts in respondent organisations. 
Answer Options Response Percent (Count) 
NIHR funded 96.6% (85) 
Pharmaceutical Company 59.1% (52) 
Research grant - e.g. - MRC 42% (37) 
Charity grant - e.g. - CRUK  33% (12) 
Nursing Directorate 13.6% (29) 
Other (please specify) 24% (21) 
Answered question (skipped) 88 (23) 
5.7.4. Line management 
Figure 5.7-3 illustrates the role of those responsible for the line management of 
CRNs. The majority of organisations (82%, 73/89) have senior CRNs 
responsible for the line management of some CRNs within their workforce. 
However, 36% (32/89) indicated that CRNs were line managed by a clinical 
nurse (Matron, Consultant nurse or CNS) and 38% indicated that they could be 
line managed by the R&D Manager. Other post holders had line management 
responsibilities in a small amount of organisations including Consultants (16%, 
14/89) and Research Managers (16%, 14/89). In 10% (9/89) of responses there 
was no nursing involvement in the management of the CRN workforce. Overall, 
the table demonstrates that there is often a range of managers, nursing and 
non-nursing, involved in the line management of the CRN workforce.  
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Figure 5.7-3 Line management of CRNs. The proportion of respondent organisations indicating named 
post holders are responsible for CRNs. Question: “Please indicate which of the following in your 
organisation are responsible for the line management of CRNs - tick any that apply.” 
5.7.5. Summary 
In relation to the ‘structural’ challenge, the survey identified that just over half of 
the organisations had reviewed their CRN workforce but only a few of these 
(25%, 15/59) had carried out a full review. The majority of respondents 
indicated that a review would usually take the form of an internal re structure of 
teams and / or posts. The survey also identified the lack of consistency both 
within and across organisations as to the structure of the CRN workforce and 
the establishment of teams within organisations, especially relating to the range 
of possible research related roles within teams, sources of funding and line 
management of post holders.  
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5.8. Challenge 2: Culture 
The questions within this section aimed to examine and reveal how research is 
viewed across organisations and what value and importance is placed upon it. 
They also aimed to explore the understanding from clinical staff of the CRN role 
and examine how CRNs were perceived whilst in the clinical environment.  
Respondents were asked to rate the importance of research across their 
organisation on a five point Likert scale. The majority of the participants (70%, 
72/102) agreed or strongly agreed that research was considered important or 
relevant within their organisation and 51.5% (52/102) agreed or strongly agreed 
that research was considered important by senior nurses across their 
organisation. However, only 26.5% (27/102) agreed or strongly agreed that 
research is considered important by all staff within the clinical areas. This was 
reflected in the open comments of all the respondents who acknowledged the 
strategic importance of research. For example, respondents commented that 
the “CEO and clinical leads think it is important to raise the profile” and that 
“staff will tell you that research is important to the organisation”. Therefore for 
some respondents there was a feeling that “clinical research is definitely rising 
up the priority list” and that they were “moving forward in many areas”.  
For many organisations there was recognition from the Executive team of the 
importance of research - it was “mentioned in most strategy documents” and 
often seen as “useful and important” - but respondents also highlighted the 
difficulties from an operational perspective. Many comments focused around the 
lack of priority accorded to research and variation in response across their 
organisation. Respondents felt that research was “viewed as an added extra” 
and “not fully embraced as core business”; there was an overall “lack of 
understanding“ and “clinical areas still struggle with seeing research as 
important”. Respondents highlighted a feeling of “apathy” from staff due to 
“added pressures” from a busy clinical workload and that research was a “nice 
to have not an important to have”.  
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There was a feeling of a lack of consistency within organisations as to the 
importance of research. Respondents commented that the response was 
“highly variable” with “pockets of excellence but still a long way to being core 
business”. One respondent commented that “in some areas it is seen as core 
business but in other areas research is seen as unimportant” while another 
stated that “nurses on the wards where research protocols take place are very 
helpful but the senior nurses across the trust are not so engaging”.  
Some of the issues around the importance of research seem related to it being 
seen as separate from clinical care. CRNs have been viewed as a “university 
employee” and “one of the historic barriers was probably the fact that research 
was very much seen as the domain of the university and not the trust”. Although 
the development of research units known as Clinical Research Facilities (CRFs) 
has provided dedicated space for research , it has also led to it being seen as a 
“separate entity” with “limited understanding of the day to day running of the 
unit” and a lack of “visibility”.  
Responses relating to the understanding around research 57% (56/98) 
disagreed or strongly disagreed that research was misunderstood and there 
was little general support for its success. However, 69.5% (67/97) did agree or 
strongly agree that research is generally low on people’s agenda due to the 
importance given to and workload implications from government targets, 
initiatives and reports. Respondents felt that “there is a general positive attitude 
to research” and “staff are aware of its importance and in calm periods are keen 
and happy to facilitate”. For many clinical workload was a big factor and “when 
the pressure is on one of the first things to suffer is research”. There were many 
reasons stated for this including that “clinical requirements always take priority”, 
“research is low on peoples agenda because of competing pressures” and “ 
research can often be deemed as an add on”. However, research teams are 
keen to increase awareness of research. One respondent explained that the 
CRNs “are working hard to improve this (research awareness and 
understanding) overall and beginning to see results where research is seen as 
a natural treatment choice and not as an optional extra”.  
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The survey also looked at the understanding of the CRN role. Forty per cent of 
respondents (39/98) said that the role was not understood and 32.5% (32/98) 
were not sure. Only 27.5% (27/98) felt that the CRN role was understood. 
Respondents felt that clinical nurses “very often lack insight into the true nature 
of the role”,  “fail to see the research nurse role as a clinical role” and “senior 
nurses often ask how are research nurses going to get revalidated as they need 
to demonstrate clinical practice”. Respondents explained that often there is a 
lack of understanding as to what the role involves with clinical nurses thinking it 
is an “easy option”, “a computer based job” and would “openly admit a lack of 
knowledge and confidence in managing research nurses”. Respondents also 
felt that clinical nurses “do not understand the varied aspects of the role”, “the 
scope of the role” and that generally research “is an add on rather than integral 
to the day to day work of the clinical area”. Reasons for the lack of 
understanding included that it is “difficult to see what the role involves without 
spending some time in research” and “there is confusion regarding the role of 
the research nurse and the nurse researcher”. Some even felt that CRNs are 
“often viewed with suspicion when in outpatient clinics or ward areas until the 
role is explained and the staff realise that they do not have to do the work”.  
Some respondents did comment in a more positive way and highlighted some 
of the work that had been done to “dispel the myths”. They felt that some nurses 
“partially understand our role” and that this is better “in areas where there is a 
strong research culture” but it depends on “how much we have infiltrated the 
area”. Lead CRNs had spent time working to increase awareness of the role. 
One commented that they now “hold regular research forums and participate in 
events in wards and across the organisation”. This meant that now awareness 
was “improving slowly but surely” and there had been “huge improvements” so 
that “many more colleagues have a greater understanding of the research nurse 
role now compared to 5 years ago”. 
Despite an apparent lack of understanding and awareness of research and the 
CRN role, 92% (95/103) of respondents felt that non research colleagues did 
help to facilitate research. Related to this 92% (84/91) said that staff would 
inform CRNs about patients who may be suitable to be included in studies and 
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76% (69/90) thought that clinical staff are interested in the studies and willing to 
remain updated about new protocols. Furthermore, 83% (74/89) thought that 
staff are willing to collect a small amount of research data if seeing the patient 
as part of a clinical appointment (See Table 5.11-1). 
Despite this apparent support, the majority of comments related to this indicated 
that within most organisations there was a “mixed” and “patchy” response to 
research with “varying degrees of engagement”. Reasons for this were related 
to “how common research activity is and the relationships with the research 
team”. Many of the comments indicated that the reason for the difficulties 
experienced in gaining engagement and support were due to the fact that 
“research is not embedded into normal practice and care”.  Respondents also 
indicated that clinical areas often felt that research “adds to their clinical 
workload which is already huge” and “they feel it is not their remit to contribute 
even if it is something that is routinely done for their patients”. Respondents 
also indicated that clinical staff often view research as separate with one 
commenting that “there is a reluctance to collect any data which is additional to 
routine clinical care as nurses do not see this as part of their role and perceive 
requests for help as detracting from routine patient care”. One Lead CRN 
summed it up as follows: 
“I could answer yes or no to all of the above questions as there 
are some engaged staff who will do all these things and some who 
absolutely would not. We experience extremes of negativity and 
positivity and everything in between” 
― Question 11, comment 40 
Many of the respondents indicated that they and their team spent time and 
energy in working to raise the awareness of research in order to gain support 
from clinical colleagues. This included assisting CRNs to “maintain good links 
with clinical and non-clinical staff”, “build up very good relationships within their 
immediate clinical teams so the awareness of local specific research is 
relatively good” and develop “strong working relationship with wider clinical 
teams as this is key to continuity, consistency and quality of care for patients”. 
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Only 44% (43/98) respondents agreed or strongly agreed that CRNs feel 
welcome within the clinical environment and are allocated dedicated space to 
see research patients;  28.5% (28/98) disagreed or strongly disagreed with this 
and 27.5% (27/98) were unsure or neutral in their response. Related to this 52% 
(51/98) agreed or strongly agreed that the CRNs frequently comment on the 
difficulty of seeing patients in the clinical environment and being able to spend 
the required amount of time with the patient; 30.5% (30/98) disagreed or 
strongly disagreed and 17.5% (17/98) were neutral or unsure (see Table 
5.10-1).  
Respondents indicated that CRNs experience a range of responses across their 
organisation when seeing patients for their research appointments within the 
clinical area. Responses experienced were “variable”, at times “obstructive” but 
often “dependent on department”. Respondents indicated that often the “CRNs 
feel welcome but due to capacity issues they cannot often find space” and that 
often there are “challenges in many areas to find dedicated space due to clinical 
pressures and patient flow”. One respondent said that “clinical staff help as far 
as possible to enable rooms to be available for study visits, but if the rooms are 
required for clinical visits then study visits are cancelled”.  Others referred to 
“borrowed space” or “a lot of variety across the trust in the physical resources 
available to the research teams”. So that overall many agreed that some of the 
problem lies in the fact that “the CRN is at the bottom of the chain when trying 
to organise space”. This may account for why 59% (57/98) of respondents 
indicated that CRNs report that patients are sometimes missed, due to the 
difficulty in organising allocated space.  
Therefore, in summary research is not yet viewed as core business or 
integrated into clinical care. Clinical staff do acknowledge it is important and 
from a strategy perspective it is viewed as important and relevant. However, as 
it is not yet seen as a priority there is a lack of consistency in staff engagement 
and as clinical workload increases the importance assigned to research drops 
as staff focus on competing pressures such as “acuity of patients, safe staffing 
and meeting quality targets and KPI’s (key performance indicators)”. There is a 
similar picture with the CRN role as it is seen as not understood, not a clinical 
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role and a lack of understanding regarding the workload. At times it is also 
confused with the role of a Nurse Researcher. Many CRNs and their teams 
have worked hard to increase the awareness and understanding but there is a 
recognition that this work will need to be ongoing. 
 
5.9. Challenge 3: Education 
The education of the CRN workforce was examined in order to gain an overview 
of how CRNs are supported both academically and in wider personal 
development terms. The survey aimed to explore both induction programmes at 
commencement of the role and ongoing training to support professional 
development. Related to this was questions concerning funding support and 
time allowed in which to attend training courses. The current academic profile of 
the CRN workforce was also explored.  
Looking at the education of nurses, 90% (93/103) of respondents said that their 
organisation supported the professional development of nurses. Positive 
influences included that “R & D hold funding for the research team and do not 
put up any barriers to study days” and “nurses are encouraged to keep learning 
and progress”. Respondents also commented that “research nurses are very 
fortunate as we get quite a lot of opportunities compared to the general ward 
staff” and “we are always actively supporting development opportunities 
supporting CRNs through leadership courses as well as Masters Programmes”. 
Respondents also remarked that their nurses had been “successful with NIHR 
fellowships”. 
However, within this many constraints were also mentioned such as “funding 
resources are limited and there are significant challenges in releasing staff from 
clinical duties” and it “has to be mandatory for the job role”. One respondent felt 
that “the organisation appears supportive but opportunities appear limited” and 
another stated that “despite claims that it does there has been little evidence of 
this”.  For one respondent CRNs were not a priority when allocated courses and 
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“only tend to get on courses like nurse prescribing when there are places left 
after the clinical staff have been offered it”. This was confirmed by another who 
stated “other CNSs do get professional development but research nurses do not 
have that support”. One respondent summarised their situation as follows: 
“staff can access training but have to complete in their own time. 
Generally speaking there is support in principle but things are tight 
so due to workload and recruitment and retention issues that this 
makes it very difficult”. 
― Question 14, comment 24 
The survey aimed to examine the academic profile of the CRN workforce.  
However, the results demonstrate that many respondents were unsure of this 
and a large amount indicated that they did have CRNs at some or all of the level 
options but were not sure of numbers. Many respondents confirmed their CRNs 
had a first degree but of those who responded, 55% (37/67) did not know the 
exact numbers. This was the same for the Masters and PhD / Doctorate 
programmes although the numbers stated were smaller. This question also 
received the smallest number of responses which may indicate that 
respondents did not have this information regarding their workforce. Those with 
a larger workforce were less likely to provide this information, possibly 
demonstrating the difficulty in obtaining it and keeping it up to date for large 
numbers of staff. 
As shown in Figure 5.9-1, funding for academic programmes appears to be 
limited with less than half of respondents (ranging from 22-49%) confirming that 
CRNs were always able to access financial support from a variety of sources. 
Approximately a third of respondents (ranging from 28-38%) confirmed that 
funding would occasionally be available. Internal funding related to the CRNs 
own department was the most common source of funding although all possible 
options within the survey were confirmed as available.  
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Figure 5.9-1 Source of funding for academic courses. 
There was a range of responses as to how the study leave was arranged within 
organisations. Some indicated it was “negotiable on a case by case basis”, “at 
Managers discretion” or “according to trust policy”. Others indicated it was 
“related to the organisational training needs analysis linked with the appraisal” 
or “considered in relation to how relevant the course is to the role”. One 
organisation allowed 18 days a year for study leave but this was an exception.  
Respondents indicated which induction programmes their CRNs attended when 
initially commencing their role. As shown in table 5.9-2, 96.5% (87/90) indicated 
their staff attended a Corporate Trust induction programme, 96.5% (78/81) 
indicated their staff attended a local induction programme and 91% (79/87) a 
research induction programme.  
Slightly fewer (82%, 54/66) attended a trust nursing induction programme. A 
few respondents (33.5%, 4/12) indicated their CRNs attended other induction 
programmes although no examples were given.   
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Table 5.9-1 Summary of induction programmes for new research nurses in respondent 
organisations. 
Answer Options Yes No Response 
Count 
Corporate Trust Induction 87 3 90 
Trust Nursing induction 54 12 66 
Local Induction programme 78 3 81 
Research Induction programme 79 8 87 
Other 4 8 12 
Other (please specify) 15 
CRNs also attended a range of generic and research-related training as 
indicated in Figure 5.9-2 and Figure 5.9-3 respectively. 
 
Figure 5.9-2 Non research-specific training & development courses available for CRNs. Question: “Please 
indicate which generic Training and Development programmes a RN within your organisation is expected 
to attend - Tick any that apply” (indicates number of respondents out of 90) 
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Figure 5.9-3 Research-specific training & development courses available for CRNs. Question: “Please 
indicate which research training and development programmes a CRN within your organisation is 
expected to attend?” (Indicates number of respondents out of 95). 
Within the required clinical skills, additional training included anaphylaxis, 
physical assessment skills and nurse prescribing. For research related training, 
additional requirements were dependent on the individual’s role and CRNs were 
“expected to attend any course relevant to the studies that they do”. This 
included skin biopsy training and handling of dry ice training. 
All respondents confirmed that their CRNs undertook regular Good Clinical 
Practice (GCP) training. However, although the Human Tissue Act (HTA) 
covers the removal of human tissue including blood and 93% respondents 
confirmed their CRNs undertook phlebotomy training, only 49.5 % confirmed 
that their CRNs received HTA training. The survey did not question rationale for 
answers although organisations may provide informal practical training which 
respondents may not have included within their responses.  
A small number of respondents confirmed that they ran a regular structured 
training programme for their CRN workforce (26.5%, 24/91). The frequency of 
these programmes varied within and across organisations ranging from monthly 
to annually. For those who ran a regular session the duration was generally one 
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to two hours but respondents indicated that their annual training sessions 
generally ran for a whole day. Some organisations incorporated their mandatory 
research training sessions within their programme (examples included GCP, 
consent and data management). Others included “mixed generic sessions 
related to research and general nursing updates” within their programmes. 
Respondents generally indicated that these sessions were not for those working 
in a non-research related role with all respondents except one confirming that 
the sessions were open to anyone working within research (including R&D 
Managers). 
In summary, the majority of respondents reported that their organisation 
supported the professional development of nurses.  However, within this there 
was a mixed response with some reporting that CRNs are more fortunate 
compared to clinical staff while others felt that CRNs were not a priority. Within 
the CRN role there was a range of courses attended by CRNs both at induction 
and within the role to support professional development. Challenges to support 
training include funding and time allowance and there was a range of 
developmental opportunities across organisations. Although academic 
development was supported the majority of respondents were unable to 
describe the academic profile of their workforce. This was especially on those 
organisations with a large CRN workforce.  
5.10. Challenge 4: Politics 
Survey questions related to the ‘political’ challenge aimed to explore the 
reception that CRNs receive within the clinical environment and how 
accommodating clinical staff were towards them, including whether staff would 
help with identifying dedicated space for CRNs or support small amounts of 
workload related to research (such as helping to identify suitable patients). The 
role of CRNs within the research team and degree of Principal Investigator (PI) 
involvement was also explored. 
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Table 5.10-1 Summary of responses relating to the Political challenge 
Answer Options Strongly 
agree 




RNs are made to feel accepted within the clinical environment 
by their nursing colleagues and efforts are made to 
accommodate their requirements. 
7% (6) 57% (50) 20.5% (18) 12.5% (11) 1% (1) 2% (2) 88 
Clinical nurses are happy to help identify suitable patients for 
studies if asked or collect small amounts of data if requested. 
4.5 % (4) 51% (45) 29% (26) 12.5% (11) 1% (1) 2% (2) 89 
The RNs find the clinical environment a difficult working 
environment. 
2% (2) 27.5% (24) 28.5% (25) 33% (29) 8% (7) 1% (1) 88 
The RNs within the team are able to express their own ideas and 
opinions in tem meetings and have an influence on decisions 
being made. 
34.5% (31) 52.5% (47) 12% (11) 0 0 1% (1) 90 
The research team (PIs and RNs) meet regularly at a dedicated 
research meeting and individual PIs discuss the studies they 
would like to set up taking into account the current capacity of 
the research nurse workload. 
18% (16) 50% (45) 19% (17) 10% (9) 2% (2) 1% (1) 90 
My staff turnover is no different compared to the general nurse 
workforce in my organisation. 
10% (9) 36% (32) 11% (10) 25% (22) 14.5 % (13) 3.5 % (3) 89 
The PIs are actively involved in all stages of their research 
projects and regularly check on its overall progress and the 
progress of the patients involved. 
11%(10) 42% (37) 31.5% (28) 13.5% (12) 2% (2) 0 89 
The PIs regularly engage with the progress but leave the RNs to 
take overall management of their project. 
27.5% (24) 53.5% (47) 12.5% (11) 4.5% (4) 2% (2) 0 88 
It can be difficult to involve the PIs in the day to day leadership 
of their projects. 
11% (10) 39.5% (35) 27% (24) 16% (14) 5.5% (5) 1% (1) 89 
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Table 5.10-1 shows the reception experienced by CRNs in the clinical 
environment and that 63.5% (56/88) agreed or strongly agreed that CRNs are 
made to feel accepted within the clinical environment by their nursing 
colleagues and efforts made to accommodate their requirements. 55% (49/89) 
also agreed or strongly agreed that the clinical nurses are happy to identify 
suitable patients if asked, or collect a small amount of data if requested. Only 
29.5% (26/88) respondents felt that the CRNs find the clinical environment a 
difficult working environment.  
Many of the free text comments provided demonstrated that overall the 
response experienced by CRNs in the clinical environment can be very varied 
and inconsistent across an organisation. Some respondents felt this question 
was “difficult to answer as some areas can be very involved and happy to 
contribute to the research but others can be quite difficult to build up 
relationships with” whilst others said it was “difficult to give a blanket answer for 
the whole workforce as it depends on the area they work”. Some referred to a 
“struggle” and “feeling daunted” when in the clinical environment. However, 
respondents did comment that “staff are accommodating and generally 
supportive” and that “there is a willingness of the clinical staff if approached”. 
There was a wide agreement that clinical space is a difficult and frequent issue 
with one respondent remarking that “lack of space is the main issue why 
research nurses find it difficult to fit into the clinical environment and be 
accepted”. Others commented that “space is often an issue particularly in the 
acute areas where CRNs are ideally allocated space within the department but 
research is not seen as important enough to warrant this”. The impact of this 
can be that CRNs “feel they are getting in the way of the clinical nurses” and 
that they may be “moved from room to room depending on the number of 
medical staff requiring rooms”, so that at times “there is nowhere for the CRNs 
to see patients which means they have to waste time looking for a suitable 
area”. 
There was a strong response that the CRNs are involved within their research 
team with 86.5% (78/90) agreeing or strongly agreeing that CRNs within the 
team are able to express their own ideas and opinions in team meetings and 
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have an influence on decisions being made. A  majority (68%, 61/90) agreed or 
strongly agreed that the research team (PI’s and CRNs) meet regularly at a 
dedicated research meeting and individual PIs discuss the studies they would 
like to set up taking into account the current capacity of the research nurse 
workload. Again free text comments indicated a varied and inconsistent 
experience across different teams with one commenting: 
 “answers vary considerably between teams. Some have a 
dedicated nurse team and monthly meetings to approve study set 
up/acceptance onto the portfolio. Other research nurses work 
alone or with a colleague in other specialities across the trust. 
Nurses employed through the university work exclusively with a 
team and I do not know how a decision is made” – Participant x  
― Question 51, comment 3 
Some felt that the CRNs “are able to express ideas and opinions but not 
necessarily always able to influence” and that there is a “variation in team 
discussions and agreement on capacity depending on the size of the research 
team”. 
Exploring Principal Investigator (P.I) engagement, 53% (47/89) agreed or 
strongly agreed that the P.I’s are actively involved in all stages of their research 
projects and regularly check on its overall progress and the progress of patients 
involved. However, 81% (71/88) agreed or strongly agreed that the P.I’s 
regularly engage with the progress but leave the CRNs to take overall 
management of their project and 50.5% (45/89) agree or strongly agree that it 
can be difficult to involve the P.I’s in the day to day leadership of the project.  
The free text comments highlighted the varied engagement of P.I involvement in 
the studies. Respondents referred to “some who are very active and very 
engaged” whereas others “need constant encouragement from the research 
nurses to engage”. One respondent commented: 
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“P.I role is variable. There are some who are extremely engaged 
and demonstrate active P.I oversight, whilst others it is more 
challenging for the CRN to engage with them” 
―  – Question 49, comment 38 
Looking at staff turnover, 46% (41/89) agreed or strongly agreed that theirs was 
no different compared to the general workforce in their organisation. Free text 
comments related to this reflected the same breakdown as the Likert scale 
scoring. There was an approximate equal amount of comments related to 
whether respondents felt they had a high or low turnover rate. Those who felt it 
was high related this to “CRNs being on short term contracts which are a 
difficulty that other clinical areas do not have”. One of the respondents summed 
up many of the comments with the following: 
“Funding for the nurses via the NIHR is on an annual basis. This 
does not provide stability for the nurses who have families and 
mortgages to pay and prefer to have a permanent contract. A lot 
of time and effort is spent in training research staff and then they 
leave for permanent posts”. 
― Question 51, comment 18 
Some felt their “turnover is probably lower than the rest of the organisation”. For 
most this was probably a subjective opinion as it was not formally measured. 
Respondents equated this to “the team being dynamic and friendly” and that 
“the majority of nurses wish to remain and pursue research as a career option”. 
Almost half (45%, 43/95) respondents said that their CRNs worked across more 
than one organisation. In terms of organisation of governance requirements 
(honorary contracts / research passports), of these 67.5% (29/43) said it was a 
very easy and smooth process, 23% (10/43) said the process was not so easy 
and seemed to take longer than necessary and 9.5% (4/43) said the process 
was very difficult and slow which lead to delays in the study. There was a 
limited number of free text comments to this question and as only 39% (43/111) 
of the total survey respondents answered yes to this question, indicating that 
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their staff worked across more than one organisation, this does not seem to be 
a significant issue that Lead CRNs deal with.  
Therefore, in summary over half the respondents said that CRNs feel accepted 
within the clinical environment. However, the reality within organisations was 
that the response was varied and inconsistent. The main difficulty appears to be 
the availability of dedicated space for CRNs to see their research patients. The 
role and influence of CRNs within the research team appears variable. 
Respondents indicated that CRNs often take overall management of the 
research studies with some indicating the difficulty in ensuring P.I engagement. 
A main influence on staff turnover within the CRN workforce appears to be their 
contract of employment which for some is renewed annually and so provides 
less security. 
5.11. Challenge 5: Emotions 
Questions relating to the emotional challenge aimed to explore the awareness 
had by clinical staff to research and the CRN workforce. This section also 
looked at adherence to research governance requirements and whether the 
CRNs experienced any difficulty in achieving compliance with the research 
team.  
Table 5.11-1 Responses related to research awareness within respondent organisations 




Neutral Not v. 
aware 
Unsure 
The presence of a dedicated nurse 
workforce related to research 
22.5% 
(22) 
60% (59) 5% (5) 12.5 % 
(12) 
0 
The importance of research to the 
national NHS agenda 
15% 
(15) 





The current structure of research 
within your organisation and the way 
to access resources to support 
research studies they may wish to run 
11.5% 
(11) 





The volume of studies currently 
running within your organisation 





Table 5.11-1shows the perceived awareness of research and the CRN 
workforce from staff across each responding organisation A large amount 
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(82.5%, 81/98) felt that staff were very aware or somewhat aware of the 
presence of a dedicated nurse workforce related to research, and 58% (57/98) 
felt that staff were very aware or somewhat aware of the importance of research 
to the NHS agenda. Only 12% (12/98) thought that staff were not very aware of 
the presence of a dedicated nurse workforce related to research and 21.5% 
(21/98) thought that staff were not very aware of the current structure of 
research across the organisation. However, many of the open text comments 
related to the lack of awareness that respondents felt there was around 
research and the CRNs. Responses included that awareness was “patchy”, 
“low” and “not fully appreciated”. Others felt that staff generally “haven’t got a 
clue” and “are amazed when they come to our department and see what we can 
offer”.  
As with many of the other issues explored within the survey, they was a general 
feeling that the awareness was varied and very much depended on whether 
staff had a personal interest or work within research active areas. Comments 
included that “those staff who are research active / work close with research are 
very aware but some are not aware at all” and “there is awareness within the 
specialities of the CRN role but outside of their own area I would say they don’t 
see the whole trust picture”. Respondents highlighted ongoing efforts of 
research teams to raise awareness. This included “flyers on the canteen”, “roll 
up stands in outpatient areas”, “notice boards around the trust showing 
research activity” and “slots in local and regional conferences”. Many 
respondents commented they were “working on awareness” and that 
“awareness now is better than it was 5 years ago”.  
Regarding research governance 90% (88/98) agreed or strongly agreed that the 
CRNs report that adherence to all research governance requirements is high 
and 80.5% (79/98) agreed or strongly agreed that the CRNs reported that 
attendance at research governance training sessions was high and team 
members attend updates as required. Comments were generally positive and 
respondents felt that “research nurses are very good at ensuring all research 
and researchers adhere to research governance rules and this is something we 
reiterate to research nurses all the time”. Generally governance training was 
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“well co-ordinated and regularly offered” and for larger organisations in general 
“the infrastructure strongly supports a positive culture”. 
Negative comments related to governance compliance and included that it “is a 
huge challenge to clinical teams”, “becoming increasingly difficult particularly for 
medical staff” and that “finding time can be problematic”. However, some 
respondents did comment that it was “easier now we have online training” and 
that generally “most research nurses are the guardians of good governance and 
are often involved in ensuring good practice occurs in research”.  
As expected and shown in Table 5.11-2 there was a mixed portfolio of research 
studies at many organisations.  
Table 5.11-2 Structure of research portfolio within respondent organisations 
Answer Options Response Percent (Count) 
Assigned to mixed portfolio of NIHR 
and Pharmaceutical studies 
89.5% (84) 
Assigned to studies on the research 
portfolio only – e.g. CLRN, NCRN etc 
33% (31) 
Working within a Clinical Research 
Facility 
23.5% (22) 
Assigned to single research grant 
studies 
21% (20) 
Assigned to Pharmaceutical sponsored 
studies only 
17% (16) 
Working on own nursing research 17% (16) 
Assigned to other NIHR funded studies 
– e.g. BRC 
14% (13) 
Answered question (Skipped) 94 (17) 
Only 33% (31/94) respondents said that their staff were assigned to studies on 
the research portfolio (CRN, NCRN etc.) although 89.5% (84/94) said that their 
CRNs were assigned to a mixed portfolio of NIHR and pharmaceutical 
sponsored studies. 
Therefore, in summary the responses indicated that awareness around 
research and the CRN workforce was varied and appears in part to be related 
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to the level of research activity within the individual areas. A small number did 
express that they felt awareness was “patchy” and that some staff “haven’t got a 
clue”. However, many teams actively work to raise awareness across their 
organisation in a variety of ways. Adherence to the research governance 
requirements seems to be high although some did report that they experienced 
a few difficulties with this.  
5.12. Challenge 6 – Information Technology (I.T) and 
Infrastructure 
This section aimed to examine the impact of technology changes in research 
both related to I.T changes that had been introduced across the whole 
organisation (for example electronic patient notes) or research based I.T 
changes that had been implemented and just involved research related 
projects. The survey examined whether future plans were in place related to the 
introduction of either of these types of I.T changes.  
Table 5.12-1 I.T changes across organisations. N/A - Not Applicable due to no change in IT provision. 
Answer Options Yes No Unsure N/A Count 
Has there been any organisation wide I.T 
developments that have been introduced 






3% (3) _ 96 
Have you implemented any research 





4% (4) _ 96 
Have new I.T developments across your 
organisation impacted on the data 





10% (9) 26% 
(24) 
92 
Are current I.T developments within your 











Are there future planned I.T developments 
that may impact on the running of clinical 









In terms of IT developments 66.5% (64/96) confirmed that IT developments had 
been introduced across the organisation during the previous 2 years. The 
majority of these developments related to electronic notes and electronic 
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prescribing. For most respondents these IT developments were currently 
ongoing and so, for many, staff were working with a mixed system of standard 
paper patient records and a new “electronic patient record (EPR) system”. 
Within the responses, 48% (45/94) confirmed that IT developments were 
uniformly used by CRNs across the organisation whereas 16% (15/94) said 
they were not and 13% (12/94) were not sure. The few open comments 
provided stated that they had “different systems of electronic notes in place 
within some areas” and that there was “a lot of disparate working across the 
teams” and they were in a “period of transition”.  
Implementation of IT changes was not a smooth process and respondents 
referred to “it being challenging” with “lots of teething problems” as “R&D issues 
had not been taken into account”. Specific difficulties mentioned included an 
“inability to provide monitors (of the research studies) login passwords so all 
monitoring visits must be chaperoned” and “the research team still do not have 
the correct access to enter data”. The system “was not validated for research 
and “there was no involvement of research or a strategy to address this”. 
Looking at research specific I.T changes, 46% (44/96) confirmed that they had 
been implemented over the last two years. Many organisations were in the 
process of, or had just, introduced the EDGE database system. This is an 
online research management system which supports the collation and oversight 
of NIHR research. It is used by research managers, CRNs, Clinicians and R&D 
to actively manage their research within a single system so that information can 
be better organised and analysed in real time (Edge 2017). Others referred to 
their “own research tools”, a “new research portfolio database” or specific 
internal “systems to document research patient care on the electronic patient 
record system”. At the time the survey was being completed, many NHS 
organisations were in a period of transition regarding their IT changes; 
consequently there were diverse responses. 
Looking at future I.T developments that may impact on the running of clinical 
trials and research within an organisation, 52% (50/96) confirmed that they were 
aware of plans to implement changes where as 15.5 % (15/96) said there was 
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no planned changes and 32.5% (31/96) were not sure. The majority of 
comments related to the planned implementation of an electronic patient notes 
system. Some raised concern that the impact that this would have on research 
and so hoped to confirm that “research requirements are considered and 
understood”.  
In summary, although over half of the respondents reported that IT changes had 
been implemented across their organisation, for most implementation was 
ongoing and so it was difficult to truly gauge the impact it would have on 
research.   Many organisations appeared in transition with new systems such as 
electronic patient notes and so were using a mixed paper and electronic 
system.  Over half of the respondents confirmed that there were future planned 
IT changes and 32.5% were unsure. Therefore, if the survey was re circulated 
now the results may be very different. 
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5.13. Phase 1b – Analysis of NIHR recruitment data 
NIHR recruitment data was analysed in relation to the variables trust type, 
review and CRN workforce size. Variation in the number of studies undertaken 
was largely explained by trust type and year. The effect of review of the CRN 
workforce was not statistically significant throughout (p>0.05). Trust type 
explained more of the variation than year for three out of four of the models. 
The recruitment of people was primarily determined by trust type. 
Table 5.13-1 Number of studies (intervention, observation) and recruitment of people into 
observational and interventional studies by trust type, by year, and by whether the trust has 
undertaken a review. 
Effect Studies Recruitment(people) 
  Intervention Observation Intervention Observation 
 χ2 p χ2 p χ2 p χ2 p 
Trust Type 
(6d.f.) 
246.20 <.001 222.19 <.001 200.43 <.001 129.77 <.001 
Year (5d.f.) 113.27 <.001 247.26 <.001 25.61 <.001 25.29 <.001 
Review (1d.f.) 0.00 0.99 0.15 0.70 0.03 0.87 1.61 0.21 
Looking at trust type, teaching hospitals conducted more studies and recruited 
more people into studies than other types of Trust (Table 5.13-2). The number 
of studies steadily increased up until 2013/14 before levelling off. The number of 
people recruited into intervention studies peaked in 2012/13, falling in 
subsequent years (2013/14, 2014/15) and then increasing again in the last year 
(2015/16) (Table 5.13-2). The numbers recruited into observational studies 
fluctuated with peaks in 2010/11 and 2013/14. The performance of Trusts who 
underwent review was similar to those who did not review although the latter 
recruited over 300 more people into observational studies (1775 versus 1450) 
during the period 2014/15 (Table 5.13-2) 
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Table 5.13-2 Estimated marginal means for the following factors: Trust type; NIHR recruitment by year (Year); Review status (Review). 
Effect Studies Recruitment (People) 
 Intervention Observational Intervention Observational 
 Mean SE (95% CI) Mean SE (95% CI) Mean SE (95% CI) Mean SE (95% CI) 
Trust type             
Large 54.0 5.0 (45.0-64.9) 42.5 3.3 (36.5-49.6) 679.7 119.9 (481.1-960.3) 1503.4 188.6 (1175.7-1922.4) 
Medium 33.0 3.1 (27.4-39.7) 27.8 1.8 (24.5-31.6) 300.2 35.1 (238.7-377.6) 779.2 118.3 (578.6-1049.3) 
Small 21.1 1.8 (17.9-25.0) 23.0 1.8 (19.7-26.8) 223.9 35.0 (164.7-304.2) 593.1 181.0 (326.2-1078.6) 
Specialist 44.3 17.4 (20.5-95.7) 22.9 3.5 (16.9-31.0) 507.7 110.2 (331.7-777.1) 909.4 191.4 (602.0-1373.7) 
Teaching 134.4 12.1 (112.6-160.5) 107.6 10.0 (89.6-129.2) 2092.1 289.8 (1594.6-2744.7) 6906.4 990.2 (5214.4-9147.4) 
Wales, 
Scotland & NI 
93.2 24.7 (55.4-156.8) 69.0 13.3 (47.3-100.6) 1971.7 565.7 (1123.6-3459.9) 4289.8 1285.8 (2384.0-7719.2) 
Year                   
2010/11 43.1 4.3 (35.5-52.4) 30.0 1.8 (26.7-33.8) 535.1 62.0 (426.3-671.6) 1716.7 341.4 (1162.6-2534.9) 
2011/12 49.0 4.8 (40.5-59.3) 36.7 2.3 (32.5-41.4) 645.8 79.9 (506.7-823.1) 1268.9 174.3 (969.5-1660.9) 
2012/13 53.8 5.1 (44.6-64.7) 40.5 2.5 (35.9-45.7) 828.8 121.7 (621.5-1105.3) 1551.7 210.0 (1190.1-2023.1) 
2013/14 59.0 5.3 (49.4-70.5) 48.2 2.7 (43.2-53.7) 728.4 85.6 (578.5-917.0) 1848.3 265.5 (1394.7-2449.3) 
2014/15 57.1 4.7 (48.6-67.0) 50.1 2.6 (45.2-55.5) 704.2 79.9 (563.7-879.6) 1835.8 196.5 (1488.3-2264.3) 
2015/16 60.8 4.9 (52.0-71.2) 49.8 2.6 (44.9-55.2) 785.1 106.5 (601.8-1024.1) 1486.8 168.9 (1190.1-1857.5) 
Review                   
No 53.5 4.4 (45.5-62.9) 42.6 2.6 (37.9-48.0) 707.5 83.0 (562.2-890.4) 1774.7 174.1 (1464.2-2151.1) 
Yes 53.4 6.6 (41.9-68.0) 41.1 3.4 (34.9-48.3) 688.0 103.7 (512.0-924.3) 1450.3 196.5 (1112.0-1891.5) 
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NIHR recruitment data was also analysed through a long liner model examining 
difference in the recruitment numbers and number of studies in each Trust by 
Trust type, CRN quartiles, type of Trust and whether reviewed or not. For this 
analysis only data from year 2013/14 that the study was conducted was 
available for CRN nurses.  Table 5.13-3 suggest that after accounting for 
variation across type of Trust and CRN workforce quintiles the act of reviewing 
did make a difference to recruitment numbers into interventional studies 
(x2=255.38, 1d.f., p<0.001) and a marginal difference for recruitment numbers 
into observational studies (x2=3.68, 1d.f., p=.055).  However, there was no 
difference for the number of interventional (x2=2.45, 1d.f., p=0.11) or 
observational (x2=2.30, 1d.f., p=0.12) studies undertaken in the Trust. 
Table 5.13-3 Examining the associations between number of studies (intervention, observation) and 
recruitment into observational and interventional studies by trust type, CRN workforce Quintiles, and by 
whether the trust has undertaken a review: 
Effect Studies Recruitment(people) 
  Intervention Observation Intervention Observation 
 χ2 p χ2 p χ2 p χ2 p 
Trust Type 
(6d.f.) 
146.51 <.001 308.87 <.001 25451.42 <.001 41179.06 <.001 
CRN Quintiles 
(4d.f.) 
942.45 <.001 383.41 <.001 12652.49 <.001 19857.6 <.001 
Review 
(1d.f.) 
2.45 0.11 2.30 0.12 255.38 <.001 3.68 0.55 
There was broad variation in the degree of review undertaken. The survey 
revealed that fifteen trusts had carried out a full review of their CRN workforce. 
Therefore NIHR recruitment figures for these organisations were subjected to χ2 
analysis using the methodology previously described.  The impact of review 
was statistically significant for observational studies (p = 0.030) and nearly 
reached significance for recruitments of participants for interventional and 
observational studies (Table 5.13-4). This suggests that where a full review has 
occurred a positive shift in research delivery (study numbers and recruitment) 
may occur.  
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Table 5.13-4 Examining statistical associations between study types and recruitment levels with the 
previously established effects of trust type, year-by-year recruitment levels and review for the15 trusts who 
undertook a full review. 
Effect Studies Recruitment(people) 
  Intervention Observation Intervention Observation 
 χ2 p χ2 p χ2 p χ2 p 
Trust Type  
(2d.f.) 
6.20 0.045 29.01 <.001 11.64 0.003 19.67 <.001 
Year  
(5d.f.) 
58.60 <.001 33.75 <.001 39.72 <.001 11.10 0.049 
Review  
(1d.f.) 
2.82 0.093 4.73 0.030 3.76 0.052 3.68 0.055 
Therefore in summary, the results indicate a mixed picture of the impact of 
reviewing the CRN workforce structure. When considering trust type and year, 
there was no statistical difference in whether the organisation was reviewed or 
not. However, after accounting for variation across trust type and size of CRN 
workforce the act of reviewing did make a difference to recruitment into 
interventional studies. Closer scrutiny of the fifteen organisations who had 
carried out a restructure showed a statistically significant increase in recruitment 
to observational studies. 
Having reviewed the results from the phase 1 survey and NIHR recruitment 
figures, results from the four organisational case studies will now be presented. 
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Phase 2: Case studies 
Four case studies were chosen from those organisations which had offered in 
their survey response to take part in phase 2 of data collection. A brief 
description of each of the 4 organisations is provided below with information 
taken from the relevant trust website and annual report. A summary and 
diagrammatic illustration of the current structure of each organisations CRN 
workforce - based on relevant survey responses - is included. Further 
information is presented in appendix 21 on the set up of research and the CRN 
workforce within each of the four organisations (drawing on the detailed phase 1 
survey responses and using the 6 challenges of the ‘Organising for Quality’ 
framework).  
Selection criteria has previously been explained in section 4.8.1 (page 73). The 
aim of selection was to identify 4 organisations that could be examined through 
a case study approach in order to provide detailed examples of some current 
workforce structures. In doing this it is important to ensure that anonymity of all 
organisations and participants is ensured in order to maintain full confidentiality. 
This can become more difficult when including larger organisations which may 
have distinctive characteristics or unique post holders not found elsewhere. 
Therefore, when describing the participating organisations minimal information 
has been provided in order to prevent recognition from those who may be more 
knowledgeable about this topic or the organisations involved.  
5.14. Characteristics of four organisational case studies 
5.14.1. Case study 1 
Case study 1 is a medium sized acute trust in the south of England.  It is 
located in a largely affluent area with relatively low unemployment and above 
average life expectancy. The main hospital has approximately 600 inpatient 
beds, including maternity critical care. It provides healthcare services to 
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370,000 people. The trust was placed in special measures in November 2013 
and this was still the case throughout the period of fieldwork.  
The trust annual report 2014-15 states “The Trust is committed to the 
integration of research in clinical practice to provide all patients access to 
research trials as legislated by the NHS Constitution”. During 2014-15 there 
were 1006 participants recruited into portfolio studies. Recruitment to NIHR 
portfolio studies over the last five years is as follows: 








2011/2012 38 23 1001 
2012/2013 36 29 637 
2013/2014 36 33 760 
2014/2015 31 32 1006 
2015/2016 37 28 768 
The organisation has a small CRN workforce of 15 staff. These are comprised 
of two teams, cancer and generic, as shown in Figure 5.14-1. The generic 
workforce are at a band 6 and led by the Research Trials Nurse Manager who 
is at a band 7 level. The workforce has not been reviewed. 
Due to the small size of the workforce the research nurses are not integrated 
into clinical teams as they are in some larger organisations. Therefore the 
generic team work within numerous clinical teams which are dictated by the 
studies currently open and recruiting patients. The clinical areas covered 
change as research studies close and others open. 
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Figure 5.14-1 Organisational structure of case study 1 
5.14.2. Case study 2 
Case study 2 is a large teaching hospital in the north of England which is 
located across two main acute sites, has approximately 2000 inpatient beds and 
employs approximately 16,000 staff. .  
The trust annual report 2014-15 states its vision as “To be recognised as the 
best provider of health care, clinical research and education in the UK” and one 
of its five overarching aims is “to deliver excellent research, education and 
innovation”. Recruitment to NIHR portfolio studies over the last five years is as 
follows: 







2011/2012 149 109 4909 
2012/2013 169 119 6999 
2013/2014 187 148 7645 
2014/2015 166 161 7786 
2015/2016 193 178 8587 
The organisation has a large CRN workforce of 120 staff ranging from band 5 to 
band 8b and is led by a Lead CRN at an 8b level (see Figure 5.14-2). The trust 
has three models of CRN employment, one of which involves appointment 
through their partner university.  The organisation initially undertook a full review 
 Page 127 
of their CRN workforce in 2004.  Following this they implemented a structure led 
by a clinical manager who would take professional responsibility and line 
management accountability for the CRNs. A group was established to provide 
the managers with guidance and information to manage their staff. The 
workforce has been through a number of iterations and there is now a move to 
a more centralised model with the Clinical Research Facility (CRF) being 
identified as the central appointing point for new CRNs. A number of mainly 
historical posts remain within the clinical directorates and so more recently a 
trust-wide Matron role has been established to provide more operational 
management of these staff 
. 
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Figure 5.14-2 Organisational structure of case study 2. Abbreviations: TRG – Translational Research Group; NIHR – NIHR funded research group. 
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5.14.3. Case Study 3 
Case study 3 is a teaching trust in central England. The trust is located across 
three sites, employs 14,000 staff and has approximately 1700 beds The trust 
currently supports two NIHR Biomedical Research Units.  
Recruitment to NIHR portfolio studies over the last five years is as follows: 







2011/2012 176 117 8874 
2012/2013 211 122 8586 
2013/2014 233 149 7184 
2014/2015 220 159 9145 
2015/2016 208 136 5549 
The organisation has a large CRN workforce of approximately 130 post holders 
ranging from band 5 to band 8a. Most of the post holders are at a band 6 level 
(73%, 95/130) and some of these work across the research network region 
although the exact number was not specified. The majority are appointed 
through the trust but a small number (n= 12) are appointed through their partner 
university. The workforce is led by the Clinical Research Matron who is at an 8a 
level (Figure 5.14-3). 
At the time of phase 1 data collection the CRN workforce had not been 
reviewed. However, at the time of my visit the organisation was planning what 
the Lead CRN referred to as “a big organisational change” which research was 
planning to replicate although no details were available. 
 
 Page 130 
 
Figure 5.14-3 Organisational structure of case study 3 
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5.14.4. Case study 4 
Case study 4 is a District General hospital (large acute NHS Trust) which 
serves a population of just over 750,000 in outer London.  It operates over two 
sites and has a total of approximately 1100 beds and employs approximately 
5,500 staff over the two sites. It was placed in special measures in December 
2013 and this remained the case at the time of data collection.  
Recruitment to NIHR portfolio studies over the last few years is as follows: 








2011/2012 49 26 694 
2012/2013 42 28 572 
2013/2014 46 29 2398 
2014/2015 48 29 6685 
2015/2016 47 29 1171 
The trust has a small CRN workforce comprising of 24 nurses which are divided 
across two main teams, general and oncology as shown in Figure 5.14-4. The 
workforce was reviewed in 2014 to coincide with the change in the research 
network structure. Many of the CRN posts became band 6 posts. There had 
been a decision to develop a Lead CRN post to cover support of the trust wide 
CRN workforce. This had been discussed in conjunction with the Chief Nurse. 
However since that time there had been a change in post holder and so these 
discussions were currently on hold. 
In summary this section has given an overview of the CRN workforce within 
these case studies. A summary table is shown in Table 5.14-5, page 1333. 
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Figure 5.14-4 Organisational structure of Case Study 4 
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Table 5.14-5 Summary of key characteristics for all case studies 
Case 
Study 
Type of Trust Size of CRN 
workforce 
Level of Lead 
CRN 
NIHR study patient 
recruitment figures 
Number of NIHR 
portfolio studies  
Structure of CRN workforce 
(Taken from questionnaire survey) 
12/13 13/14 14/15 13/14 14/15 
1 Medium Acute 15 nurses Band 7 637 760 1006 69 63  Working within clinical teams with non-research 
colleagues. 
 Working directly with Consultants on their 
research studies.   
2 Acute Teaching 120 nurses Band 8b 6999 7645 7786 335 327  In a structured team within one clinical area 
 Working in one area in different research teams. 
 Working within clinical teams with non-research 
colleagues. 
 Working directly with Consultants on their 
research studies.   
 Working within a Clinical Research Facility. 
3 Acute Teaching 130 nurses 
(approx) 
Band 8a 8586 7184 9145 372 379  In a structured team within one clinical area 
 Working in one area in different research teams. 
 Working within clinical teams with non-research 
colleagues. 
 Working directly with Consultants on their 
research studies.   
 Working independently in one or more clinical 
teams but not within the team.  
4 Large Acute 24 nurses Band 8a 572 2398 6685 75 77  Working within clinical teams with non-research 
colleagues. 
 Working directly with Consultants on their 
research studies.   
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5.15. Case study interviews and focus groups 
Phase 2 of data collection involved conducting fieldwork in these four NHS 
acute trusts. To further address the 7 research questions semi–structured 
interviews were conducted in each trust with the R&D Director, the Lead CRN 
and Principal Investigators of studies. A focus group of CRNs was also carried 
out in each Trust.  
Interview questions were structured around the six challenges as identified and 
defined within the “Organising for Quality” framework. Analysis of the data 
identified specific themes and sub-themes within the six challenges. 
5.16. Challenge 1: Structure 
Table 5.16-1 Definition of the structure challenge as described in Table 3.4-1  
Challenge Original definition in framework Definition applied to CRN 
workforce 
Structure Structuring, planning and co-
ordinating the quality and service 
improvement effort, and 
embedding it within the 
organisational fabric. 
Structuring, planning and co-
ordinating the Clinical Research 
Nurse workforce, and embedding it 
within the organisational fabric to 
ensure high quality research 
governance and patient safety. 
Four key themes emerged in relation to the structure of the CRN workforce and 
the research structure in which they work. These were: 
- Leadership 
- Research delivery  
- Lead CRN role 
- Challenges and Limitations 
Each of these four key themes had a number of sub themes as shown in Table 
5.16-2. 
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Table 5.16-2 Themes and sub themes: Structural Challenge 
Theme Sub theme 
Leadership  Formal support and line management 
 Quality of senior support for research 
Research delivery  Management structure 
 Non nursing roles 
 Team structure 
Lead CRN role  Leadership 
 Impact 
 Support for CRNs 
 Awareness from senior clinical nurses  
Challenges & limitations  Organisational issues 
 External pressures 
 Internal pressures 
5.16.1. Leadership 
Lead CRNs were asked to describe their role and the nature of the line 
management and accountability arrangements in place. Those that had been 
able to establish working links with senior management, within nursing and R&D 
appeared to have been able to develop more effectively within their role and 
see the benefits including raising awareness of research and supporting CRNs 
within the clinical environment. 
Formal support and line management 
Case study 1 was a small DGH that had been in special measures for two 
years. It had a stable CRN workforce of 16 who had all been in post prior to the 
arrival of the Lead CRN. There was a feeling that due to ongoing pressures 
CRNs had become de-motivated and potentially less engaged with the wider 
organisation. The Lead CRN was a band 7 and had been in post for just over 
two years. She was not linked in with the wider nursing workforce and so her 
role felt isolated with minimal support structures in place. Since coming into her 
current post she had had four nursing managers but felt that she “didn’t link in at 
all” with senior nurses across the trust and - as a band 7 - “was not autonomous 
enough to be given the authority to make decisions”. This left her feeling 
“frustrated” at her lack of authority and the lack of support and feedback she 
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received. She described herself as never having “satisfactory line management” 
with no appraisals and just a monthly meeting with her manager. The R&D 
Director was in his role as part of the remit of the Deputy Medical Director in the 
trust but he was not an active researcher. He spoke highly of the Lead CRN and 
agreed that her management arrangements were “a little opaque and not ideal”. 
Overall he seemed aware of the unsatisfactory support structures relating to her 
role and confirmed that “she hasn’t really had a clear regular sustained line of 
professional reporting”. However, he appeared to have no sense of 
responsibility towards supporting the implementation of an effective 
arrangement; it had been left to the Lead CRN to find a solution. 
In Case study 2 the Lead CRN was at a band 8b level and her role appeared to 
encompass a more strategic perspective. She had been in post for 4 years and 
had developed strong links with her senior nurses; she reported directly to the 
Nurse Director. There was a regular meeting in place where she could provide 
updates on developments within research and also discuss professional nursing 
issues if required. She also met with the Chief Nurse twice a year in order to 
update her on progress within the CRN workforce. The Lead CRN described 
what she perceived as gaps in the senior accountability of her role, such as she 
did not attend the senior nurses meeting chaired by the Chief Nurse. However, 
she was able to articulate the positive outcomes of the leadership structure that 
was in place. It had, for example, enabled her to help develop awareness of 
research across the organisation bringing about “a complete sea change” 
around peoples understanding of research; she felt that “over the organisation 
there’s a real will to engage in research”. This had impacted positively on the 
work she had been able to do to develop the CRN workforce of 120 nurses and 
embed it more effectively across the wider organisation.  
In Case study 3 the Lead CRN was at an 8a level but felt that the reporting and 
accountability for her role was not well structured. The Lead CRN did attend a 
monthly senior nurse Forum chaired by the Chief Nurse; this had been “good for 
research and helped raise general awareness around research”. She had also 
been able to develop informal links with a clinical Head of Nursing (HON) who 
had knowledge and awareness of research and this had been her main source 
 Page 137 
of support and linkage with the clinical nurses within her organisation. The HON 
had discussed with R&D the possibility of taking on direct line management of 
the Lead CRN. This had not been confirmed due to concerns from R&D that if 
her post “was completely let out of the R&D structure, then some of the control 
would also be lost”. The R&D department appeared to be in a state of flux. The 
R&D Director post was vacant and work was ongoing to make an appointment. 
The Lead CRN was also due to leave but no decision had been made regarding 
the future of her role and whether a replacement would be appointed. The 
department had just undergone an internal review which had concluded that the 
structure was quite “top heavy”, although no further details were available due 
to the absence of an R&D Director. The Lead CRN expressed concern that 
once she had gone her role “might no longer be a priority”.  
Case study 4 was a large DGH that was - like case study 1 - in special 
measures. The Lead CRN was an 8a level but the role did not have a formal 
trust-wide remit for the CRNs. The post holder was officially responsible for 
covering cancer research with only informal support for the remaining non-
cancer CRNs. The post was line managed within the clinical oncology service; 
the line manager had come from a large research active organisation and so 
was supportive and aware of research. He also linked in with the R&D Director 
so felt that his post was well supported from both a research and clinical 
perspective; appraisals involved all 3 people. As part of his role he attended 
monthly clinical meetings within oncology and so was up to date with research 
activity in that particular service. At these meetings he also received general 
nursing updates and so had decided not to attend any trust-wide nursing 
meetings. He explained that “in the cancer area, research is embedded” and 
“almost part of the patient pathway”. However, for the remainder of the 
organisation there was less awareness and research was “in a silo, hidden 
somewhere, doing our own thing”. The lack of any trust-wide initiatives seemed 
to mean that outside of oncology there was less awareness surrounding 
research and the CRNs felt less integrated. 
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Quality of senior support for research 
Within case study 1, there was a feeling of a lack of understanding and 
engagement towards research. The Lead CRN had occasional meetings with 
the Director of Nursing but explained they comprised of “a little chat about the 
service” but with no tangible output or direction from the arrangement. She was 
not invited to the senior nurse meetings and felt that “there is a circle where 
everything is going on and we just overlap a tiny bit and are not considered”. 
Overall there was a sense that the CRN workforce were not linked in with the 
wider nursing workforce; the Lead CRN described this as “often we don’t 
belong, we are on the edge, on the outside”. 
Within case study 2, the Lead CRN talked about feeling “frustrated” as she was 
aware that “stuff happens that I don’t always find out about through a formal 
route”. She spoke of her “struggle” to develop effective links with the “clinical 
side”. However, the structure of her role appears to have at least given her the 
authority and autonomy to address this. A new Nurse Director was in post and 
so they were due to meet to “address” what she saw as some of the gaps in her 
structure. She was also working on a “strategy” that she planned to discuss with 
the Chief Nurse to further develop nursing accountability within her role. She 
linked in and had regular meetings with the Clinical Director for the Clinical 
Research Facility (CRF) where her role was based; this ensured effective senior 
links within R&D. Her appraisals were done by both of these senior Directors 
ensuring both effective feedback and communication within these two 
relationships.  
The Lead CRN in case Study 3 was directly accountable to the Deputy Director 
of Research but this did not appear to be an active relationship; there were no 
regular meetings. This arrangement had left her feeling professionally “isolated” 
as she was not line managed by a nurse and so was unable to access support 
that was “needed with clinical decisions”. She also described her sense of 
“conflict” as she was often “asked to make decisions that don’t sit well with the 
nursing side of things”. She had been able to develop informal links with a 
clinical HON   and this had been her main source of support and link with the 
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clinical nurses within her organisation. She felt this had “very much brought 
research on the map”. However, the role of the HON was more focused towards 
Nursing Research and Clinical Academic Careers; the focus on the CRN 
workforce has been more directed towards supporting them with their academic 
studies and developing nursing research within this. Therefore, this relationship 
did not provide active support in developing the CRN workforce or raising 
awareness of their role within the clinical environment.   
Within case study 4 a new Chief Nurse had recently been appointed. The 
outgoing post holder had been supportive of research and had been looking into 
the possibility of developing a trust-wide Lead CRN role. However, this work 
was on hold and at the time of data collection the new Chief Nurse had only 
been in post for 3 months so there had not been the opportunity to develop any 
formal links. However, the Lead CRN role did formally link in with the R&D 
Director and regular meetings took place between the two of them facilitating 
support for the CRN workforce. However, they did not discuss the development 
of research across the organisation as he (the Lead CRN) had no official remit 
to do this.  
5.16.2. Research delivery  
Management structure 
Line management was an emotive subject in most of the case studies 
especially when directly discussed with the CRNs. Within case study 2 there 
was a well-structured hierarchy with three research matrons who oversaw the 
CRN workforce (see Figure 5.14-2 on page 128). This had enabled the 
development of a well-defined arrangement where all the research nurses had 
direct links into a more senior CRN. However, across the remaining case 
studies the structure at times appeared chaotic and undefined and the presence 
of a Lead CRN did not ensure direct CRN line management for all the research 
nurses. Some were still line managed by those in a clinical role and there were 
strong feelings as to the preferred model of support.  
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Within case study 1 all the CRNs had been in post prior to the arrival of the 
Lead CRN and had been able to directly experience the benefits of having 
dedicated management from a nurse who also understood their role and work; 
this had helped them to feel “more a part of the organisation”. However, within 
case study 3, some of the CRNs were managed by more senior clinical nurses 
who left them at times feeling “isolated” with a lack of “interest” in them. This 
also left them feeling separated from the rest of the organisation and “in our 
own little world”. In contrast others within case study 3 favoured being managed 
by clinical nurses who they felt “didn’t know anything about research” as they 
were then “left alone” and they could “do what they want to”. This was echoed in 
case study 4 where many of the CRNs were jointly managed by the R&D 
Director and clinical Matrons. Here they explained that the Matron “tends to just 
leave us to just get on as long as nobody has complained to her about anything, 
then she is happy”. They would meet more often with the R&D Director but 
although this gave some direct research related support it still did not provide a 
satisfactory arrangement; the nurses appeared unfulfilled. One of them 
explained she met with the R&D Director but when asking for advice he would 
say “blah, blah and if it works, fine”.  
For some an understanding of research from a line manager was more 
important than having support from someone clinical. Some felt that “it is better 
to have someone who understands the particular type of work that you do” and 
the “nitty gritty” of research. Others clarified this further with the view that a 
manager needed “to have an understanding not just of research but of the type 
of research”. They explained this by saying: 
“Paediatric Research is very different from Intensive Care and the 
emergency room and it’s different from our Biomedical Research 
Unit” 
― CRN – Case study 3 
Some research nurses compared their current line management arrangement 
with that which had been in place prior to the restructuring of the national 
research network infrastructure in April 2014. Within this they had been 
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overseen by a research manager who may have been another health 
professional: 
“we have had managers who were not a nurse within the 
Medicines for  Children Research Network and they were very 
successful. They understood the in-depth studies as well as the 
basic data collection, so long as nurses were performing and 
recruiting and doing everything to the protocol, it didn’t affect them 
not being nurses.” 
― CRN – Case study 3 
Therefore, for the CRNs the important factor seemed to be that their line 
manager understood their role and area as this enabled them to provide 
meaningful support and advice. 
Non-nursing roles 
Each of the four organisations were developing non-nursing roles to work within 
their research teams. However, comments about these roles ranged from being 
supportive to greater scepticism about what they were capable of doing. Some 
could see their importance within the research teams: 
“we have posts in the CRF which are Data Co-ordinators, band 
3’s. We’ve got one leading on our flu study under the direction of a 
band 6 nurse.  She’s doing really well.” 
― Lead CRN – Case study 2 
However, for some there was a sense of “conflict” between the nursing and 
newer non-nursing roles because “traditionally there is a research nursing post 
and now you have someone that is, they feel, less qualified” and “they don’t 
actually do anything different”. 
Some CRNs appeared to view the non-nurses as a threat to their own role and 
had quite strong opinions as to who should be doing what within the team, 
especially when it involved the inputting of patient data into a research 
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database. CRNs felt that the data “needs to be put in by a nurse” because “as a 
research nurse that’s part of my role”. There was a feeling that a research nurse 
would “understand” the data better as “I’m the one who collected it and I’ve 
written it down”. 
There was also a feeling of uncertainty, including from within the teams, 
especially in case study 1 where these roles were being introduced for the first 
time. Here the CRNs felt that they were “struggling a bit” trying to understand 
the new non-nursing role and “just trying to find their feet”. This was because 
historically they had been doing many of the tasks that the non-nurses had now 
taken over. However, they did recognise the value of this and commented that 
“when you look at what it involves there isn’t really any reason why somebody 
with training who hasn’t got a nursing background, couldn’t do some of these 
roles”. 
The Lead CRN in case study 1 had just recently introduced a non-nursing role 
and explained her reasons: 
“I needed somebody that was going to be able to see patients, 
potentially take on some very low level observational studies but 
also help the nurses with data entry and also some follow up work. 
My team were actually not keen in having this person in, they 
didn’t see the value of it, what was I doing, I ‘had gone mad’, and 
now they do see the value of it which is great”. 
However, for many there were clear benefits of these new roles. Those 
overseeing the research could see that there were many “long term benefits”, 
not least that they attracted “young, keen people” and that they are “cheaper 
and generally appointed at a lower band”. There was also the 
acknowledgement that with the evolution of research and a move to a greater 
use of technology for data capture, new skills were required that the CRNs did 
not always have. Recruiting young graduates into non- nursing roles was seen 
as beneficial as they were often “whizzes” on computers and “could do a lot 
more of the data entry in a shorter time”. 
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CRNs in the larger organisations (case studies 2 and 3) seemed relatively more 
open and receptive to these roles and could see the benefit. They could see the 
overlap in the roles and thought that “they probably do 98% of what we do 
anyway, it’s just the 2% that we do that they don’t”. There was recognition in the 
difference in the role and that the CRN was “the one giving the drug and taking 
the blood”. One CRN summarised it by saying “even though there are 2 aspects 
that they can’t do there is still 10 aspects that they can do”. 
Team structure 
Within the four case studies, individual teams of CRNs were situated - to 
greater or lesser degrees - within an overall structure. For the larger 
organisations (case studies 2 and 3) these comprised of clinically specific teams 
of CRNs working solely in one area. For the 2 smaller DGHs (case studies 1 
and 4) the CRNs were divided between cancer and non-cancer teams. The 
non-cancer teams covered numerous areas and in case study 1 the CRNs 
worked across all clinical areas.  
Within all four case studies cancer research was supported by a standalone 
team. The roots of this are based within the beginnings of the national research 
network structure as discussed in the background chapter. However, the 
response to this was at times negative and not always seen as conducive to 
efficiency. In case study 2 the cancer CRNs were appointed via the university. 
They came under their own management structure and so were not totally 
within the remit of the Lead CRN; she could see they were “remote” and 
“isolated” from the remaining CRNs. She also described a lack of consistency 
within the workload across the teams and “a huge discrepancy in the amount of 
funding they got compared to the amount of activity they supported”. From her 
recruitment figures she was able to see that more patients were put into non-
cancer studies than cancer studies but that the funding allocation did not reflect 
this.  
Within case study 3 there was an “established oncology research team” 
comprising of 50 full time research staff (but not all were CRNs). The Lead CRN 
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had a cancer background herself and could see the benefit of a specialist 
workforce within this particular clinical area. However, she also felt that in some 
areas “you can go to work as a research nurse without being specialist in that 
area”.  She felt that overall the team set up was “not the most effective” and she 
was “trying to achieve a more flexible workforce”. However, the “workforce is 
not very moveable” and nurses were “very loyal to their specialities and areas”. 
At the time of data collection the organisation was being re-structured into a 
division-led model whereby the pre-existing directorates were being merged into 
five divisions. The plan was for research to become part of this so that “each 
division will host their research staff and be division-led”. 
However, as in case study 2, there was a discrepancy between the amount of 
funding allocated to cancer research and the amount of recruitment activity. The 
Lead CRN reported that “about 40% of our CRN funding goes to cancer but 
only about 25-30% of recruitment comes from there”. The R&D department 
were therefore looking to review their funding model in order to grow activity. 
This would likely affect the setup of the research teams as there was a need to 
make them more efficient. The Lead CRN felt that currently they had a 
“structure that is not joined up” with “a lot of different pockets of facilities” and 
“the money could be used a lot better”. 
Within case study 1 the cancer CRNs were separately managed under 
Oncology Cancer services and so the Lead CRN had no remit to support them. 
The non-cancer CRNs were referred to as a “generic” workforce but the Lead 
CRN felt this was a derogatory word and stated that she tried “not to use the G 
word”. However, she worked hard “to be flexible with the workforce” and so 
consequently was able to cover a large range of specialties across the 
organisation. CRNs often worked in more than one clinical area and the Lead 
CRN in this case study site appeared to be the only one of the four  who had 
achieved some success in involving the Clinical Nurse Specialist workforce: 
“we have a vascular study for example at the moment that needs 
a lot  of pedal pulses and assessments and scans on the legs and 
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we couldn’t be able to do that without the Clinical Nurse 
Specialists”. 
― Lead CRN – Case study 1 
Within case study 4, there was a workforce of 24 CRNs but 8 of these were 
working within cancer. The remainder worked across various clinical areas but 
each CRN only worked within one clinical area. This meant that currently some 
areas did not have any research activity as there was no CRN to support it. The 
Lead CRN was himself based within cancer and so was more supportive of this 
model having spent most of his career working within this area. He commented 
that as a trust they had been “growing research for a number of years” but had 
“got to the point where we couldn’t grow anymore and so are concentrating on 
delivering best quality research”.  
5.16.3. Lead CRN role 
Two of the sites (case study 1 and 3) had not had a Lead CRN before, whereas 
in case study 2 the post had been established for just over 10 years and the 
current post holder was the second person to hold the post. The final site did 
not have a dedicated trust-wide Lead CRN and so the Oncology Lead CRN was 
trying to fill this role. 
Leadership  
The perception that having a dedicated senior research nurse to oversee the 
running of research within an organisation had a positive impact was common 
among the individuals interviewed. Positive outcomes of the role related to the 
strategic and symbolic leadership it provided such as the post holder having 
been able to “draw things together” and “manage the capacity”.  
Across the four case studies the Principal Investigators (PI) all expressed their 
support for the Lead CRN role. In developing a structure one PI (case study 1) 
felt the Lead CRN had “built up a fantastic team” and done an “impossible job”. 
He remarked on the “huge change” that had occurred since the Lead CRN took 
up post and how the CRN workforce structure now worked “very well”. Many of 
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the PI’s described how they now liaised directly with the Lead CRN when 
considering whether to set up new studies and how “having someone with 
experience makes a big difference” to the running of their studies.  
In this same organisation (case study 1) many of the CRNs had been in post for 
a number of years and so were able to reflect on the difference that the Lead 
CRN role had made. Before the post holder had arrived they had “tried to do 
things” themselves but “that wasn’t the done thing”. One CRN remarked that 
“we couldn’t even order pens, we were really stuck for a while. So having her 
(the Lead CRN) has definitely improved things”. 
Impact 
There was general agreement as to the positive impact that the role of the Lead 
CRN had, firstly, on the whole research process and, secondly, the nature and 
extent of the support that research nurses received. Examples were given of 
some of the significant errors or mistakes that had occurred prior to the 
appointment of a dedicated Lead CRN. These included, for example, a 
governance breach where a clinical nurse had misunderstood instructions and 
removed all clinical information from the notes of a patient who was involved in 
a study as well as a lack of proper oversight for studies. A research nurse at 
case study 1 commented: 
“the day I walked in I couldn’t actually believe what I looked at. I 
mean there were some studies that didn’t even have site files and 
recruitment logs were bits of paper randomly put in a file. I mean it 
was shocking”  
There were also observations that a dedicated Lead CRN post had enabled 
research to run more efficiently. The PIs leading research projects saw the role 
as “essential” and described the CRNs working under her as “faultless in their 
efficiency” and providing a “seamless” service which overall “works really well”. 
They explained that for research “a different kind of discipline is required” in 
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order to ensure that the projects run smoothly. The Lead CRN has been able to 
develop a team that had “got that discipline and it makes it much better”. 
Support for CRNs 
Another beneficial impact of the Lead CRN role was the level of support that the 
research nurses received in being able to carry out their role effectively. One felt 
that since the Lead CRN had been in post they “had learnt so much” and it was 
a “wonder we didn’t do anything disastrous” before. One CRN likened her 
experience before the Lead CRN’s arrival “as the blind leading the daft”. 
CRNs across all organisations commented on feeling “supported” and “focused” 
upon. It was felt the role was also able to “open doors” and speak on behalf of 
the nurses, especially if this involved an awkward conversation. One nurse 
commented “I didn’t feel I was in a position to say we can’t do that study but she 
can do that” (case study 1). This was also acknowledged by the Lead CRN; she 
wanted her nurses to “take the lead and feel empowered” but was also aware 
that her role provided them with “back up” when they were “not feeling confident 
to deal with something”. 
P.I s in two of the case study sites (1 and 2) commented on the importance that 
having someone who was knowledgeable and with previous “experience” who 
“has done the role (of the CRN) before”.  They felt that this then gave the CRNs 
“someone with experience to guide them” as they often arrive in the role 
“without previous experience”. 
There was also a recognition of the importance of having a Lead CRN who was 
able to line manage the research nurses. It was felt that this would ensure “a 
very clear performance schedule” because “to line manage research nurses you 
have to have been a research nurse”.  
At one of the sites visited the Lead CRN was moving to another post. At the 
time of the fieldwork visit there were no plans in place to replace the post 
holder; this was causing a large amount of concern amongst all members of the 
research team. The research nurses felt they would be “missing out” and that it 
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was sending a “mixed message” about the importance of research across the 
organisation.  
Awareness from senior clinical nurses 
The lead CRN also provided representation at senior nurse meetings across the 
organisation. In some case study sites this had led to an increase in the 
awareness of research from this nursing group - including the Chief Nurse - and 
the CRN role. Case study 3 had a relatively new Chief Nurse who was seen as 
“supportive” with some understanding of research; CRNs here felt they had 
“visibility” from a senior nursing level and that their role was “seen as important”. 
The role had also enabled links to be developed within senior nurse peer 
groups across research and clinical services. Within one organisation (case 
study 2) the Lead CRN had enabled the research matrons to be part of the duty 
rota that provided site cover. This was seen as having a positive impact: 
“I’ve pushed to do it. We’re seen as equals because we muck in 
and do the rota just like every other Matron. Its challenging but I 
think it’s beneficial to us that sit in this lovely research bubble. It 
increases awareness”. 
However, individuals in other sites also described struggles with achieving links 
with more senior nurses across their organisation: 
“I don’t link in at all. I see her once a month and we have a little 
chat about the service. Often I am not autonomous enough to be 
given authority”. 
― Lead CRN – Case study 1 
5.16.4. Challenges and Limitations 
The success of the different research nurse structures observed in the four case 
study sites appears to have been impacted by various local challenges and 
limitations. 
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Organisational issues 
The organisations studied had a variety of models in place that supported the 
CRN team. However, one P.I described their structure as “an accident in 
history” (case study 1) and agreed that if they “could start with a blank piece of 
paper today you wouldn’t have what we’ve got”. He described it as a system 
“that’s evolved reactively depending on what’s there and it’s different across the 
whole organisation”, adequately summarising the situation in the other case 
studies. The Lead CRN in case study 3 explained: 
“this structure that we’ve got in place now is something that has 
historically been there” 
Case study 2 had undergone a re-organisation process about 10 years earlier 
and put a desired new structure in place. However, even this organisation 
acknowledged that a small section of their workforce (cancer research) had not 
been included in their restructure and it consequently remained within a 
“historical” model which “just doesn’t work”. This model involved appointing the 
CRNs through the university which the Lead CRN felt left them “remote” and 
“isolated”. This approach was with a result of the initial establishment of cancer 
research networks in 2001; the model established then had remained for this 
clinical area despite further development and changes across the rest of the 
workforce. The Lead CRN described it as her “biggest challenge” and - despite 
some of the ongoing work to address and change this structure - she 
recognised that “it had been a very tricky and political” project.  
Interviewees in other case study sites also described how the arrangements for 
cancer research were different and how - at times - there was a feeling of 
conflict with the remainder of the CRN structure. In case study 1 the cancer 
CRNs were managed under cancer services and not R&D like the rest of the 
nurses. The Lead CRN described cancer as “a bit precious at times” and felt 
that “sometimes there is not always the appreciation of the non-cancer side of 
the service”. Cancer CRNs did not come under her remit which had led to some 
“competition between the 2” teams. In case study 4, the cancer research nurses 
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made up a third (8/24) of the total research nurse workforce; this was the only 
area to have a dedicated team. Other areas shared a research nurse as their 
role was seen as more generic and would cover more than one clinical area. 
The Lead CRN here also only officially covered cancer with no trust wide remit. 
The post holder helped supported the non-cancer CRNs but had “no mandate, 
just consultation” so could only offer informal support. 
External pressures 
Two of the organisations (case study 1 and 4) were in special measures at the 
time of data collection. This appears to have had a big impact on research and 
its relative importance: 
“there is no awareness of the role in terms of looking at the future 
at the  moment and that would be an inadvertent consequence of 
being in special  measures and therefore you are focusing on 
certain things.” 
― Lead CRN – Case study 4 
“I came here in September and that was the month we went into 
special measures, so establishing myself in a new role in this 
environment has been particularly challenging because the 
emphasis has not been on research.”   
― Lead CRN – Case study 1 
However, for some there was a sense of hope that research would improve 
once the external pressure had been resolved. The Lead CRN in case study 4 
remarked that “once we are out of special measures, the discussions around 
the table will be different and they will look into the future and we can start 
living”. 
Other external pressures were also mentioned. Interviewees in one organisation 
stated that some of their clinical services had now been contracted out to “social 
enterprise” schemes and so groups of patients had been lost (for example in 
case study 1 the diabetes outpatient service had been contracted out). As 
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research had not been discussed at the point of contract negotiation, the CRNs 
were not able to approach these patients for studies and so no diabetes studies 
could be run. This directly impacted on the potential clinical areas from which 
research nurses could recruit. 
Internal pressures 
Interviewees also cited the impact of wider financial pressures on the research 
infrastructure and the “difficult economic climate”. One PI commented that: 
“we are £40 million overspent. In that context I can’t imagine it 
being a fertile ground for blue sky thinking about research nurses”. 
― Principal Investigator – Case study 1 
In this context research activity was perceived as being a very low priority for 
members of the trust senior executive team: 
“If you asked the Chief Executive of this trust to list in order the 
things that are important to this trust it would be ambulance waits 
and the 2 week targets and the 100 day waits and right down on 
the bottom of the list, somewhere on page 3  would be research. It 
is not seen as high priority” 
― R& D Director – case study 1 
Funding for the research nurse workforce was an ongoing concern especially as 
NIHR funding is calculated on the previous year’s recruitment figures. Any 
constraints which limited the ability of CRNs to recruit to studies would directly 
impact on their future funding. Many of the CRNs understood this and realised 
that “if we don’t recruit we don’t exist as we are not there to fund the clinical 
budget”.  
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5.17. Summary of key findings: Structure Challenge: 
Leadership: 
- Effective links with Senior Managers both within research and the clinical 
areas helped in the support of the CRN workforce and the general 
awareness around research. 
Research Delivery:  
- An effective line management structure for the CRNs involves someone 
who understands their role and clinical area. 
- Initial lack of understanding regarding the benefit and input of non-
nursing roles but this reduced over time. 
- Differences in team structures are related to the size of the CRN 
workforce. The structure of cancer research teams is based on a 
historical model which at times causes conflict. 
Lead CRN role: 
- Importance of a dedicated senior research nurse to oversee the efficient 
running of research. 
- CRNs feel better supported and more empowered within their role. 
- Role provides a senior link into nursing across the organisation helping to 
raise awareness of research. 
Challenges and Limitations: 
- A historical and reactive growth of research and the CRN role has at 
times resulted in a less than ideal structure. 
- External and Internal pressures can have a negative impact on the 
success of research across the organisation.  
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5.18. Challenge 2: Culture  
Questions aimed to explore the culture of research across the organisation 
including an understanding of the value and importance ascribed to it; support 
from those in the clinical environment was also explored. 
Table 5.18-1 Definition of the culture challenge as described in Table 3.4-1 
Challenge Original definition in framework Definition applied to CRN 
workforce 
Culture Building a shared understanding, 
commitment and community 
around the improvement process 
Building a shared understanding, 
commitment and community around 
research and the CRN workforce 
Five key themes emerged in relation to the culture of research within the case 
study organisations. These were: 
- Clinical perspective on research 
- Interaction between research and clinical staff 
- Value of research across the organisation 
- Physical space for CRN work 
- CRN Uniform 
Table 5.18-2 Themes and sub themes: Cultural Challenge 
Theme Sub theme 
Clinical perspective on research  Understanding  
 Lack of time and competing priorities 
 Managers as gate keepers 
 Opportunities to support understanding 
Interaction between research and 
clinical staff 
 
 Benefits  
 Favours and ‘bribes’ 
 Embedding & integration of research nurses 
Value of research across the 
organisation 
 Importance from clinical colleagues 
 Lip service 
CRN Uniform  Professional Identity 
 Patient perspective 
 Lack of consistency 
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Each of these five key themes had a number of sub themes as shown in Table 
5.18-2. 
5.18.1. Clinical perspective about research 
This theme and its sub themes largely emerged from the question that was 
asked to all interviewees: “What is the importance associated with research 
across your organisation and how much value is put on it?” The responses 
indicated that there were numerous factors that influenced levels of awareness, 
understanding and attitude amongst the clinical nursing staff who were working 
alongside research nurses. There was also a variety of experiences within each 
organisation. 
Understanding  
This theme relates to both a lack of understanding about the research process 
and the research nurse role; all levels of nurses openly admitted their lack of 
understanding. CRNs expressed frustration as their colleagues “they just don’t 
know how research works and they don’t know what a research nurse does”. In 
one organisation the Director of Nursing had referred to the research nurse 
workforce as “feral”. The research nurse further explained: 
“we weren’t feral because we were doing crazy, stupid things but it 
was because no one knew what we were doing and that is a real 
problem. So we were a part of the nursing workforce and yet the 
senior nurses hadn’t got a clue what research nursing is”. 
― CRN – Case study 1 
Lack of understanding from senior nurses was perhaps inevitably seen to have 
had an impact on the support they were felt to provide to CRNs. The R&D 
Director in case study 4 felt the CRNs were “very poorly supported”. due to a 
variety of factors including  “one, she is too busy, two doesn’t have the 
knowledge and three, they don’t understand and hence they do next to nothing 
about it”. There also seemed to be concern from senior nurses that if they 
supported research it would impact their workload and so consequently they 
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“won’t touch it with a barge pole because they think it means more work for 
them”.  
Such lack of understanding appeared more common in the District General 
Hospitals (DGH) (case studies one and four) as the clinical Matrons here were 
often line managers for the CRNs with minimal input. The CRNs felt that the 
clinical Matrons “literally left me on my own because a lot of the speciality is not 
her field”. However, it was not total abandonment as there was a realisation that 
the Matron was “willing to delve in if I have an issue on the nursing side of 
things”.  
In many organisations CRNs themselves recognised that other staff generally 
had a lack of understanding and “zero interest” about research:  
“people don’t understand research and they are not aware. Even 
one of our executives didn’t know research is a core principle of 
the NHS” 
― R&D Director – Case study 1 
“the staff know so little about research or what our role is that they 
don’t really understand and it’s certainly not a priority”. 
― CRN – Case study 1 
At times this lack of understanding about the role appears to have also led to a 
feeling from the clinical nurses that the CRNs were a possible threat, stemming 
from the amounts of time that research nurses were often able to spend with 
their patients. Staff viewed the care within research as different and noted that 
patients would approach the research nurses first in the event of any problems 
or clinical concerns. At times the specialist nurses felt they “got a bit side lined”. 
This was often because “the research patients were ‘phoning the research 
nurses” first. At other times differences in the patient care delivered within the 
context of research studies was noted: 
“I needed a meeting with the Service Manager because some of 
the staff thought that the research patients were getting a better 
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deal than the other patients, and they didn’t like that, they thought 
it was wrong. It took some time to explain to them that these 
patients were having standard care”. 
― Lead CRN – Case Study 1 
As the opinion above illustrates, much of the lack of understanding centres on 
the CRN role. This sub-theme came out quite strongly especially within the 
focus groups where participants variously described ward nurses as perceiving 
the role as “a cushy number”, “they think we just wander around with a diary” 
and “not even proper nurses”. But as two CRNs explained: 
“there are many days when some of us don’t have lunch because 
we are too busy. We stay after hours to do sampling in the lab, 
and they just don’t see that side of things; they think it’s all 
paperwork and sitting down and that’s it” 
― CRN – Case study 4 
“Its lack of knowledge, just because we don’t work on a ward 
doesn’t make us any less busy”. 
― CRN – Case study 3 
However, factors external to the organisation were also seen as influencing 
understanding of the CRN role. This particularly related to the 2 DGHs who 
were both in special measures and where the CRN role was “viewed as 
bringing something extra that’s not required”. This seemed to mean that there 
was “no positive active support from the top down”, with “resistance” and 
“ambivalence” further down the organisation hierarchy. 
Lack of time and competing priorities 
This was felt quite strongly by the CRNs across all case studies who felt that the 
clinical nurses “can see all the positive benefits” of research but often view it  as 
an additional task that could be left undone in the context of an increasingly 
heavy clinical workload. There was a strong feeling that frontline NHS staff are 
currently so busy that there is no time for research:  
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“I think everyone is really, really busy. And I think across the NHS 
everybody is expected to do more for less and I think it is just 
something else that they really don’t want to engage in because 
they have already got such a lot on their plate”. 
― CRN – Case study 1 
Some more senior research staff felt that research was seen as being in conflict 
with clinical service provision.  
“senior nurses find themselves in a very challenging position 
because they are in positions where there is a huge conflict and 
tension between their professional obligations and their 
managerial obligations to deliver the service. I am sure they would 
say that they are very supportive of research and say that they 
would support people doing research but in brackets they would 
say as long as we have managed to do all the other things first, 
close brackets” 
― R&D Director – Case study 1 
Managers as Gatekeepers 
There was a feeling among some of the CRNs that managers of clinical nurses 
were preventing their staff from supporting research and being very “protective” 
about what their role included: 
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“She literally said ‘my girls do enough, you can do the research 
but they’re not doing anything on it’. It’s almost like the gate 
keeping thing, she won’t let you in”. 
― Lead CRN – Case study 1 
“there are some senior nurses on the ward who put the cross sign 
up by the door, don’t come near us, because they think we are 
going to make them more work” 
― CRN – Case study 3 
However, it was acknowledged that this may often have been a protective 
action from the manager to prevent their staff from having even more work to 
do.   
Opportunities to support understanding 
When discussing the difficulties that CRNs face when carrying out research 
within clinical services there was a strong feeling from more senior research 
nurses that CRNs should take active steps in order to facilitate clinical staff 
having a better understanding of research and the CRN role:  
“there’s something pre-reg that we need to be showcasing what 
research nursing and nursing in research does” 
― Research HON – Case study 3 
“there’s a lot more we could do with the ward nurses to get them 
to understand what the role is, that it’s not just swanning in and 
swanning out” 
― Lead CRN – Case study 3 
This then led to further discussions about some of the remedial steps which had 
been taken in some of the case study sites. 
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5.18.2. Interaction between research and clinical nurses 
This interaction is important because in order for research to run smoothly 
within the clinical area the CRNs must be able to work alongside their clinical 
colleagues, often within the same outpatient clinic or patient area and/or along 
the same patient care pathway. 
Benefits  
Many of the CRNs commented on the benefits that they felt their presence 
brought to the busy clinical areas including such activities as “take on care, put 
up the drug and take blood”. The CRNs remarked that the clinical nurses 
appreciated this as they did “see it as coming in and being helpful as we are 
taking the patients off their hands for a couple of hours”. 
The CRNs in case study 1 also explained that the clinical nurses appreciated 
the support that they gave to patient care because it “takes some of that 
pressure off them”. A PI in one of the case studies highlighted the direct 
benefits that research offers patient care, especially in relation to drug 
treatments which otherwise would not be available: 
“the commercial trials allow us to give drugs that we would never 
be able to give in the NHS for another five years. We love using 
those drugs.” 
― Principal Investigator – Case study 4 
Access to new drug treatments administered within research studies also 
means that when the same drugs came onto the market, the CRNs may often 
be the ones who train the clinical nurses in how to administer them: 
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“quite often it is us who train the clinical nurses because we’re 
pioneering the using of drugs in trials well before they’re marketed 
and when the drugs get marketed, my research team will educate 
them”. 
― Principal Investigator – Case study 2 
 
There was also a feeling that the presence of the CRNs within the clinical area 
allowed mutual support between themselves and their nurse colleagues. CRNs 
spoke of this as a “two-way thing” with each learning from the other. Direct 
benefits to studies were also recognised; CRNs were able to identify a link 
between successful study recruitment and “engaging with the clinical staff 
especially the nurse specialists”. They highlighted that nurses would contact 
them if a patient arrived who may be suitable for a study. 
Favours and ‘Bribes’ 
CRNs also talked about doing “favours” for the clinical nurses in order to 
integrate themselves with the wider team. It was felt that this would them give 
them an “equal footing” with their clinical colleagues. The CRN would “muck in” 
with the workload as this would help to “open up lines of dialogue” which may 
assist in the future if they needed a favour in return.  
One of the Lead CRNs felt that the benefits of this were apparent and thought 
that “the clinical nurses are more likely to do something, go the extra mile, if 
they’ve had something back”: 
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“so we quite often will go out and do favours. It’s like ‘I’m not busy 
at the minute do you want me to take that blood?’ So when we 
need a favour back we’ve generally got them onside” 
― Lead CRN – Case study 2 
Concern was expressed by this Lead CRN as to whether this amounted to 
being “manipulative” but overall she recognised that it is about “working as a 
team because it brings such huge benefits”. 
CRNs also referred to “bribing people with sweets” or “thanking the nurses” with 
chocolates or cakes which helped gain support for their studies or reward the 
assistance they had received. The reciprocal nature of this was also highlighted. 
The CRNs felt that the clinical nurses were often very “accommodating if we 
need to ask a favour”.  Overall it was felt that it was “give and take” between 
everyone. 
However, this level of collaboration was not apparent in all the case study sites; 
other CRNs found that if they were not integrated into the clinical service to the 
same extent as their colleagues, this meant that they were not “ there all the 
time" and so  it was more difficult to build up favours.   
Embedding & integration of research nurses into clinical areas 
Many of the teams felt that the success of the research was helped by how 
much time they were able to spend within their clinical area. Some of the 
research nurses spent all their time working within a department and so felt that 
research had a presence and was integrated and part of that team: 
“in our team we spend a lot of time in the department , and in their 
induction research is always highlighted. I think because we are in 
there quite a bit they really see us as part of the team”. 
― CRN – Case study 3 
Others acknowledged that those nurses who had previously worked in the 
clinical area and then moved across to a research role within that same area 
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found integration with the clinical team much smoother. The Consultants 
favoured this and remarked that because she “was a long time clinical stroke 
nurse, she has a good rapport with the rest of the stroke team” and “she came 
from the clinic and so everyone knows and she works very well with the team”. 
However, where clinical services were dispersed, it was very difficult to become 
truly integrated as often the clinical staff were “quite segregated”.  An example 
given for this was renal medicine where “the wards are one thing, outpatients 
are another, haemodialysis is another and peritoneal dialysis is another”.  
As outlined above interactions between the clinical and research staff was also 
helped if the CRNs were seen to help out in times of extreme need: 
“when we have had a nursing and clinical crisis the research 
nurses have undoubtedly contributed to the clinical service by 
being part of the clinical team and stopping being research nurses 
for a period of time” 
― R&D Director, Case Study 1 
However, some CRNs were quite cautious about becoming too integrated in 
case it detracted from their research studies. It was pointed out that it is always 
important to remember that the CRN role is aimed at supporting research and 
the outputs from that. As one Lead CRN explained “if my girls aren’t doing 
research we aren’t getting bums on seats and therefore that impacts on my 
funding”. 
Expressing similar sentiments, some PIs felt that if “you embed the nurses even 
more” there was a danger of losing them to the clinical service as they would be 
asked to “support the service gaps”. In this case it was viewed that “there are 
clear benefits in reminding people that they are wearing a different colour dress 
and there to do research and not provide a service”. 
5.18.3. Value of research 
This theme and its sub-themes emerged from questions concerning “what is the 
importance associated with research across the organisation and how much 
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value is put on it?” There was a broad recognition of the importance of research 
within the wider NHS; nonetheless, some organisations seemed to struggle with 
integrating research into the day to day business of patient care. 
Importance from clinical colleagues 
Although there was recognition of its importance some interviewees felt that the 
organisation “did not put enough focus on research” as it is just a “niche area”. 
Researcher’s felt it was “fundamental” and “in my opinion, everybody’s 
business”. However, in some organisations, especially the two in special 
measures, the importance and value of research was relative low with respect 
to other priorities. Research was “not a priority” and because the focus was on 
“sorting out people at the front door, they are not going to be thinking about 
research which might give rewards 10 years down the line”. For many the real 
priority was seen as the “day to day balancing of the books”. 
The PIs could gauge the importance that they felt the organisation assigned to 
research. In case study 2, a PI had been supporting research for 15 years and 
so had developed a successful research service alongside the clinical service. 
He explained: 
“the ethos really is that every patient who we see clinically 
potentially could be a research subject, and so it is our duty to 
offer our clinical patients the opportunity to take part because that 
opens different avenues to them otherwise not available”. 
Within the same organisation another PI felt that at times the importance 
assigned to research was “a sort of nominal value in name”. He continued that 
he felt there was a recognition that “research forms part of being a successful 
trust” but that generally “other clinical priorities take precedence and you can 
see why”. 
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Lip Service: 
Although the value and importance of research was acknowledged, many 
participants still felt that it was never high on the priority list. A lot of the time the 
support it received was ascribed to lip service: 
“every mission statement of any trust has research as top priority 
but like every trust there is a big financial squeeze. I think 
surviving financially is probably more important than research 
excellence”. 
― Principal Investigator – Case study 3 
“what you are saying is we are really engaged in research, it’s 
really important, we want everyone to do research but you’re not 
actually backing that up with someone who can facilitate that. It 
gives a mixed message” 
― CRN – Case study 3 
The R&D Director in case study 1 acknowledged that research was often used 
as an “opportunity to sell the trust and something that was good to talk about” 
but that the reality was very different and the support was not always there. This 
was sometimes felt to be due to completing priorities so there was a feeling that 
people would “talk about research but wouldn’t necessarily walk the walk”. He 
felt that overall “it is one of those things that is really valued but without 
necessarily being supported”.  
5.18.4. Clinical Research Nurse Uniforms 
Many of the research nurses had very strong views on whether they should 
wear a uniform and, if so, what this should be. This had not been anticipated 
prior to the fieldwork commencing and initially arose in the first research nurse 
focus group. As their opinions had been so strong this issue was then explored 
further in all the subsequent focus groups.  
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Professional Identity 
A lot of the feeling about uniform was related to how it made them feel, 
confirming their professional identity and role as a nurse. CRNs commented 
that “I think we all kind of base our identity as a nurse”; and that by wearing a 
uniform it “makes us nurses” and if you “didn’t wear a uniform you weren’t seen 
as a nurse”. So that overall it was a felt that the uniform was “embedded in that 
nurse culture” and “very, very important as it’s the person you are”. 
Patient perspective  
Linked to their feelings around professional identity was the response CRNs felt 
they received from patients. Many felt that the reception they received was 
better when they were in uniform: 
“I think patients can relate to us better, rather than in mufti. It’s just 
more   professional … I think if they see you in uniform the 
patients respect you”   
― CRN – Case study 4 
The colour of the uniform was also important. Some CRNs wore the specialist 
nurse uniform of their organisation. Some felt that if the colour of their uniform 
linked in with the colour of more senior nurses across the organisation, then this 
led to a different approach from patients and more respect for them: 
“if you are walking around the hospital people usually stop you 
particularly if you’re in dark blue, ‘excuse me sister, can you help 
me find’ whatever? I think it does give us a level of respect all 
wearing the same”. 
― CRN – case study 4 
Lack of consistency 
There was no consistency regarding the uniform within organisations. However, 
the wearing of uniform was often related to the influence that the Lead 
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Research Nurse had in initiating the practice. In case study one, it was noted 
that the Lead CRN “initiated” the uniform on her arrival. In case study 3 the 
Lead CRN had been seen to be “working very hard to push the uniform side of 
things” and put all the CRNs in “one uniform, to be recognised”. 
Within organisations, some research nurses would wear the uniform of their 
clinical nurse colleagues especially if it was a designated area such as the 
emergency department. Other nurses worked in a distinct research area such 
as a Biomedical Research Unit (BRU) and so wore a uniform attached to this 
setting.  
None of the case study organisations had a consistent practice regarding their 
uniform for research nurses. One of them was having a trust-wide review of 
their nursing uniforms and the research nurses had been offered a red uniform 
to wear. This evoked a large amount of discussion primarily based on colour 
and cost.  
“a dedicated research nurse uniform, so that’s very new. I don’t 
know whether we’re going to do a massive roll out or are we going 
to start putting new staff in it because we haven’t got much 
money”. 
― Lead CRN – Case study 3 
The CRNs within this organisation (case study 3) displayed a mixed response to 
the recent decision of a trust-wide uniform for them. It was felt that it may 
“alienate our team because we would be in a different colour”. When 
considering a red uniform some nurses stated that they couldn’t “think of a 
worse colour to wear”. Whereas, others recognised the benefits of a bright 
dedicated uniform. Those already wearing it had found the response 
“phenomenal “and felt that it had given them “real visibility” within the trust. They 
recognised that it “helps going onto wards and things as everybody knows who 
we are”. 
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Increased visibility of the CRNs due to their uniform was also noted at another 
organisation (case study 1). On her arrival the Lead Research Nurse had 
introduced a green uniform for her small team of research nurses and this 
appeared to have had a positive impact: 
“I would say that the unit that she set up with the green uniform 
seems to work very well and if she thinks that the green uniforms 
are a major  contributor of that I will sign up to it.” 
― Principal Investigator Case study 1 
―  
“That helps our patients as well, especially that first meeting 
because if you are having to meet them in the main reception area 
or something like that you might not know who they are, but 
actually they will see you in green so that’s quite good.”  
― CRN Case study 1 
Also linked to the uniform was the issue of cost and for one group of university 
funded research nurses (case study 3) this had led to them having no uniform 
despite their desire and request to have one. This meant they worked alongside 
their trust appointed research and clinical colleagues:. 
“I would never have dreamed of not wearing a uniform. I hate 
wearing my own clothes. I feel very exposed wearing my own 
clothes when I am dealing with patients. I feel very exposed going 
into a ward. I would feel better in a uniform, but it’s not going to 
happen, no funding. We are funded differently and therefore our 
uniform is our lanyard around our neck” 
― CRN Case study 3 
The negative impact of this was felt to be heightened as their trust appointed 
CRN colleagues worked across two different sites and so many of them had two 
uniforms. When they changed site they were expected to “change our uniform 
and go into the nurse practitioner, the royal blue”.  
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5.18.5. Summary of key findings: Culture Challenge 
Clinical perspective on research 
- Many perceived that clinical nurses do not fully understand the CRN role. 
- Current pressures within the NHS adversely impact on the amount of 
support given to research. 
- Senior nurses feel protective of their staff and act as a gatekeeper as 
what they see as additional workload.  
- More could be done to promote a better understanding of research and 
the CRN role. 
Interaction between research and clinical nurses 
- CRNs have a beneficial role within the clinical environment and can 
support patient care. 
- CRNs often carry out favours or ‘bribes’ within the clinical environment to 
help promote research and gain further support. 
- Working alongside the clinical team either currently or in the past aids the 
embedding and integration of CRNs into that team. 
Value of research across the organisation 
- Broad recognition of the importance of research across the NHS. 
- However, some struggle with integrating research into the day to day 
business of patient care. 
- There appears to be wider consent but not individual co-operation within 
areas. 
- Support received was sometimes ascribed to lip service. 
CRN Uniform 
- CRNs stressed the importance of their uniform related to their feelings of 
professional identity. 
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- CRNs felt they received a better response from patients when wearing 
their uniform. 
- There was a lack of consistency across organisations related to the 
uniform worn by CRN teams. 
5.19. Challenge 3: Education 
Table 5.19-1 Definition of the education challenge as described in Table 3.4-1 
Challenge Original definition in framework Definition applied to CRN 
workforce 
Education Embedding and nurturing a 
continuous learning process in 
relation to quality and service 
improvement issues, including 
both formal and informal 
mentoring, instruction, education 
and training, and the acquisition 
of relevant knowledge, skills and 
expertise. 
Embedding and nurturing a 
continuous learning process for the 
CRN workforce in relation to high 
quality research governance and 
patient safety including both formal 
and informal mentoring, instruction, 
education and training and the 
acquisition of relevant knowledge, 
skills and expertise. 
Lead CRNs were asked to describe how the education for CRNs was structured 
and supported within their organisations. During the focus group the CRNs were 
also asked to comment on the educational support they received towards their 
role. 
Two key themes emerged in relation to the structure of the CRN workforce and 
education. These were: 
- Quality of Leadership 
- Culture 
Table 5.19-2 Themes and subthemes for the challenge: education 
Challenge Theme Sub Theme 
Education Quality of Leadership  Attitude of senior leaders 
 
 Culture  Educational Structure  
 Management support 
 External influences 
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Each of these key themes had a number of sub themes as shown in Table 
5.19-2 
5.19.1. Quality of Leadership 
This relates to leadership both within research and across the organisation.  
Attitude of senior leaders 
There was a link between the attitudes of senior leaders and the Lead CRN as 
to the focus of educational support provided. Within one of the smaller 
organisations (case study 1) the R&D Director demonstrated a lack of 
engagement towards the education of the CRNs. He saw education as being 
within the remit of the Lead CRN and stated that the he would trust her (the 
Lead CRN) “to provide the education that they need in order to fulfil their roles”. 
He also appeared to demonstrate some apathy towards the CRN workforce and 
felt they were not engaged or motivated towards education: 
“a number of then have become research nurses for a variety of 
reasons. Seldom because they are fascinated by research and 
some because it offers them a work / life balance opportunity and 
they may not be interested in taking that further. They are happy 
contributing that way without necessarily developing themselves” 
This was also demonstrated by the Lead CRN when she described her nurses: 
“I haven’t had any of my team ask me about a degree yet. When 
you meet them you will see what I mean. 2 or 3 have got young 
families so it’s not appropriate at this time. One just comes to 
work; I don’t really know why to be honest with you. Two of them 
would say they are too old. So it’s not that I don’t support them”. 
However, one of her CRNs had arrived in post having completed a Masters 
degree. She was not convinced of its benefit and remarked “it’s quite interesting 
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having one who is so academic and can show off a piece of paper but we can 
see the practical skills are not there”.  
In contrast, case study 4 was a larger DGH that was also in special measures. 
Here, however, the attitude was very different. The R&D Director felt it was 
important to encourage his staff to undertake academic studies and remarked 
that he was “happy to fund anything within reason”. However, he also ensured 
that the drive to develop came from the individual themselves. He was aware 
that “you can’t push anyone into education” and that individuals “need to do it 
on their own accord”. He was very supportive of the whole CRN workforce and 
stated “If I don’t invest in my staff then nobody will”. 
Attitude towards education was clearly linked to the behaviour of the Lead CRN 
and whether they were a role model and valued academic progress. Within 
case study one the Lead CRN had not done any further academic studies 
herself. When asked whether she discussed academic development with her 
staff she appeared to have dismissed their interest in it and remarked “nobody 
has come up to me” to ask about it.. She agreed that for her team “training was 
more related to the role of the post holder rather than looking at ongoing 
academic development”. This was the opposite to case study 2 where the Lead 
CRN had completed a Master’s degree and was exploring the possibility of 
starting a PhD. She was keen to develop her staff and had already “had a 
number of research nurses go and do the Masters in Clinical Research course”. 
She had been supported by her R&D Director to establish a training facilitator 
post and after 3 years could appreciate the full benefit this provided to the 
workforce. It also enabled her to focus her attention on other strategic projects 
for ongoing development and support of the workforce.  
Within case study 3 the Lead CRN was supported in her role a Head of Nursing 
(HON) who had an understanding of research. Education was very much part of 
the culture for the CRNs and seen as “very important” by the Lead CRN who 
“always tried to take everybody’s training needs into account”. Within case 
study 3 the Lead CRN confirmed that funding was limited due to “reductions” 
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and the trusts “financial position”. However, the CRNs were still encouraged “to 
seek out alternative sources of funding” to support their development.  
In case study 4 the Lead CRN was studying for a PhD that was fully funded by 
the department and encouraged by the R&D Director, who was himself studying 
for a PhD. The positive attitude from management appears to have filtered 
down towards the CRNs who felt “very supported when it comes to education” 
and referred to being “encouraged” to carry our further study and “proactively 
look for courses”. The R&D Director was aware of the benefits of investing in his 
staff and was aware that “if you give them the opportunity and training, you build 
up a good culture”. He helped facilitate and support their studying by allowing 
them to adapt their working hours in order to allow sufficient time for study: 
“I allow them to do four long days and one day off to do whatever 
they need. The ones that are doing extra degrees all do long days 
and one day off.” 
There was also a supportive attitude to providing study leave to attend courses; 




The academic profile of the four case studies was explored (see Table 5.19-3). 
However, the Lead CRNs in the larger organisations (Case study 3 and 4) were 
unable to describe what level of study their workforce had achieved. This was 
not the case in the other organisation which had a smaller workforce. 
In case study 1 the Lead CRN was involved in training the clinical research 
network. She remarked that they “have a really robust education system” and 
was “one of the few areas that have an “Advanced research in Practice” 
course”. This was available for all CRNs within the network to attend annually 
and included role related training, professional updates and teaching.  No other 
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case study had access to this type of programme. However, within the 
organisation due to funding restrictions there did not seem to be a strong focus 
towards professional development outside of mandatory training.  
Table 5.19-3 Levels of education of CRNs in case studies 
Case Study  Lead 
CRN 
Band 
Lead CRN  - 
Academic 
level 





of CRN workforce 
1 7 Nursing 
qualification 
15 No  10 x RGN 
 1 x BSc 
 1 x MSc 
 3 x NK 
2 8b MSc 120 Yes Not known 
3 8a MSc 130 Yes Not known 
4 8a MSc and doing 
PhD. 
24 No  3 x PhDs 
(current) 
 2 x MSc 
 13 x BSc 
 3 x RGN 
 2 x Diploma 
In case study 2, the Lead CRN felt that within her organisation there was a 
“good culture around education and training”. Within the CRF the staff were 
“positive and “always looking for opportunities to develop and promote 
professional development for staff”. With a larger workforce there had been 
more opportunity to develop an education structure. The Lead CRN had been 
able to develop a band 7 post specifically around supporting the education and 
training of the CRNs. This post holder was able to oversee the induction 
programme for new staff, which the Lead CRN saw as a “robust programme”. 
By linking in with external research structures, such as the UKCRF network, 
they had been able to “incorporate anything into their programme that was 
relevant and current”.  
In case study 3 the Lead CRN was able to run a regular research forum that 
was open to all CRNs across the organisation. This included organisational and 
local updates. The trust also had a HON whose role was to embed evidence 
based practice within the clinical environment and develop clinical academic 
careers. She also helped support the Lead CRN and had seen a significant 
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benefit of this forum and referred to it as being “fantastic” and “phenomenal”. 
Having a senior identified individual that the CRNs could access to support their 
training and development was seen in a positive light. However, there was a 
sense that her role had “expanded” and that she could no longer “personally 
mentor everybody”. She was seen as someone that could “set up a structure of 
work streams across the trust” that was available for all clinical nurses. 
The Lead CRN in case study 4 described the department as having “embedded 
education as part of routine assessment or management”. He also described 
how education was incorporated into the regular team meeting: 
“we are quite proactive in that in every month in the meeting , as 
part of  the agenda, is the study days and training that people are 
going to, how  did it go and what did you learn? So a bit of 
reflection and sharing.” 
Management support 
Personal attitudes to academic development also appeared to have an impact 
on the culture of education. In case study 2, the Lead CRN as mentioned above 
had completed a Master’s degree and had plans to commence a PhD. This 
appears to have given her the academic oversight to promote and support this 
level of education across her organisation. Her strong links with the senior 
nurses had enabled her to share her ideas and realise that “she needed to be 
pulled more into the organisation infrastructure to work with people to take this 
forward”. She was proactive in her plans to develop an education strategy and 
was keen to look for “opportunities” as to what she “could push and drive next”. 
The structure and level of her role appears to have given her the permission 
and authority to take her plans forward. Having been in her post for four years, 
the Lead CRN could now see “a complete sea change” in people’s attitudes to 
research and education. She could also see clear benefits for education of this 
cross working between research and the more clinical side of nursing now 
becoming apparent and confirmed that she got “a number of people getting in 
touch with me about going on a Masters Course and the research side of 
things”. 
 Page 175 
Within case study 3, the HON felt that the CRNs had very good educational 
support and this was due to a combination of “leadership” from the Lead CRN 
and the cross working with other senior nurses such as herself. Although the 
HON had a trust-wide remit, the Lead CRN had been able to link in with her to 
gain educational support for her team and also raise awareness around 
research.  
External Influences  
Funding for courses was an issue within all four case studies and all Lead 
CRNs had experienced a reduction in the amount of financial support available 
to them for training. In case study 3 the Lead CRN had a positive attitude to 
education which she saw as “important” but also a “real challenge”. A reduction 
in funding had impacted the amount of internal funding available and funding for 
academic courses was only available from external sources. By developing her 
informal links with the HON for Research and Midwifery, the Lead CRN had 
enabled her CRNs to have a greater awareness around the external training 
and funding available from places such as the NIHR for Masters Fellowships.  
5.19.3. Summary of key findings: Education challenge 
Quality of Leadership 
- Attitude of senior leaders and the Lead CRN was linked with the degree 
of focus on educational support and academic development. 
- There appeared to be a link between the academic profile of the Lead 
CRN and the degree to which they focused on academic development for 
their staff. 
Culture 
- A positive culture towards education helped to ensure the development of 
a robust education system. 
- Personal attitude of the Lead CRN to academic development had an 
impact on the culture of education within the CRN team. 
- External influences also impacted upon the educational culture. 
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5.20. Challenge 4: Politics 
Table 5.20-1 Definition of the politics challenge as described in Table 3.4-1 
Challenge Original definition in framework Definition applied to CRN workforce 
Political Negotiating the politics of change 
associated with implanting and 
sustaining the improvement process, 
including securing stakeholder buy in 
and engagement, dealing with conflict 
and opposition, building change 
relationships and agreeing and 
committing to a common agenda for 
improvement. 
Negotiating the politics of change 
associated with implanting and sustaining 
the CRN workforce, including securing 
stakeholder buy in and engagement, 
dealing with conflict and opposition, 
building change relationships and agreeing 
on a common agenda to ensure high 
quality research governance, support the 
achievement of NIHR objectives and 
ensure ongoing patient safety. 
Questions were asked in an attempt to gauge the ‘politics’ of an organisation 
and what impact this had on research. Individuals were asked about the 
interaction of research and non-research teams and whether the CRNs felt 
empowered within their role.  
Three key themes emerged in relation to the structure of the CRN workforce 




Each of these three key themes had a number of sub themes as shown in Table 
5.20-2 
Table 5.20-2 Themes & subthemes for challenge 4 – “politics” 
Theme Sub theme 





Reluctance to change  Historical models 




 Page 177 
5.20.1. Integration of research within an organisation 
Facilitate  
There was a sense that at times efforts to facilitate the integration of research 
within an organisation were lacking; research activity was seen to “come below” 
clinical activity. Research teams were not prioritised when considering office 
space and were sometimes “geographically dispersed” across a site which was 
seen as reflecting on their lack of “importance”. In some areas the ward or clinic 
manager would impose barriers which would prevent the integration of 
research. Efforts to carry out research related training were refused and 
although CRNs were not prevented from carrying out their role, in some areas 
there was no effort to support them or enquire about research.  
CRNs remarked on the lack of interest towards research from clinical staff with 
comments such as “they’re very nice when you go up there but interest (in 
research) nothing”. 
It was easier to facilitate integration if the CRN had worked in the area as a 
clinical nurse prior to moving into research. In this situation they felt “one of 
them” and were able to help the nurses out with clinical tasks. The CRNs felt 
they got “a better response from them” as they were “available” to help out and 
do a “bit of back scratching”. This helped to build up relationships (as discussed 
further in the emotional challenge).  
Other CRNs based themselves within their clinical area in order to help facilitate 
their integration. This allowed them to assist their clinical colleagues when the 
workload increased. One CRN remarked that in these situations “you’ve got to 
weigh up whether caring for people at the time is going to be more beneficial to 
staff”. However, the CRNs knew that ultimately they would benefit from this 
when recruiting patients: 
“the more time we spend in the department helping it becomes 
more of an advantage because people will then think, they are 
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brilliant those research  nurses and I’m going to ring them 
because I’ve got this amazing patient  for them”. 
The wearing of a uniform also facilitated the integration of CRNs with their 
clinical colleagues. As discussed within the culture theme, uniform was very 
important for professional identity and patient perspective. However, it was also 
felt to impact on how they were received by their clinical colleagues. Where as 
many CRNs wore a specific colour for their role, some had chosen to wear the 
same uniform as their department. One team based within an emergency 
department wore the “team colour”. They felt that if they wore the CRN uniform 
they “would alienate our team because we would be in a different colour”. 
When the organisation had a dynamic Lead CRN who was well networked with 
senior managers within R&D and nursing, efforts to integrate were more diverse 
and successful. In case study 2 the CRNs spoke of their efforts to integrate with 
the clinical nurses. This included invites to spend time in their team as well as 
newsletters and posters in the clinical environment. The CRNs were aware that 
research was “on the top of the agenda for the trust” and “it’s part of what the 
Chief Executive wants”. There was a political awareness that research was 
supported across the organisation and it was acceptable to promote it and raise 
its profile.  
Conflict 
Many articulated the sense of “conflict” that was sometimes felt between 
research and the clinical service. Some organisations had implemented joint 
roles where a nurse divided their time across the clinical and research 
requirements of a specific area. The aim of this was to support an “awareness 
and understanding of research” and “help train clinically based nurses”. 
However, this often led to “conflict between the demands of each area”. One 
Lead CRN (case study 4) cited a recent example where it was felt that 
developing a joint role had not worked. A chemotherapy CRN post had been 
developed which was divided across research and delivering chemotherapy as 
part of the clinical team. The aim of the post had been to be a “champion for 
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research” and to train other nurses “how to handle research patients on an 
ongoing basis”. The Lead CRN reported that “how they divide their time 
becomes a problem”. This leads to conflicting demands on the individual as 
explained: 
“e-mails turn up that have deadlines and they won’t be available. 
They will not be in the research area when the data comes, and 
that becomes a problem to the extent that it almost becomes too 
stressful for the person to perform the task.” 
In this example the post had eventually been withdrawn because “it wasn’t 
working”. 
There was often an “expectation” that if CRNs became an “integral” part of the 
team they should be “more flexible”. This would entail helping out more clinically 
especially if “the study is a bit quiet”. However, this may ultimately lead to 
research losing if CRNs are not focused on patient recruitment. 
Funding of CRNs was also another cause of potential conflict especially when 
considering potential integration. Funding provided by the NIHR for CRN posts 
gives an expectation that these post holders will work solely on NIHR research. 
However, as cited by one R&D Director this poses the dilemma that although 
the aim “is to arrive at a situation where research is just normal business, it 
clearly isn’t”. He also felt that conflict within integration was also caused by what 
uniform the CRNs wore. He remarked that “it is very difficult to make research 
everybody’s business if at the same time you identify special nurses and give 
them different colour dresses” to wear.  
Some remarked on the conflict felt by senior nurses between their “professional 
obligations and managerial obligations”. They knew that their “number one 
priority is to deliver a service”.  The R&D Director in case study one confirmed 
this saying “they would say they are very supportive of research and would 
support people doing research but in brackets they would say as long as have 
managed to do all the other things first, close brackets”. 
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Control 
At times control, or loss of control, was cited as one of the political challenges 
between the R&D department and others. In case study 2 the recently 
reorganised CRN structure had a Research Matron that came under the remit of 
the Lead CRN but also supported the trust-appointed CRNs within the 
directorates. Tensions had at times developed when appointing new CRNs due 
to the involvement of R&D; the Clinical Directorates felt that they had lost some 
control over the posts. A researcher within this organisation also talked about 
his attempts to maintain “control”. He confirmed that due to not always receiving 
the support he wanted “the best way to move forward is to have my own team 
and my own funding”. His CRNs were appointed within the trust model but he 
maintained control by providing the funding, either directly or indirectly.  
Some organisations had looked at the possibility of clinical nurses supporting 
research and developing joint research/clinical roles. However, there was a fear 
from some senior managers that they would want to “keep control of their senior 
nurses” to prevent their team being “muddied up with the research team”. From 
an R&D perspective it was also viewed as potentially negative. One R&D 
Director expressed that this would be “a negative move”. He felt that if the 
CRNs were more integrated into the clinical service they would be “hijacked to 
do different things” and R&D would “lose control as the CRNs would spend their 
whole time seeing clinical patients”. Within case study 3 the PI referred to the 
“danger” of integrating CRNs and the “fear that suddenly research nurses will 
be pulled to support service gaps”. Within case study 2, the PI felt strongly that 
CRNs need to be a “separate team” as “when you mix clinical activity and 
research activity, clinical activity will always take over”.  
5.20.2. Reluctance to change 
Historical models 
Much of the structure behind the CRN workforce appears to be linked to a 
historical evolution in response to the external environment and funding 
available. As discussed, across all organisations visited, regardless of size, the 
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structure for cancer research CRNs was a standalone team that had been in 
place for many years. This could be traced back to the set-up of the national 
research network system which had begun in 2001 with the set-up of the 
National Cancer Research Network (NCRN). In case study 2, which was a large 
acute teaching trust, the cancer CRNs were a standalone team but also 
appointed via the university and working in the trust on honorary contracts. This 
was a double challenge because of the complex nature of managing a team 
that were not substantively employed by the organisation. Work had started 
between the trust and the university to review these posts with the long term 
aim of making CRNs trust employees. However, this was seen as potentially 
“quite contentious”. The Lead CRN had an awareness of the political 
sensitivities of her actions and so had proceeded with caution: 
“it’s very political, very tense, and I think they feel it’s a big 
takeover bid so it’s got to be very carefully managed which is why 
we are being quite careful about how we do this.” 
There was an awareness that change could “destabilise” the team. The aim was 
to bring them under the trust system of being under Research Matrons as the 
benefit of this had already been realised. The Lead CRN confirmed that “I know 
that in terms of effectiveness and performance management we get much 
better outcomes through the CRF and the trust Matron”.  
5.20.3. Senior leadership within an organisation 
Stability 
The senior leadership within an organisation had an impact on the degree of 
awareness around research and this appeared to influence the experience of 
CRNs within the clinical environment. In one of the smaller case studies (case 
study 1), there had not been a substantive Chief Executive for 3 years leading 
but a series of interim post holders; consequently, there had been a lack of 
consistency around the Director of Nursing post. When talking to the CRNs they 
spoke of a lack of awareness and engagement from many of the clinical staff. 
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Some spoke of clinical staff having “zero interest in research” and research 
“being low on their priority list”. The R&D Director also commented: 
“this has been a challenge for research because it drops even 
further. It  drops even further because if you make any traction, 
you make a little bit  of progress and then go away and every time 
you have to go back to go and you never collect £200, you just 
have to keep going back to go and start again. So it’s been one 
step forward, one step back”. 
Within case study 4 the Chief Nurse was new to the organisation. The previous 
post holder had been very supportive and aware of the benefits of developing a 
Lead CRN role. However, this had not been implemented before her departure 
and so discussions regarding this were due to recommence with the R&D 
Director taking the lead.  
Within case study 2 the Lead CRNs links with the Chief Nurse had helped raise 
awareness around research across many of the senior nurses. Her role 
reported directly to a nurse director who then reported to the Chief Nurse. She 
was able to meet with the Chief Nurse twice a year to provide updates. The 
Lead CRN explained a positive impact of this had been that “all nurse directors 
know that if anybody’s talking about appointing a research nurse they need to 
get in touch with me and it’s our Chief Nurse that drives that”. 
Empowerment 
Effective senior leadership and sufficient seniority in the role appeared to 
support individuals being empowered and proactive to bring in change and 
develop autonomy in their role. As already explained, the Lead CRN in case 
study 2 was at a band 8b level and received ongoing and regular support from 
her R&D Director and one of the Nurse Directors. This appears to have 
empowered her to initiate changes that she could see would benefit the CRN 
workforce and ultimately the research portfolio. She was able to work with her 
senior managers in order to carry out initiatives to support the development of 
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the CRN workforce and articulate the benefits of much of the recent work she 
had done.  
In contrast across the remaining case studies, two of the Leads CRNs were at 
band 8a level and one was a band 7. Within their roles they seemed less 
proactive about initiating actions that would bring about change. The band 7 
Lead CRN spoke about feeling “frustrated” in her role and not “autonomous 
enough” and with limited “authority”. This may have left her less empowered to 
bring about change. However, she was within a much smaller organisation that 
was currently in special measures. Within case study 4 the Lead CRN only 
officially covered cancer with an informal remit for the trust CRNs. However, he 
was aware he had “no mandate” for the general CRN workforce and so did not 
feel it was his role to implement any trust wide strategies to benefit the CRN 
workforce.  
Setting up an effective structure for the CRN workforce with trust based 
research matrons appears to have helped them feel more “empowered” within 
their teams and helped them to feel they had a “voice”. Within case study 2, the 
CRNs based within the Directorate attended a structured regular meeting that 
provided them with an opportunity to raise issues and concerns which could 
then be managed or escalated up to the Lead CRN. Across all case studies, 
some type of regular meeting took place within the research teams where 
current and future research studies were discussed and “where everybody can 
share ideas”. CRNs felt that they were “listened to” and were able to be involved 
in the setting of “realistic” recruitment targets.  
5.20.4. Summary of key findings: Politics Challenge: 
Integration: 
- Research activity was not always a top priority but this could be 
enhanced when CRNs were better integrated into the area or were 
already known to the clinical area. 
- Conflict develops between research and the clinical environment due to 
different priorities. 
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- There was a concern that by integrating clinical and research workloads 
some control may be lost if one aspect had more priority over the other. 
Change: 
- Some CRN workforce structures are linked to historical models that 
evolved due to the external environment. Although these may no longer 
suit the current environment, care is need if change is going to be 
implemented.  
Leadership: 
- Senior leadership within an organisation can impact the degree of 
awareness around research. 
- Effective senior leadership and allocation of seniority to the role of Lead 
CRN enabled the individual to be more empowered and proactive. 
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5.21. Challenge 5: Emotions 
Table 5.21-1 Definition of the emotions challenge as described in Table 3.4-1 
Challenge Original definition in framework Definition applied to CRN workforce 
Emotions Energising, mobilising and inspiring 
staff and other stakeholders who 
want to join in the improvement 
effort by their own volition and 
sustain its momentum through 
individual and collective motivation, 
enthusiasm and movement. 
Energising, mobilising and inspiring 
staff and other stakeholders to be 
involved in processes to ensure high 
quality research governance and 
patient safety. 
Questions within the emotional challenge focused around exploring the reality of 
running research studies within a clinical environment, the reception from 
clinical colleagues and any difficulties encountered. Themes within this 
challenge were less apparent than some previous themes. However, two key 
themes did emerge in relation to the emotional factors shaping the status of 
research and CRNs within the four case study organisations. These included: 
- Engagement 
- Recruitment 
Each of these two key themes had a number of sub themes as shown in Table 
5.21-2. 
Table 5.21-2 Themes and subthemes of challenge 5, “Emotions”. 
Theme Sub Theme 
Engagement with research  Relationships 
 Buy in 
Recruitment  Emotional energy 
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5.21.1. Engagement with research 
Relationships 
There was a strong theme around the importance of relationships across all 
case studies; some participants likened this to a sense of “family”. This was also 
linked to having a sense of “mutual benefit” between the CRNs and those within 
the clinical area where they recruited their patients. CRNs felt they were able to 
“develop a working relationship” which helped them to become accepted “as a 
colleague” and this worked both ways. It was also felt to be important if 
recruitment into the study was going to go well as the CRNs would get more 
support from clinical colleagues: 
 “you spend such a long time in there and it’s helpful to be building 
up those sorts of relationships because they will ring you and say 
oh there’s a patient” 
― CRN – Case study 3 
 “I think the clinical nurses are more likely to do something, go the 
extra mile, if they’ve had something back” 
― Lead CRN – Case study 3 
However, the building and maintaining of relationships was for some an ongoing 
process depending on where their study recruitment was based. CRNs were 
aware that “when a new study starts you are always trying to build up those 
relationships again”. They referred to relationships being “strong” and 
“supportive of each other” but that once a study closes “you leave because you 
go on to another project. So it doesn’t disappear necessarily but you have to 
build it up again if you ever go back into that area”.  CRNs often expressed a 
sense of loss and regret that they were leaving an area they had become 
settled in. Others were able to benefit from longer term studies where they were 
in an area for a prolonged amount of time and so could really cement their 
relationships and this benefitted the study. The CRNs felt that this benefitted the 
study as “some of the long term studies are easier to do because people 
understand why you are there”. 
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The flexibility of research nurses within the clinical areas was also important as 
they were then seen in a positive light and so this helped towards building the 
relationship. It was felt that there was some “give and take” and that overall they 
got “a better response from them if also available to them” and so “if you’ve got 
a quiet minute and they need a bit of help, you build up relationships”. The PI’s 
could also see the importance of relationships when engaging with patients for 
research: 
“we are all to do with relationships. You can’t treat us like pawns in 
a chess game. The whole thing about informed consent is that the 
patient has to trust the person who is taking consent and that’s all 
about human relationships.”  
― Principal Investigator – Case study 1 
Another PI could also see the impact of relationships between the CRNs and 
patients and referred to it as a “meeting of equals as you are asking the patient 
for a favour”. He felt that this equality of interaction was more productive as it 
moved away from the “patriarchal relationship” that is found within a 
conventional clinic.  
Buy in 
A busy clinical environment and competing priorities meant that often the “buy 
in” or general commitment was at times low. CRNs were aware that clinical 
colleagues had “101 other things going on” and “it's just so low down on their 
priority list they don’t even get to grips with the basics”. 
There was awareness that everyone faced “challenges” but CRNs explained 
that at times they encountered “a lot of resistance on the floor” which in turn 
made their role more challenging. In case study 4 the Lead CRN explained that 
the CRNs had “to fight for everything, if you’re asking for space, time or 
whatever” and in that scenario “you have to get extra emotional energy to make 
that request because the relationship is not a good one”.  
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5.21.2. Recruitment 
Emotional Energy 
The workload behind organising patient visits was often seen to require a lot of 
emotional energy. The CRNs spoke of the implications of a lack of dedicated 
space. Time was spent planning and organising patient visit appointments and 
this often required them to book a clinical room. However, this did not 
necessarily guarantee that it would be available on the day and there was an 
awareness that they were “at the bottom of the pecking order when it comes to 
clinical space”. One CRN explained: 
“you might think you’ve booked a room, organised it, but you go 
over and they’ve given it to somebody else. You will be the first 
one they will knock on to give the room to somebody else. It’s as if 
they say, oh that’s only research. I’ve even had the room taken off 
me for a doctor to sit and do dictaphoning, which is very 
disheartening.” 
― CRN – Case study 1 
Others also commented on the effort required to organise and see patients. 
Sometimes they were only able to access “quiet rooms which aren’t clinical 
spaces”. However this then required additional effort as the CRN “had to take 
them to phlebotomy to have their bloods done and take them to where the blood 
pressures machines are in clinic”. All of this required a lot of “energy” and 
additional “effort”. 
The difficulties within the clinical environment impacted how the CRNs felt 
within that environment. Some spoke of “not belonging”, being “stuck in a 
corner” or “pushed to one side” and that they “struggle every week”. Due to 
these difficulties some reported that at times they would “take the patient off and 
find space elsewhere”. Although this may not be in a clinical environment. In 
case study 2 one CRN commented she had decided to take firm action and so 
explained: 
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“I was running a study that was literally nearly everybody in the 
clinic that I could get in, and I basically got a piece of A4 and stuck 
it on the door and said this is for me” 
― CRN – Case study 2 
She was uncertain as to whether this was acceptable but explained that it had 
enabled her to spend the morning in clinic and recruit all eligible patients into 
her study. 
5.21.3. Summary of key findings: Emotional challenge 
Engagement with research: 
- There was strong agreement concerning the importance of relationships. 
This was mainly related to the experience of CRNs within the clinical 
environment. 
- A busy clinical environment meant that general commitment to research 
was at times low requiring additional effort by the CRNs in order to 
achieve a result.  
Recruitment: 
- CRNS’ spoke of the large amount of effort that is often required in order 
to organise dedicated space for patient visits. 
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5.22. Challenge 6: Technology and Infrastructure  
Table 5.22-1 Definition of the technology and infrastructure challenge as described in Table 3.4-1 





The design and use of a physical, 
informational and technological 
infrastructure that improves service 
quality and the experience of care. 
The design and use of a physical, 
informational and technological 
infrastructure that improves research 
governance and the experience of 
patients who take part in research 
studies. 
Questions focused around any recent technology developments which had 
occurred within research or across the organisation and - if relevant - how easy 
it had been to incorporate these into the research process. The overall 
infrastructure within which the work of CRNs took place was also discussed.  
This was difficult to analyse as the data relating to this particular challenge was 
relatively sparse and so themes were not obvious to identify. However, those 
that did emerge are shown below: 
Table 5.22-2 Themes and subthemes for the challenge: technology and infrastructure. 
Challenge Theme Sub theme 
Technology Attitude  Hindrance 
 Avoidance 
 Engagement 
Infrastructure Dedicated clinical space  Room issues 
 Organising 
 Staff support 
5.22.1. Attitude 
Hindrance 
From some participants there was a perception that IT changes were disruptive. 
This was more marked in the two smaller organisations (case study 1 and 4). 
Neither had a system of electronic patient notes but other IT changes that had 
occurred were viewed negatively. With case study 1 a new clinical portal had 
been introduced to manage all the pathology systems. However, comments 
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such as “terrible”, “abysmal” and “difficult” were made with an overall view that 
“the clinical portal doesn’t work very well” and “the organisation has taken a 
step back rather than a step forward as a consequence of its introduction”. Staff 
had also experienced problems with lack of compatibility from external data 
capture systems used within research studies (leading to delays in starting 
studies). These problems were seen as due to the use of old computer systems 
within the NHS. In case study 4 there was a collection of different IT systems; 
most participants viewed them as “more of a hindrance than a help”.  
There was a general feeling across the 4 case study organisations that IT 
changes were problematic and caused “problems because research wasn’t 
considered”. In case study 3 a new IT system was under development but the 
CRNs remarked that “research wasn’t engaged with at all” and they “were a by-
product”. There was acknowledgement that for success “there needs to be a 
centralised approach funded by the trust to R&D”, however CRNs felt that 
“research doesn’t seem to have been a priority in digitalising health records” 
and was seen as “more of a hindrance than anything else”. 
Avoidance 
At time, staff also appeared to actively avoid the use of new or emerging IT 
systems. In case study 1 the Lead CRN confirmed “I deliberately don’t use it, I 
leave it to the girls (CRNs)”. When asked, the R&D Director was unable to 
explain the clinical portal and expressed frustration towards it. Related to the 
introduction of electronic patient notes there was a feeling of relief that currently 
they were not implemented and the CRNs remarked “we are lucky in our 
poverty”.  
There was also a feeling of avoidance by the organisation of trying to take 
research needs into account. Staff had arranged a meeting while new IT 
systems were under development but they were met with comments of “we 
can’t fit that in now” and “it’s a bit late”.  
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Engagement 
However, the situation was very different in case study 2. Here they had just 
moved across to a system of electronic patient notes that had been met with 
engagement from the research teams and a positive approach. The Lead CRN 
remarked that “we engaged quite early on in the process around research and 
made sure it was included in the initial set up phase”. She attributed the 
success of research integrating the new IT system successfully to their “good 
links” and admitted that “three years ago we wouldn’t have got a look in, we’d 
have been shouting and shouting but it’s definitely changed”. She attributed this 
to being able to generally lay the foundations around research over the last 18 
months so that when new initiatives come along, research is considered 
because links are already in place. 
5.22.1. Dedicated Clinical space 
Many of the CRNs worked within outpatient settings and finding dedicated 
space in which to see their patients was frequently highlighted as an issue. 
Individuals mentioned that they often felt they were “squatting”, “at the bottom of 
the pecking order” and “not a priority”. 
Room issues 
Issues with space were ongoing and in many cases had to be renegotiated with 
each clinic and on a “case by case basis”. CRNs mentioned difficulties such as 
that the clinical areas “try to fit us in where they physically can” and “there’s a 
priority order and you are at the bottom”.  There was a strong sense of much 
time spent on “negotiation” by the CRNs when it came to identifying space in 
which to see research patients. This would often result in a room but often it 
was quite last minute and so CRNs had to “ring the day before” in order to get 
confirmation. Ultimately the research nurses would work where ever there was 
space and this resulted in a wide array of locations where research patients 
were seen: 
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“I have seen research patients in the cardiac catheterisation unit, 
in the day surgery unit, on the respiratory ward and in a clinic 
area”. 
― CRN – Case Study 3 
Organising: 
Difficulties in finding allocated clinical space meant that a lot of time was spent 
organising clinic visits: 
“there’s an awful lot of, you know like a swan, there’s paddling 
going on underneath and I think a lot of effort goes on getting the 
kit moved around   the hospital”. 
― Principal Investigator – Case study 1 
“and so every time we go over there we come out of this 
environment and you have to drag everything with you”. 
― CRN – Case study 1 
Staff support 
It was often the case that allocating dedicated space for research was down to 
the support of the clinical staff who would “fit us into a room that’s free for 5 
minutes if at all possible” and “find an empty room if there is one”. However, 
some CRNs did encounter a negative response when organising space to see 
research patients. In case study 1 the CRN remarked that staff would not 
actively prevent them from finding dedicated space but they were aware that the 
staff “don’t want to do it” and that they (the CRNs) were always “the first one 
they will knock on to give the room to somebody else”. Therefore this often left 
them with the uncertainty that they would be asked to be asked to move in the 
middle of a patient research appointment. 
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5.23. Summary of key findings: Technology and 
Infrastructure Challenge 
Technology - Attitude 
- I.T changes were often perceived as more of a hindrance than a help. 
Especially in smaller organisations. Research is not always considered 
by the organisation when I.T changes are planned. 
- Staff were also known to avoid using new I.T systems if possible. 
- In organisations with a good research infrastructure the implementation 
of I.T changes had been an easier process. 
Infrastructure – Dedicated Clinical Space 
- Finding dedicated space in which to see their patients was frequently 
highlighted as an issue 
- CRNs often struggle to organise dedicated space as research was not 
viewed as a priority. 
- Research appointments were often held in a variety of locations across 
the organisation. 
5.24. Summary 
This chapter has presented the results from both phases of this study. Chapter 
6 will now discuss the results of each phase in order to explore the current 
structure of the CRN workforce and the experience of the CRNs who work 
within it.  
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Chapter 6: Discussion 
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6.1. Introduction 
This thesis has presented the findings from a mixed methods study exploring 
the experience of CRNs within acute NHS trusts and the structure of that 
workforce. This chapter will consider the study findings and will discuss these in 
relation to the limited amount of evidence concerning CRN experience and 
workforce structure.  The findings will be interpreted in order to inform the 
development of a ‘model’ organisational structure for CRNs working within 
acute hospital trusts. It will highlight the study’s original contribution to 
knowledge and suggest implications for practice and future research. The 
strengths and limitations of this study will also be considered.  
6.2. Summary of key findings and recommendations 
The study has identified that the CRN workforce has evolved in a reactive and 
inconsistent manner shaped by internal and external influences. Within many 
organisations this has included the development of a Lead CRN post to oversee 
the workforce. This study has revealed the importance of this role not only in 
providing leadership and direction for the workforce but also as a link to the 
remainder of the nursing workforce as well as a conduit to increase awareness 
of research and the CRN role.  
RECOMMENDATION:  
Organisations should ensure that the CRN workforce is well led with the 
establishment of a Lead CRN post. This should be linked in with both the R&D 
Director and the senior nursing leadership team. It should be placed at a band 8 
position within agenda for change but the exact level within this band will 
depend on the size of the CRN workforce and the responsibilities within the 
role. Consideration of the proposed CRN workforce model (see figure 6.8.1, pg 
223) may assist practice and provide organisations with a suggested framework 
for structuring their CRN workforce and the aspects within this that a Lead CRN 
will need to implement.  
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STAKEHOLDER = R&D Department and senior nursing leadership team. 
The current NHS climate means that the delivery of research is at times difficult 
and often overlooked as it is not perceived as a priority. This has an impact on 
the experience of CRNs within the clinical environment and the level of support 
and understanding from clinical nursing colleagues.  
The CRN workforce appears to be isolated from their clinical nursing colleagues 
with possible fragmentation between Oncology research and the remaining 
clinical areas. 
Research and the CRN role appears to be misunderstood by the remainder of 
the nursing workforce with lack of awareness in some areas. 
RECOMMENDATION   
Work should be undertaken to address the lack of understanding of research 
and the CRN role. This would in turn address the isolation of the CRN workforce 
within an organisation.  
STAKEHOLDER = R&D Department and senior nursing leadership team. 
Work to review and restructure the CRN workforce may not directly benefit an 
organisation in terms of increasing NIHR recruitment activity. However, benefits 
may be gained in demonstrating support and leadership for the CRN workforce 
as well as increasing awareness around research and the experience of the 
CRN workforce. 
RECOMMENDATION 
Review of the CRN workforce should be a decision taken by the R and D 
Department  
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STAKEHOLDER = R&D Department 
6) The structure of the CRN workforce is being influenced by the 
emergence of non-nursing roles within the research team.  
RECOMMENDATION 
Further work is required in order to understand these roles and their ongoing 
development and integration within the overall research team.  
STAKEHOLDER = R&D Department 
 
 
6.3. Original contribution to knowledge 
The literature review provided a small amount of information on the CRN 
workforce and its structure within a few organisations. This study reviewed this 
in greater detail and demonstrated the lack of consistency within the CRN 
workforce structures and the factors that impact on the experience of CRNs. It 
has demonstrated the reality of running research within a busy healthcare 
system comprised of what is often viewed as conflicting priorities. 
This is the first study that has examined the CRN workforce and how 
organisations have structured their individual workforces. It has identified the 
importance of having a dedicated Lead CRN to support and lead a CRN 
workforce and the positive benefits this can bring.  It is also the first study to 
examine NIHR recruitment in relation to the CRN workforce and the relationship 
between the two. These both have important implications for research delivery 
which will be discussed in this chapter.  
The thesis concludes with a proposed CRN workforce model that aims to assist 
practice and provide organisations with a suggested framework for structuring 
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their CRN workforce and the aspects within this that a Lead CRN will need to 
implement.  
6.4. Interpretation of findings 
These will initially be discussed in relation to each of the study aims. A more 
general discussion will then be presented. 
6.4.1. Study aims 
To explore how the CRN workforce is currently organised within NHS 
Acute trusts 
As reported in Chapter 3 there is little contemporary evidence as to how the 
CRN workforce is structured in trusts across England and Scotland. The three 
empirical papers examined gave an overview of the CRN workforce but did not 
report on how CRN roles had been structured within research or clinical teams. 
The three unpublished workforce reviews were presented in slightly more detail 
but again gave no insights as to any workforce structures. Findings from this 
study demonstrate that the NIHR has provided the infrastructure to form the 
essence of the architecture that underpins the CRN workforce. Within this 86% 
(73/85) confirmed that their CRN workforce works as part of one of the local 
Clinical Research Networks with additional structures such as CRF’s, BRC’s, 
and BRU’s. Examination in more detail within the four detailed case studies 
revealed a lack of consistency within the CRN workforce structure; cancer 
remained a standalone team within each of them. Across three of the case 
studies the structure of the CRN workforce appears to have developed in a 
reactive manner influenced by both internal and external factors. Internal factors 
related to the size of the trust and engagement of clinicians whilst external 
factors largely related to the level of funding available. Case study 2 was the 
only organisation to have fully reviewed and re-structured their CRN workforce; 
this had resulted in good support both from R&D and the wider organisation. 
Case study 4 had carried out a smaller review of their workforce which had 
primarily involved changes within the two main teams (cancer and non-cancer) 
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regarding the banding of the CRNs so that the majority of posts were now a 
band 6. Other possible changes discussed within the review had been put on 
hold by a change of senior nursing leadership within the organisation.  
The effectiveness of the CRN workforce structure appears to be influenced by 
strong nursing leadership. Within the questionnaire, 68% (76/111) of 
respondents were in a nursing role with the remaining 32% (35/111) in a non-
nursing role.  Within case study 1 the Lead CRN at band 7 level expressed 
isolation, a lack of autonomy and a lack of links with senior clinical nurses so 
preventing the integration of the workforce with the wider nursing workforce. 
There appeared to be a lack of acknowledgement from the Chief Nurses office 
of the need to develop links with the CRN workforce (the Lead CRN remarked 
that in the space of two years she had had “4 managers at Associated Director 
of Nursing” level). Although the R&D Director was aware of the deficiencies in 
the structure of her role he did not appear motivated to address them.  
Of the 68% that were nurses (76/111), the length of time that their post had 
been established ranged from one to 20 years (mean = 47 months). In addition 
66% of the roles had been established within the previous six years suggesting 
that the role is relatively new and so the impact may still be emerging within 
many of these organisations. Within the literature review, Ledger et al (2008) 
highlighted the need for a dedicated Lead CRN to oversee the workforce. Case 
study 2 demonstrated the impact of an established role which had become 
embedded within the organisation. The current post holder had held the post for 
four years but the overall duration may in part account for the successful 
integration of the CRN workforce.  
Conversely the Lead CRN role at case study 2 was at a band 8b level which 
enabled the post holder to develop a robust leadership structure including 
strong links into the senior nursing and R&D infrastructure (as well as provision 
of a well-supported leadership structure for the CRN workforce). Her strong 
strategic perspective alongside her role autonomy and authority had enabled 
her to develop a well-supported CRN workforce that appeared embedded within 
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the wider nursing workforce; this had enabled an increasing awareness and 
understanding of research to be developed within the organisation.  
The impact of this robust leadership structure was evident in several respects. 
Projects were underway or being planned to integrate research and raise 
understanding. These included: appointing research champions within clinical 
areas; the set-up of a dedicated post to support and deliver training 
programmes around research and professional development, and the 
integration of research matrons with clinical matrons to support the out of hours 
clinical cover service.  The Lead CRN referred to putting out a “tentacle into 
what’s normal, clinical infrastructure” in order to facilitate raising awareness and 
integration; this appears to have been effective with positive outcomes 
becoming increasingly evident.  
The two remaining case studies had a Lead CRN role at 8a level but exhibited a 
mixed picture. Case study 3 had a poor structure for reporting and 
accountability but the Lead CRN was linked in with the Senior Nurses forum. 
However, she had no support with clinical decisions and so felt professionally 
isolated. Within case study 4 the remit of the Lead CRN role remained within 
oncology with no formal responsibility for the trust wide CRN workforce. This 
meant a lack of overall leadership for the CRN workforce; although research 
was embedded within cancer, there was less awareness across the 
organisation with research seemingly “hidden”. Although the Lead CRN had 
developed strong links with the R&D Director there was no formal links with the 
Chief Nurses office although there had been a recent change in post holder so 
plans were in place to initiate these.  
Overall the study identified the importance of the Lead CRN role in providing 
support for the CRN workforce. Despite the reported lack of senior oversight for 
some of the post holders, the presence of an identified lead for research had a 
positive impact across all of the case studies. An ability to “draw things 
together” and “open doors” have been highlighted as some of the positive 
benefits for the CRNs. Post holders highlighted the visibility of research across 
the organisation and although some did struggle to achieve effective links, the 
 Page 202 
mere act of striving to establish a link helped to support an increase in 
awareness of the workforce.   
Study findings indicate that the structure of the CRN workforce is being 
influenced by the emergence of non-nursing roles within the research team. The 
pilot survey identified an additional fifteen roles that were involved in supporting 
delivery of research. Within the main survey an additional twenty-nine roles 
were identified. There may be a degree of crossover of responsibilities in these 
roles but with over half of organisations (n = 55/95, 59%) confirming they have 
Data Managers within their teams and almost three quarters (n = 65/93, 70%) 
having Clinical Trial Co-ordinators, this does show clear evidence that the 
structure of the whole research workforce is changing and evolving; this will 
undoubtedly impact the CRN workforce. Currently this development is viewed 
with some scepticism by CRNs especially within smaller organisations. 
Although there appeared no difference in these roles between the reviewed and 
un-reviewed organisations, there was a difference between the large and 
smaller organisations. The concern expressed by the CRNs in Case study 1 on 
the introduction of a non-nursing role may indicate the uncertainty initially felt by 
CRNs around this change. Despite the fact that posts such as Data Managers 
will release CRNs from the burden of inputting study related data into databases 
- a non-clinical activity not traditionally associated with nursing - some nurses 
expressed feelings of ownership and appeared quite territorial towards this 
activity. Even in Case study 3 where more of the nurses had worked with non-
clinical roles, some CRNs expressed that they were “struggling” and “finding 
their feet” when working alongside these roles. CRNs were aware that non-
nursing roles are appointed at pay bands lower than themselves but in many 
cases cover a large amount of the activities that they do. They had an 
awareness of the significance of research funding and the continual drive from 
R&D to recruit more participants into studies. Therefore, some of their 
trepidation towards these roles may be related to a personal feeling of a 
growing threat towards their own role. 
The presence of a stand-alone CRN team for cancer research across all four 
organisations appears to have caused a degree of hostility and competition. 
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Across all sites this could be traced back to the setup of the National Cancer 
Research Network which appears to have now resulted in a section of the CRN 
workforce being isolated and separate from the remainder of the workforce. The 
survey identified that cancer studies are run in the majority of organisations 
(n=88/95, 92.5%) and only 7/95 respondents indicated that this was not the 
case. If the case study findings were to be replicated across the country then 
the CRN workforce may be slightly fragmented in its overall structure. Focus 
groups held in case study 2 and 4 included a CRN working within cancer. Within 
case study 2, where they were appointed through the university, the individual 
had not met any of the other CRNs before. She confirmed that the team was 
“managed on its own” and worked “very much within their own clinical area”.  
Therefore in summary, the overall picture exhibits a workforce comprised of an 
inconsistent structure but primarily divided between cancer and non-cancer. 
The Lead CRN is a developing role to take oversight of the CRN workforce but 
may not yet been developed within many organisations. More recently the 
workforce has seen the development of non-nursing roles which are viewed 
with uncertainty. This may well prove to be the catalyst for changes within the 
CRN workforce itself. 
To explore and compare the experience of CRNs within different 
organisations 
This study identified that the experience of CRNs within different organisations 
is multi-factorial. It is mainly influenced from within their organisation but where 
external factors are impacting across their organisation this was found to also 
shape experiences. 
The theme of isolation is consistent with findings of previous studies. However, 
it is generally not the individual CRNs that feel isolated but the workforce that 
feels isolated from their clinical colleagues; there was a sense that they belong 
to each other but not to the organisation. This appears to be related to the 
feeling that they are not linked in with the wider workforce and are “hidden” from 
their clinical colleagues. Some of the Lead CRNs expressed this in greater 
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detail as they could see the result of not having formal links with the senior 
nursing structure across their organisation. For case study 4 this only applied to 
links outside of oncology but for case study 1 and 3 it applied across the 
organisation. Within the literature review isolation was linked to a lack of 
understanding around the CRN role; this was a theme across the whole study. 
The questionnaire found that only 27.5% had confirmed that they thought the 
CRN role was understood. This was further explained in the case studies by the 
CRNs who revealed a range of reasons which included that they were 
perceived as having a “cushy role” which meant they were not a “proper nurse” 
and viewed as being “data collectors”. The CRNs felt they were perceived as a 
threat by their clinical colleagues; this was exacerbated when patients 
contacted the CRNs first when a problem developed as they felt the CRNs had 
the time, leaving the clinical nurses feeling side-lined. This also appears to be 
related to another factor: the CRN experience is impacted by the current 
pressures within the NHS. Within the questionnaire and across all case studies 
there were numerous references to “competing priorities”, “conflict” and “lack of 
time”. This was especially evident in the two smaller case studies (1 and 4) 
which were both in special measures and had been for the previous two years. 
Research staff were aware that research was viewed as “bringing something 
extra that’s not required” and low on the priority list. Whilst CRNs did think that 
clinical nurses could see the benefits of research they felt they viewed it as an 
additional task that could be left undone when facing an ever increasing clinical 
workload. This was not consistent with the findings of studies discussed within 
the literature review and may indicate changes in the healthcare system within 
which NHS staff currently work. However, until research is viewed as business 
as usual it will always be seen as an additional extra that can be dropped when 
the workload pressure increases.  
Further consistency between themes within the literature review findings and 
this study included feelings of lack of support and understanding by the CRNs. 
The literature review identified that CRNs often felt unsupported by clinical 
colleagues with occasional hostility. Spilsbury et al (2007) had termed this 
“consent but not co-operation” and this quite accurately articulates the themes 
which initially came out in the pilot survey and then across the main survey and 
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which strongly influenced the experience of CRNs within the clinical 
environment. The pilot survey had initially reported that the reality of the day to 
day importance of research differed to the perception and opinion of its overall 
importance. Within the main survey almost three quarters of respondents (n = 
72/102, 70.5%) agreed that research was considered important and relevant 
across the organisation but only a quarter (n = 27/102, 26.5%) agreed that staff 
within the clinical environment felt the same. Comments confirming the link with 
Spilsbury et al’s theme include that “staff will tell you that research is important 
to the organisation but they are not always willing to co-operate” and that it is 
“mentioned in strategy documents but has a low overall priority”. The interviews 
and focus groups illustrated the challenges faced by CRNs working in the 
clinical environment including difficulties faced in identifying dedicated space for 
research and the lengths they often had to go to in order to identify a room to 
see their research patients. Overall they were aware that staff may recognise 
that research is important but with an ever increasing workload at times they 
find it hard to support. 
Spilsbury et al (2007) reported on the strategies that CRNs had developed in 
order to overcome difficulties with their clinical colleagues, including helping out 
in ward areas and involving themselves in clinical care. This was borne out 
within the case studies where CRNs discussed the strategies, referred to as 
“favours and bribes” that they had developed in order to integrate better with 
their clinical colleagues and increase awareness of research. Many CRNs 
realised the benefit they could bring to the clinical areas by taking on aspects of 
patient care which helped to open up lines of dialogue and get the clinical 
nurses “onside”. Those CRNs working within clinical teams had realised that by 
expressing their gratitude to clinical colleagues who helped identify a patient, 
ensured an ongoing relationship so possibly ensuring future support of their 
research; this also helped to raise the understanding around the research 
process and give clarity around the CRN role.  
The literature review highlighted the mechanisms for the establishment of CRN 
roles within organisations and identified the different employment routes and the 
large number of CRNs that had no nursing line management in place. Within 
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this study, the survey explored who currently line manages the CRNs and found 
that in a large number of organisations (n=73/89, 82%) there is CRN 
involvement in the line management of the workforce. However, the survey also 
identified a small number of organisations (n=9/89, 10%) where no nursing line 
management, either research based or clinical, is in place. This was further 
explored in the case studies and found to be an emotive subject that some 
CRNs had very strong feelings about. Although all four case studies did have 
examples of CRN involvement in the line management of the workforce, some 
of the workforce in case study 3 were not line managed by a CRN despite there 
being a Lead CRN in post. Here some CRNs were managed by more senior 
clinical nurses which at times left them feeling “isolated” and separate from the 
remainder of the organisation. This link between poor line management set up 
and isolation was also identified by MacArthur et al (2006) and discussed in the 
literature review. The interviews and focus groups enabled this to be explored in 
a greater depth revealing that for some CRNs knowledge and understanding of 
research from a line manager was more important than an understanding of the 
clinical side of their role, whereas others favoured being line managed by 
clinical nurses as their lack of knowledge concerning research meant that the 
CRNs were “left alone” and “could do what they want”. Across the four case 
studies there was a range of line management arrangements in place which 
demonstrates that there is not currently ‘one size that fits all’.  
The literature review highlighted the poor support that was available for the 
training and development of CRNs. This issue was explored across both 
phases of this study and revealed that support has greatly increased over the 
last decade (certainly since the three workforce reviews were undertaken). The 
aspects of education explored were initial induction programmes, ongoing 
training and support for academic development. Within the survey there was 
overall support for initial training from the majority of respondents, a point 
illustrated by high levels of attendance at induction programmes by CRNs. The 
more mixed picture regarding ongoing training revealed that some respondents 
felt that CRNs were not a priority whilst others thought CRNs had more 
opportunities. Some of this was related to the type of organisation (especially 
evident in the more positive answers given by those from a teaching trust). 
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However, regardless of organisation type, many of the respondents were 
unable to describe the full academic profile of the CRN workforce; this was 
especially true for larger organisations. Within the case studies the Lead CRN 
and their personal attitude to academic development appeared to influence their 
approach to the overall academic support of their workforce. The lower banded 
Lead CRN within Case study 1 focused more on professional development (as 
compared to academic development). The remaining case studies - with a band 
8a or 8b at the helm - had more of a focus towards academic development, a 
point that appears to be related to their own academic achievements. Overall 
the picture across the 4 case studies is inconsistent and appears strongly 
related to internal influences. At times the support appears fragmented; within 
the larger organisations it is more difficult for the Lead CRN to completely 
oversee the full training programme. This had been partly resolved within case 
study 2 with the introduction of a CRN training facilitator post who was able to 
provide dedicated support to the induction and training programmes offered to 
CRNs.  
The data was further explored for what Farmer et al (2006) had termed 
“additional categories of silence” and two further themes emerged related to the 
experience of CRNs. The first of these is the importance of relationships which 
emerged as a strong theme within all the case studies with the occasional 
mention in some of the survey open comments. This theme appeared to relate 
to various aspects of the CRN role including clinical colleagues and patients. 
Across all four focus groups CRNs spoke of the importance of building and 
maintaining relationships, their transient nature if they left an area at the end of 
a study and the benefit of remaining in one area for a prolonged amount of time. 
Lead CRNs referred to the positive impact relationships could have on 
recruitment into studies and also when developing links with senior colleagues. 
One of the Principal Investigators saw it as crucial to all aspects of the research 
and concluded that “we are all to do with relationships”. 
The second emerging theme was the importance of uniforms to CRNs and 
especially how these related to professional identity; not only how they perceive 
themselves as a nurse but their thoughts on how others perceive them. This 
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emerged in Case study 1 and so was explored throughout the remaining case 
study visits. CRNs spoke with passion about the importance they attributed to 
their uniform and there was strong agreement that it was linked to making them 
“feel” like nurses and ensuring they were “embedded in the nurse culture”. They 
felt that patients related to them better with a greater amount of respect and 
allowed them to present a more professional image. Colour was important with 
many advocating dark blue as this was linked with a more senior role (as 
traditionally it is the colour worn by ward sisters across the NHS). Colour was 
also viewed as important by those who wore a dedicated colour and so valued 
the increase in awareness they felt it gave them. 
However, not only was there a lack of consistency across case studies related 
to uniform, in the larger case studies (2 and 3) there was a lack of consistency 
across the CRN workforce as to what was worn. Within case study 3 the options 
included a dedicated uniform, the departmental uniform or one worn by nurse 
specialists. Within case study 2 the CRNs appointed by the university wore no 
uniform due to a lack of funding; this resulted in consternation and frustration for 
this particular team. 
In summary, themes identified within the literature review of isolation, lack of 
support and understanding, line management and role set up, and training and 
development have continued throughout this study although at times the detail 
has altered. Isolation remains but is now more associated with the workforce 
and not individual post holders. However, the role remains misunderstood 
despite a large increase in the workforce. A significant influence on multiple 
aspects of the CRN experience relates to the current environment of a busy 
NHS within which the workforce is based. This appears to be hindering the 
integration of research with clinical care. 
What is the experience of other senior research staff concerning the CRN 
workforce? 
The literature review revealed that this is not an aspect that has previously been 
studied. This research question was therefore included to gain an oversight of 
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how the CRN workforce is viewed but an in-depth description was not 
anticipated as it formed a short part of the overall interview. An insight into how 
other senior research staff view the CRN workforce was obtained from the case 
study interviews undertaken with the PIs and R&D Directors. Senior research 
staff across all case studies spoke highly of the reputation of the CRN 
workforce; much of this was related to the efficiency of how research studies 
were run. The PIs interviewed had been involved in research for between nine 
to 20 years. They had all experienced the changes that had occurred from 
having a dedicated CRN workforce with overall leadership from a Lead CRN. 
Comments included that the service is now “seamless”, “works really well” and 
they now “have everything in place”. However, although they could see the 
benefit of the Lead CRN role, regarding the workforce it was really only the 
benefits of having CRNs working within their clinical area that they could fully 
appreciate. They had all worked with the historical model of CRNs (when 
nurses were appointed by the Consultant and very often line managed by them) 
which pre-dates the establishment of the NIHR. As a result they all now 
appreciated the dedicated support that the CRNs received and seemed relieved 
to no longer have to involve themselves in directly managing them. There was a 
feeling that the CRNs within their area were better supported by the Lead CRN 
and that “having someone with experience makes a big difference”. They could 
also see the patient related benefits and commented that they “get positive 
feedback from patients” and that “the patients love coming up and being in 
studies”. 
The PIs had firm ideas as to how the CRNs should be structured within the 
clinical service. Many of them expressed their reluctance to fully embed their 
CRNs within the clinical nursing team preferring them to remain as “a separate 
team”.  They expressed concerns that “when you mix clinical and research 
activity, clinical activities always take over” and “in the current climate it would 
be a negative move to fully embed them as it would take them away from 
research”. They also discussed the clinical skills that they preferred the CRNs to 
have. Many of them could see the benefit of the CRN working in the relevant 
clinical area prior to moving into a research role. Comments of “she’s a fantastic 
example of a research nurse because she came from the clinic” and “she used 
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to be a clinical nurse so has a good rapport with the team” demonstrate the 
benefit this brings. However, there was also an appreciation of the downside of 
this as they were aware the CRNs then feel “more of a pressure to help out if 
they are short on the ground”. 
The interviews with the R&D Directors (in case study 1 and 4) revealed very 
different attitudes to the CRN workforce, despite them both being within the 
smaller organisations. Within case study 1 there was more of a hands off 
approach with the R&D Director seeming to leave support of the workforce to 
the Lead CRN and only receiving updates when they met. He was not aware of 
details such as how the CRNs were received in the clinical environment and 
had no involvement in education as he felt he could leave the Lead CRN “to 
provide the education that she felt they need in order to fulfil their roles”. In 
contrast with this, the R&D Director in Case study 4 took an active interest in 
the CRN workforce. He explained that when he started in post he made a “strict 
rule that the research nurses work for R&D and not the Consultants”. He had 
led the review of the CRN workforce and favoured a trust-wide Lead CRN. 
However, as this required involvement of the Chief Nurses office and there had 
been a change in post holder, he had set up an interim arrangement of the 
Cancer Lead CRN providing informal support to the CRNs across the 
organisation. He was critical of the clinical matrons and the support he felt they 
should give to CRNs as “in an ideal world clinical matrons should have research 
as part of their role but we don’t live in an ideal world and our matrons just don’t 
have time to care”. He was very supportive of the educational support for CRNs 
and would always try to fund any requests for academic support that he 
received.  
In summary, the CRN workforce appears to be highly respected by senior staff 
working within research. The P.I’s can see the benefit of the dedicated support 
provided by the Lead CRN and the positive impact this has had on running 
research studies. They prefer their CRNs to remain in a role that is dedicated to 
research but can see the benefits of working in the clinical area first in order to 
gain the relevant clinical skills. The view of the R&D Directors differed greatly 
although only 2 such interviews were undertaken.  
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To examine the effect of re-organising the CRN workforce on NIHR 
targets. 
As discussed in the background chapter the NIHR high level objectives include 
to “increase the number of participants recruited into NIHR Portfolio studies” 
and to “increase the proportion of studies in the NIHR portfolio” (NIHR 2015). In 
this study, the effect of reviewing did not make a difference to the number of 
interventional or observational studies or recruitment into observational studies. 
However, it was found to have a statistically significant effect on recruitment into 
interventional studies. As might be expected, larger Trusts and those with more 
CRNs in the workforce did have more studies in progress and more patients 
recruited. However, when just the fifteen organisations who had carried out a 
full review were examined they did appear to have increased the number of 
their interventional and observational studies over a period of five years.  
6.5. General discussion 
This study has presented an overview of the reality of research within the NHS. 
It has identified some key areas concerning the pressures within the NHS which 
impact on research leading to a lack of priority, which is associated with the 
isolation of the CRN workforce and the lack of understanding around the CRN 
role. This illustrates that the influences on research are multi-factorial and so 
need to be globally addressed within an organisation. Within the “Organising for 
Quality framework” the authors’ state that, related to quality improvement, the 
six common challenges identified are “problems which any organisation will 
need to find solutions that will work for them, and if they do not do so will 
ultimately lead to disappointment and failure” (Bate et al 2008:167). In the same 
way for research, this study has identified that these challenges apply to the 
success of the research arena within an organisation and so therefore all need 
to be addressed. The authors also state that within the framework, leadership 
was not given its own category as “it is not a challenge that can be separated 
from the other challenges but is integral to them all” (pg 175). This re-enforces 
the key role of the Lead CRN in supporting the integration of research within 
their organisation. 
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The success of research relies on being able to develop a process that allows it 
to infiltrate within the organisation to enable it to become normal practice. So 
the culture of the organisation needs to allow research to permeate through 
within all levels until it becomes business as usual. Within the “Organising for 
Quality framework” culture involves a shared mind set or ethos. This involves 
recognition and acknowledgement from the top so that all levels of staff 
understand its importance. Within the literature review, it was identified that 
Spilsbury et al (2007:553) had coined the phrase “consent but not co-operation” 
and this was confirmed within this study. A strong research culture is imperative 
to overcome this and integral to this is the Lead CRN role. Development of 
effective links and engagement with key stake holders such as R&D and the 
Chief Nurses office will serve as a channel to allow the flow of research 
awareness and understanding across an organisation. 
Associated with gaining engagement from key stakeholders may involve the 
politics of conflict and opposition in order to agree a common agenda. Again 
this is a further component of the Lead CRN role and in part illustrates the 
rationale for ensuring that the post is structured at a senior level to ensure both 
the experience of the individual and the required authority.  
One of the issues identified within this study is that currently research is not 
seen as a priority within the NHS and this impacts how the CRN workforce is 
perceived. Despite the Health and Social care act (2012) making research a 
core function of the NHS , research is often over looked especially as internal 
and external factors further increase the pressure felt by clinical staff.  
One of the factors identified within this study which has great significance for 
the success of research delivery across the NHS is the issue of isolation. 
Initially identified in the literature review related to how CRNs felt within their 
role, this theme has been further confirmed within this study but presented 
slightly differently. Within this study isolation has been identified as being 
associated with the CRN workforce as a whole. CRNs mainly work within 
research teams and so feel supported by their colleagues. However, the picture 
outside of this is very different and the workforce appears to be isolated from its 
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nursing colleagues.  However, the stipulations within the NIHR funding model 
necessitate a total focus by the CRNs on patient recruitment to ensure delivery 
of NIHR objectives. This reduces the opportunity to develop working links with 
clinically based nurses.   
If this issue of isolation can be overcome, the workforce becomes more visible 
so increasing the awareness of the clinical research agenda. At present it 
appears that for many organisations research is yet to be fully integrated into 
their ethos and culture. People need to feel that research is relevant to their role 
and not an added extra or additional burden as the healthcare environment of 
the NHS is too busy for altruism. The CRN workforce has the potential to be the 
mechanism that can be used to support developing research awareness and 
knowledge to embed a pro-active research culture within an organisation. The 
questionnaire identified thirty-nine clinical areas where CRNs are running 
studies so demonstrating the breadth of research exposure that the workforce 
can bring.  
In considering the success of research to be linked with the six ‘Organising for 
Quality’ challenges used within this study, aspects of culture and education are 
inextricably linked. A change in research culture needs to infiltrate all aspects. 
The CRN workforce primarily supports the medical model for research 
supporting the development of new treatments. However, they are ideally 
placed to facilitate research across their own profession and support nursing 
colleagues to advance the agenda of nursing research. This sharing of skills will 
impact on how nurses view the relevance of research to their own role and 
career. Within education CRNs have the potential to support the advancement 
of clinical academic careers.  
A recent guidance document on clinical academic careers provides 
organisations with advice on how to support its development (AUKUH 2016). It 
refers to identifying existing resources within an organisation including R&D. 
The phase 1 questionnaire in this study identified that 81% (73/90) of 
respondents stated that their CRN workforce are employed through R&D so 
providing a mechanism to sanction this approach. In highlighting the lack of 
 Page 214 
research awareness across many organisations, this study has identified that 
currently the CRN workforce is a lost asset in helping to drive the research 
agenda forward. Support of clinical academic careers within an education 
environment may well be the vehicle which will launch the integration of the 
CRN workforce and increase the understanding concerning their role. Figure 
6.5-1 illustrates the impact of this; increasing research awareness and support 
of clinical academic careers could lead to an increase in nursing research with a 
greater number of experienced nurse researchers who have the potential to 
develop their own research and studies which can become future NIHR portfolio 
studies:  
 
Figure 6.5-1 The research trajectory 
The proposed trajectory above forms the beginning of a potential pathway 
which could be further developed to  help support a change in culture, a shared 
mind set and a move towards research no longer being seen as lacking priority. 
Research Nurses may not all wish to pursue a clinical academic pathway for 
themselves. However, working within a clinical research environment will have 
provided them with valuable transferrable skills which include an understanding 
of research governance requirements, in-depth knowledge of the informed 
consent process and its importance, and practical experience of collecting and 
recording research data. The integration of the research nurse workforce with 
their clinical nursing colleagues would help to ensure a sharing of knowledge 
and understanding concerning the set up and delivery of research within a busy 
healthcare environment, so helping to address gaps in knowledge across this 
wider nursing workforce. Those in the early stages of directing their nursing 
career towards a clinical / academic focus would have an accessible source of 
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can only be of benefit to the wider research arena and so support the 
development of a pro – active research culture which works towards helping to 
diminish some of the earlier highlighted difficulties such as a lack of integration 
and a feeling by some that research is irrelevant within a busy healthcare 
environment. This can help to develop the CRN workforce from its current 
standing as a possible lost asset to one that helps support both the wider 
research agenda and the development of clinical academic careers within the 
profession.  
6.6. Strengths of the study 
A major strength of this study was the mixed methods design. This enabled the 
researcher to carry out a thorough examination of the data in response to the 
research questions.  
The national survey (and excellent response rate) has provided a broad 
understanding of the CRN workforce and the structures within it; prior to this 
there was no national data available which provided an overview of how 
organisations structure and support their CRN workforce.  
The case studies have provided in-depth descriptions related to the reality of 
enabling and supporting research within a busy healthcare system. This will 
provide organisations such as the NIHR with a comprehensive insider 
understanding of running research studies directly from the workforce at the 
heart of this effort. It will also highlight the importance of understanding the 
reality of how healthcare systems and research interact in order to inform future 
strategy.  Without a mixed methods approach a full understanding would not 
have been gained because use of a single method would not have provided the 
in-depth understanding which this study has revealed. 
Prior to this study there was no examination of NIHR recruitment activity related 
to CRN workforce size. As the role of a CRN is focused on supporting the 
successful delivery of research studies, this study provides an important 
overview of the impact this can have. By examining the CRN workforce within 
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the different types of acute trusts, this study had demonstrated the important 
role that acute teaching trusts have in supporting NIHR recruitment.  
A further strength was my role as researcher. As an experienced CRN with in 
excess of 20 years in the role, I have lived through first-hand the development 
of both the role and research infrastructure within which it is based. As a Lead 
CRN within my own organisation I had direct contact with the main phase 1 
study participants. I was therefore able to directly engage with this group in 
order to raise awareness of the survey. Therefore, for many, when the survey 
arrived they were already aware of the study and the importance the results 
would have. This may also have contributed to the very high survey response 
rate of 77% that was achieved.  
6.7. Limitations of the study 
This is the first study which has aimed to examine the national CRN workforce 
and develop recommendations from the findings. However, the survey findings 
only present an overview from a single perspective as the questions were asked 
to the Lead CRN on behalf of the CRN workforce. In small organisations this 
would have been easier to articulate as CRN numbers are lower and so their 
experience of the issues being examined may have been more consistent. 
However, in larger organisations, and as articulated within the responses, the 
experience of some of the CRNs differed greatly across the various research 
teams and clinical areas. Although this is a finding in itself, it may also reduce 
the generalisations that can be made from the overall results of the study. A 
more comprehensive approach would be to conduct a national survey that 
directly approached CRNs within all acute trusts.  
Four case studies were examined within phase 2 of this study. In determining 
selection criteria the researcher aimed to examine a small and large 
organisation within both reviewed and non-reviewed organisations. Case 
studies were selected on the criteria described in chapter 4. For case study 1, 2 
and 3 this was unproblematic and the initially selected site agreed to take part. 
However, the selection of Case study 4 proved more difficult. There was no 
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response from the initial invite despite a confirmation in their survey response 
that they were willing to take part. The second site approached had no Lead 
CRN as the post holder who had completed the survey had recently left the 
organisation. Therefore case study 4 was selected but this was not quite as well 
matched a case to case study 1 as the CRN workforce was slightly larger (25 
nurses as opposed to 15) and the NIHR recruitment total for 2014/2015 was 
slightly larger (6685 participants compared to 1006 participants). When case 
study 4 was visited it transpired that the Lead CRN did not have a formal remit 
for the trust- wide CRN workforce; this had not been apparent within the survey 
responses. 
It was planned to interview the R&D Director at each of the 4 case studies. 
However, this was only achieved in case studies 1 and 4. Despite multiple 
attempts by the Lead CRN in case study 2, it proved not possible to arrange an 
interview. Therefore an interview was held with the R&D Manager. Although this 
included discussion of some relevant points the interview content did not appear 
as rich as those directly obtained from the desired individual within case studies 
1 and 4. Within case study 3 the R&D Director post was vacant and efforts were 
being made to appoint a new post holder. The Lead CRN had initially arranged 
for the researcher to speak with the Deputy Director of R&D. However, on the 
day of data collection, the interview was cancelled and it proved not possible to 
rearrange. An interview was instead carried out with the Head of Research for 
Nursing and Midwifery.  
In planning this study it was hoped that the 2 reviewed organisations would be 
able to provide a report of their review and recommendations in a similar format 
to those unpublished reviews that had been obtained at the commencement of 
this work. However, the review in case study 2 had taken place over 10 years 
ago and in case study 4 there was not one available. Therefore the additional 
information that had been anticipated to provide a greater insight to the 
rationale and process of the review was not available. 
The study included a look into the impact of changes within the information 
technology (IT) systems on the process of running research studies. This had 
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been seen by the researcher as relevant due to a recent national report 
regarding implementation of a system across the NHS of electronic patient 
records. The government had previously published a document laying this out 
with the objective of developing an IT system which can “present the entirety of 
a care pathway as a single virtual electronic record (DOH 2012, pg 9). The 
researcher had seen the beginning of the implementation of this within their own 
organisation and the difficulties it had caused to researchers and CRNs in the 
running of studies. It was therefore hoped to gauge a national picture of this and 
the problems being experienced. However, the study found that in reality many 
organisations were not yet at the stage of implementing such a system and so it 
was not possible to gauge the impact on research studies. As time has now 
passed since the data collection phase of this study it is anticipated that if the 
organisations were contacted now more information related to organisation wide 
IT changes would likely be available.  
The quality and detail of information received from Trusts also varied greatly.  
The information relied on the knowledge and experience of the research lead 
responding.  Further analysis of respondents’ shows that 68% (76/111) were 
identified as a Lead CRN and of these 21.5% (23/107) had been in post 21 
months or less. Whilst this does not suggest a lack of knowledge, it may in 
some instances limit the detailed insight of the respondent regarding the 
development of the workforce over time.      
6.7.1. Implications for the national CRN workforce 
This study has offered a valuable insight into a growing workforce within the 
nursing profession and the reality of running research studies within a busy 
healthcare environment. It has demonstrated that where the workforce is well 
supported with formal links into stakeholders such as R&D and the Chief 
Nurses office, there is a positive impact which appears to facilitate a greater 
understanding and awareness of research. On the basis of the study findings a 
recommended model (see Figure 6.7-1) is proposed that will allow an 
organisation to put in place a structure that will provide oversight and support of 
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the CRN workforce and help to create a research culture that will raise the 
profile and understanding across all clinical areas.   
The study has identified the importance and value of an identified and senior 
research nurse who has oversight and responsibility of the CRN workforce. 
Central to this model and a specific recommendation from this study is the 
importance of a Lead CRN role to take oversight and responsibility of the CRN 
workforce and its role to ensure delivery of NIHR objectives and the research 
agenda of the organisation. Attention should also be paid to the banding level of 
this post as this study has given an insight into the importance of ensuring that 
the Lead CRN has the authority and autonomy to influence the CRN workforce 
and make recommendations for its development. Findings would suggest that 
this post should be placed within the band 8 bracket of the Agenda for Change 
structure. This is important as within the clinical nursing structure, posts at this 
level are often a Matron or Lead Nurse with oversight of a clinical service; it is 
important that within research there is an equivalent structure to ensure parity.  
When considering the role requirements it is important to ensure that the Lead 
CRN in experienced within the arena of research and clinical trials and has an 
understanding of the national research infrastructure and governance 
requirements. Other aspects of their experience should include previous 
oversight of research teams which would have facilitated the development of 
their management and leadership skills. An interest in academic development 
and a personal drive to progress their studies up to PhD level will ensure an 
informed oversight of the educational responsibilities within this role. Funding to 
support further academic study is limited and bodies such as Health Education 
England are seeing a reduction in the amount of funding they can provide. An 
acknowledgement that this may impact on the financial support available to a 
Lead CRN is required. However, previous experience of the Lead CRN should 
enable post holders to provide robust support for the educational component of 
their role. 
Figure 6.7-1 (Over page) Recommended CRN Workforce model 
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LEAD CRN POST 
Band 8 level – exact banding 
depends on size of workforce 
ROLE STRUCTURE 
(STRUCTURE) 
1) Oversight of trust wide CRN workforce 
(cancer and non cancer) 
2) Responsible for strategic oversight and 
direction of workforce. 
3) Involvement with trust wide polices/ SOP s 
for running of research studies. 
4) Responsibilities include autonomy to 
develop the vision, ideas and strategies for 
the benefit of the CRN workforce. 




1) Formal links with Chief Nurse’s office. 
2) Formal links with R&D Director. 
3) Line management structure of the Lead 
CRN post to incorporate senior nurse 
and R&D involvement with joint 
appraisals. 




1) Formal oversight of education support 
of CRN workforce. 
2) Access and awareness of external 
funding sources and personal budget to 
support education of workforce. 
3) Links into local higher education 
institutions. 
4) Links into organisation wide education 
and training. 
5) Consider development of Educator role 
if larger CRN workforce size  
 
CLINICAL NURSING LINKS 
(CULTURE / EMOTIONAL) 
1) Attendance at trust wide senior nursing 
meetings to ensure CRN workforce 
remains in line with nursing and trust 
processes. 
2) Links with clinical nurses of an equal 
level to provide peer support and 
professional discussion of workforce 
issues.  
3) Ensure  continual, interactive dialogue 
between research & clinical nurses 
 
ROLE REQUIREMENTS 
1) Experienced in CRN role 
2) Masters qualified (ideally MRes) with 
personal interest in academic 
development ideally with plans to 
pursue PhD. 
3) Proven track record of clinical 
leadership. 
4) In-depth understanding of national 




1) Lead on projects to raise awareness of 
research across the organisation: for 
example teaching sessions. 
2) Involvement and engagement with trust wide 
initiatives 
ORGANISATION INFRASTRUCTURE 
(TECHNOLOGY & INFRASTRUCTURE) 
1)  Ensure CRN workforce and research linked in 
with trust wide initiatives. e.g I.T changes 
RESEARCH DELIVERY 
(POLITICS) 
1) To ensure that NIHR portfolio studies 
have the appropriate CRN support to 
ensure delivery of NIHR recruitment 
objectives. 
2) Support oversight & monitoring of 
NIHR recruitment targets 
REPORTING LINES TO LEAD CRN 
(STRUCTURE) 
1) Support structure in place to support CRN 
workforce. Level depends on size of 
workforce and banding of Lead CRN. 
2) Structured management format across all 
bands of CRNs to ensure that Lead CRN 
has oversight & awareness of workforce. 
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Responsibilities within this role are multi-factorial and, if structured 
appropriately, will ensure a well-supported workforce and the successful 
delivery of research. The role needs to incorporate leadership, influence, 
autonomy, research delivery and a passage way into associated areas such as 
clinical nursing, R&D and the senior nurse infrastructure. In case study 2 the 
Lead CRN referred to ‘tentacles’ into the normal clinical infrastructure in order to 
facilitate integration. The Lead CRN must be able to understand the set-up of 
nursing across the organisation in order to ensure that the presence of research 
within clinical areas occurs in a seamless fashion; any difficulties can then be 
identified early and quickly resolved. The suggested model includes two-way 
arrows for reporting lines and clinical nursing links. Just as important as 
communication spreading out from research is ensuring the feedback and 
inclusion of research with developments and updates across the organisation. 
Therefore the Lead CRN must ensure integration with peer colleagues and 
seniors to ensure inclusion with organisational priorities and updates regarding 
the national healthcare agendas. This may include awareness of national 
healthcare regulators such as the Care Quality Commission and national 
nursing updates such as the recent changes with the Nursing and Midwifery 
council (NMC) revalidation. The flow of information is also important between 
the Lead CRN and the workforce. The size will dictate the exact structure of 
how the teams and leadership roles are structured. However, the lead CRN 
must ensure links into this to ensure her own awareness and oversight of the 
entire CRN workforce. 
In summary, this model suggests the development of a structure facilitated by a 
central leadership role which will act as the conduit to both the CRN workforce 
and the wider nursing and R&D arena whilst ensuring a two-way direction of 
flow for communication, education and oversight. Implications for research 
delivery 
This study highlighted that clinical nurses “lack insight into the true nature of the 
CRN role” with resulting confusion and lack of understanding. It is imperative 
that CRNs increase their visibility and spend more time in the clinical 
environment. The increase in non-nursing roles provides CRNs with an 
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opportunity to delegate much of their non-clinical activities to these post holders 
in order to concentrate more on patient centred activities. This will facilitate a 
greater presence within the clinical environment so further raising awareness of 
research and the CRN role.  
This study examined whether restructuring would have a positive impact on 
patient recruitment and portfolio size; this was not demonstrated in the 
statistical analysis.  A closer inspection of those organisations that had 
restructured revealed that there was great variation in the amount of 
restructuring undertaken with some only making minimal changes to banding or 
allocation of staff. Of the 59 Trusts who had undertaken some form of 
restructuring, 25% (15/59) confirmed that a comprehensive restructuring had 
taken place. From these there was a positive increase in interventional and 
observational studies within a six year time period.  However, the size of the 
CRN workforce is only known for the year 2014/15 making meaningful 
comparison unreliable as CRN numbers are known to be linked to recruitment 
of patients.  Given the importance of Trust size and CRN workforce numbers 
any future study will need to ensure this data is captured for the periods being 
compared. Variations in the degree of trust restructuring are also an important 
potential confounding factor and clear criteria should be used when making 
future comparisons in performance.   
6.7.2. Recommendations for further research 
This is the first study to examine the national CRN workforce and to explore 
first-hand the experience of CRNs and their role in supporting clinical research 
within a busy healthcare system. Previous studies have reported on local CRN 
workforces but no study has attempted to describe the national workforce. A 
future study which approached more than one individual within the R&D 
department to obtain the information or was able to carry out interviews with the 
identified individual may elicit more in-depth data. In addition 23% (n = 33/111) 
organisations did not complete the survey and all organisations in Wales and 
Northern Ireland were not approached. For a full UK picture these omissions 
should be rectified.  
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The study identified an emerging non-nursing workforce within research. This 
appears to be comprised of numerous roles although - due to the reactive 
nature of their development - there will undoubtedly be some cross over in their 
responsibilities. This workforce will have a large impact on the set up and 
responsibilities of the CRN role and workforce going forward; a national study to 
review its size and remit is indicated in order to further progress the running of 
research studies within the NHS.   
A case study design has been used within four organisations which comprised a 
medium, large and two teaching trusts. It would also be of interest and 
relevance to explore the CRN workforce within small and specialist trusts and 
more generally in a larger number of each of the five trust types. Now that a 
suitable and relevant framework has been established for data collection the 
case study component of this study could be repeated in a larger number of 
organisations to gain a more in-depth analysis of structure and CRN 
experience. 
6.8. Personal reflection 
Planning and conducting of this study provided me with the opportunity to carry 
out an extended piece of work within an area that I have based my career. I 
have seen the development of the CRN role, the growth in the workforce and 
experienced the opportunity to develop within a clinical and academic 
environment so acquiring skills and experience within this field. Therefore this 
study provided me with the opportunity to use these skills and in-depth 
knowledge to personally explore how the national CRN workforce has evolved 
following a decade of increased funding from the NIHR and an increase in 
research governance requirements. Through my current role, as Lead CRN in a 
large teaching trust, and previous roles I have seen and been involved in some 
examples of growth and development within organisations. However, it was a 
privilege to have the opportunity to personally explore and gain oversight of the 
national picture. 
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My in-depth knowledge of the area and being part of the workforce I was due to 
study, gave me easy access to my target population and so to commence my 
initial survey. My successful 77% response rate was, I am sure, in part due to 
my pre-existing involvement with the workforce I was studying. I had been able 
to raise awareness of my planned work with some of my intended respondents 
in the months prior to the survey being circulated. However, at the 
commencement of my survey planning I still had a large number of 
organisations where I needed to either identify the Lead CRN or other post 
holder responsible for the CRN workforce.  Therefore, many respondents did 
not have prior knowledge of the survey prior to my initial contact with them.  
Within phase 2 of this study I was reliant on the support of the Lead CRN at 
each organisation to help organise the required interviews and focus groups. I 
am therefore immensely grateful for their support and assistance with the 
planning of my visits to their organisation and am well aware that the success of 
this phase of the study was in part due to their support. The organisations to be 
studied were based on pre-defined criteria. Once identified it was apparent that 
I had previously met 2 of the 4 Lead CRNs. However, although this may have 
influenced their decision to support the study there was no difference in my 
experience at each of the sites on the day of data collection. 
Overall, my experience in clinical research and my current role meant that I was 
ideally placed and skilled to carry out this study. The end result has provided an 
initial overview of the CRN workforce alongside first hand personal accounts 
from those in a CRN role. Moving forward this work can provide the foundations 
for ongoing studies which can provide further insight into clinical research and 
the associated workforce.  
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6.9. Summary 
This chapter has aimed to interpret the findings of this study. It has identified the 
importance of the Lead CRN to oversee the CRN workforce. A workforce model 
has been presented as a way to ensure a well-supported and integrated CRN 
workforce which will enable an increased understanding and awareness of 
research. The strength and limitations have been reviewed together with some 
recommendations for practice and possible future research areas have been 
suggested. The concluding chapter will provide some final reflections on the 
future of research and the CRN workforce. 
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Chapter 7: Conclusion 
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7.1. Overview of findings 
As this study has progressed, it has examined various aspects of the CRN role 
and workforce to provide both a national overview and local case studies. 
Operating within a busy and pressurised healthcare system the workforce and 
the research agenda which it aims to promote and deliver on is isolated and 
currently lacks priority and wider understanding.  
There is a dearth of literature relating to the structure, effectiveness and 
experience of the CRN workforce in the UK. This thesis has attempted to 
address this gap in knowledge by undertaking a mixed methods study utilizing a 
survey of CRN workforces across England and a detailed case study of 4 
Trusts. It has used NIHR data in an attempt to understand the impact of 
conducting a CRN workforce review on the number of studies run and 
recruitment. 
The wide variation in the structure of the CRN workforce and its leadership has 
provided insight into both high performing and sub-optimal structures. This 
insight has allowed an exemplar CRN workforce model to be developed, 
providing a template for Trusts to work towards.   
Key findings from the study suggest that effective leadership and a pro-research 
culture are at the heart of successful CRN teams. Effective leaders need 
sufficient seniority to effect change, influence senior management and provide a 
credible presence at grass roots.  These leaders must be role models, 
demonstrating effective behaviors and with appropriate academic preparation to 
support a developing workforce.   
7.2. Research agenda moving forward 
Overall, the implications of this study are two-fold. They have highlighted some 
important findings regarding the structure of the CRN workforce and the 
experience of the CRNs within it and this has facilitated some 
recommendations. However, of equal importance are the implications of this 
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study to the research agenda moving forward. Development of well-structured 
CRN teams led by a strong leader with structured links into key stakeholders 
that enables integration, understanding and a progressive research culture is 
vital if some of the contemporary difficulties identified within this study are to be 
addressed. This will help support the integration of the CRN workforce and raise 
the profile of the research agenda, so supporting ongoing evidence based 
patient care and treatments. 
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